<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Kidney stone disease</title><meta name="description" content="Kidney stone disease (known as nephrolithiasis , renal calculus disease or urolithiasis) is a crystallopathy and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper urinary tract.[2] Because renal calculi typically form in the kidney, if small enough, they are able to leave the urinary tract via the urine stream.[2] A small calculus may pass..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="Kidney stones, Nephrolithiasis, Renal calculi, Urolithiasis"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Kidney_stone_disease"/><meta property="og:title" content="Kidney stone disease"/><meta property="og:description" content="Kidney stone disease (known as nephrolithiasis , renal calculus disease or urolithiasis) is a crystallopathy and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper urinary tract.[2] Because renal calculi typically form in the kidney, if small enough, they are able to leave the urinary tract via the urine stream.[2] A small calculus may pass..."/><meta property="og:url" content="https://grokipedia.com/page/Kidney_stone_disease"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Kidney stone disease"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.399Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Kidney stone disease"/><meta name="twitter:description" content="Kidney stone disease (known as nephrolithiasis , renal calculus disease or urolithiasis) is a crystallopathy and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper urinary tract.[2] Because renal calculi typically form in the kidney, if small enough, they are able to leave the urinary tract via the urine stream.[2] A small calculus may pass..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="2aa7c54337574351cd7445a1e0c22035-b82538e5aa734a1a-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=2aa7c54337574351cd7445a1e0c22035,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.24112678321409442,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#kidney-stone-disease" class="transition-opacity hover:opacity-100 opacity-50">Kidney stone disease</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#signs-and-symptoms" class="transition-opacity hover:opacity-100 opacity-50">Signs and symptoms</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#risk-factors" class="transition-opacity hover:opacity-100 opacity-50">Risk factors</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#calcium-oxalate" class="transition-opacity hover:opacity-100 opacity-50">Calcium oxalate</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#other-electrolytes" class="transition-opacity hover:opacity-100 opacity-50">Other electrolytes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#animal-protein" class="transition-opacity hover:opacity-100 opacity-50">Animal protein</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#vitamins" class="transition-opacity hover:opacity-100 opacity-50">Vitamins</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pathophysiology" class="transition-opacity hover:opacity-100 opacity-50">Pathophysiology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#supersaturation-of-urine" class="transition-opacity hover:opacity-100 opacity-50">Supersaturation of urine</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#randalls-plaque" class="transition-opacity hover:opacity-100 opacity-50">Randall&#x27;s plaque</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pathogenic-bacteria" class="transition-opacity hover:opacity-100 opacity-50">Pathogenic bacteria</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#inhibitors-of-stone-formation" class="transition-opacity hover:opacity-100 opacity-50">Inhibitors of stone formation</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#hypocitraturia" class="transition-opacity hover:opacity-100 opacity-50">Hypocitraturia</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnosis" class="transition-opacity hover:opacity-100 opacity-50">Diagnosis</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#imaging-studies" class="transition-opacity hover:opacity-100 opacity-50">Imaging studies</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#laboratory-examination" class="transition-opacity hover:opacity-100 opacity-50">Laboratory examination</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#composition" class="transition-opacity hover:opacity-100 opacity-50">Composition</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#calcium-containing-stones" class="transition-opacity hover:opacity-100 opacity-50">Calcium-containing stones</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#struvite-stones" class="transition-opacity hover:opacity-100 opacity-50">Struvite stones</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#uric-acid-stones" class="transition-opacity hover:opacity-100 opacity-50">Uric acid stones</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#other-types" class="transition-opacity hover:opacity-100 opacity-50">Other types</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#location" class="transition-opacity hover:opacity-100 opacity-50">Location</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#size" class="transition-opacity hover:opacity-100 opacity-50">Size</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#prevention" class="transition-opacity hover:opacity-100 opacity-50">Prevention</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#dietary-measures" class="transition-opacity hover:opacity-100 opacity-50">Dietary measures</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#urine-alkalinization" class="transition-opacity hover:opacity-100 opacity-50">Urine alkalinization</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diuretics" class="transition-opacity hover:opacity-100 opacity-50">Diuretics</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#allopurinol" class="transition-opacity hover:opacity-100 opacity-50">Allopurinol</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#treatment" class="transition-opacity hover:opacity-100 opacity-50">Treatment</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pain-management" class="transition-opacity hover:opacity-100 opacity-50">Pain management</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#medical-expulsive-therapy" class="transition-opacity hover:opacity-100 opacity-50">Medical expulsive therapy</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#lithotripsy" class="transition-opacity hover:opacity-100 opacity-50">Lithotripsy</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#surgery" class="transition-opacity hover:opacity-100 opacity-50">Surgery</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#ureteroscopic-surgery" class="transition-opacity hover:opacity-100 opacity-50">Ureteroscopic surgery</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#epidemiology" class="transition-opacity hover:opacity-100 opacity-50">Epidemiology</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#kidney-stones" class="transition-opacity hover:opacity-100 opacity-50">Kidney Stones</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#history" class="transition-opacity hover:opacity-100 opacity-50">History</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#etymology" class="transition-opacity hover:opacity-100 opacity-50">Etymology</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#children" class="transition-opacity hover:opacity-100 opacity-50">Children</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#research" class="transition-opacity hover:opacity-100 opacity-50">Research</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#gut-microbiota" class="transition-opacity hover:opacity-100 opacity-50">Gut microbiota</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#in-other-animals" class="transition-opacity hover:opacity-100 opacity-50">In other animals</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="kidney-stone-disease" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Kidney stone disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>

















































<!-- -->
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Kidney stone disease</strong> (known as <strong>nephrolithiasis</strong> , <strong>renal calculus disease</strong> or <strong>urolithiasis</strong>) is a <span class="inline text-[1em] leading-7">crystallopathy</span> and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper <span class="inline text-[1em] leading-7">urinary tract</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1k1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Because renal calculi typically form in the <span class="inline text-[1em] leading-7">kidney</span>, if small enough, they are able to leave the urinary tract via the urine stream.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_241abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> A small calculus may pass without causing <span class="inline text-[1em] leading-7">symptoms</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2k1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> However, if a stone grows to more than 5 millimeters (0.2 inches), it can cause a blockage of the <span class="inline text-[1em] leading-7">ureter</span>, resulting in extremely sharp and severe pain (<span class="inline text-[1em] leading-7">renal colic</span>) in the lower back that often radiates downward to the groin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3c1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3g1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> A calculus may also result in <span class="inline text-[1em] leading-7">blood in the urine</span>, vomiting (due to severe pain), <span class="inline text-[1em] leading-7">swelling of the kidney</span>, or <span class="inline text-[1em] leading-7">painful urination</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4g1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> About half of all people who have had a kidney stone are likely to develop another within ten years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4o1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><em>Renal</em> is Latin for &quot;kidney&quot;, while <em>nephro</em> is the Greek equivalent. <em>Lithiasis</em> (Gr.) and <em>calculus</em> (Lat.- pl. calculi) both mean stone.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Most calculi form by a combination of <span class="inline text-[1em] leading-7">genetics</span> and environmental factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Risk factors include <span class="inline text-[1em] leading-7">high urine calcium levels</span>, <span class="inline text-[1em] leading-7">obesity</span>, certain foods, some medications, <span class="inline text-[1em] leading-7">calcium supplements</span>, <span class="inline text-[1em] leading-7">gout</span>, <span class="inline text-[1em] leading-7">hyperparathyroidism</span> and not drinking enough fluids.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_202abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_242abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> Calculi form in the kidney when <span class="inline text-[1em] leading-7">minerals</span> in <span class="inline text-[1em] leading-7">urine</span> are at high concentrations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2s2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> The <span class="inline text-[1em] leading-7">diagnosis</span> is usually based on symptoms, <span class="inline text-[1em] leading-7">urine testing</span>, and <span class="inline text-[1em] leading-7">medical imaging</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3s2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> <span class="inline text-[1em] leading-7">Blood tests</span> may also be useful.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4c2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Calculi are typically classified by their location, being referred to medically as nephrolithiasis (in the kidney), <span class="inline text-[1em] leading-7">ureterolithiasis</span> (in the <span class="inline text-[1em] leading-7">ureter</span>), or <span class="inline text-[1em] leading-7">cystolithiasis</span> (in the <span class="inline text-[1em] leading-7">bladder</span>). Calculi are also classified by <span class="inline text-[1em] leading-7">what they are made of</span>, such as from <span class="inline text-[1em] leading-7">calcium oxalate</span>, <span class="inline text-[1em] leading-7">uric acid</span>, <span class="inline text-[1em] leading-7">struvite</span>, or <span class="inline text-[1em] leading-7">cystine</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6s2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In those who have had renal calculi, drinking fluids, especially water, is a way to prevent them. Drinking fluids such that more than two liters of urine are produced per day is recommended.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> If fluid intake alone is not effective to prevent renal calculi, the medications <span class="inline text-[1em] leading-7">thiazide diuretic</span>, <span class="inline text-[1em] leading-7">citrate</span>, or <span class="inline text-[1em] leading-7">allopurinol</span> may be suggested.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_182qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Soft drinks containing <span class="inline text-[1em] leading-7">phosphoric acid</span> (typically <span class="inline text-[1em] leading-7">colas</span>) should be avoided.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_202qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> When a calculus causes no symptoms, <span class="inline text-[1em] leading-7">no treatment</span> is needed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2g2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> For those with symptoms, <span class="inline text-[1em] leading-7">pain control</span> is usually the first measure, using medications such as <span class="inline text-[1em] leading-7">nonsteroidal anti-inflammatory drugs</span> or <span class="inline text-[1em] leading-7">opioids</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3g2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3k2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> Larger calculi may be helped to pass with the medication <span class="inline text-[1em] leading-7">tamsulosin</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_442qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> or may require procedures for removal such as <span class="inline text-[1em] leading-7">extracorporeal shockwave therapy</span> (ESWT), <span class="inline text-[1em] leading-7">laser lithotripsy</span> (LL), or a <span class="inline text-[1em] leading-7">percutaneous nephrolithotomy</span> (PCNL).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_542qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Renal calculi have affected humans throughout history with a description of surgery to remove them dating from as early as 600 BC in ancient India by <span class="inline text-[1em] leading-7">Sushruta</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Between 1% and 15% of people globally are affected by renal calculi at some point in their lives.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_s3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> In 2019, approximately 115 million incident cases occurred, resulting in about 13,300 deaths.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_143abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> They have become more common in the <span class="inline text-[1em] leading-7">Western world</span> since the 1970s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1k3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1o3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Generally, more men are affected than women.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_203abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_243abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> The prevalence and incidence of the disease rises worldwide and continues to be challenging for patients, physicians, and healthcare systems alike. In this context, epidemiological studies are striving to elucidate the worldwide changes in the patterns and the burden of the disease and identify modifiable risk factors that contribute to the development of renal calculi.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2c3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<h2 id="signs-and-symptoms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Signs and symptoms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The hallmark of a stone that obstructs the ureter or renal pelvis is excruciating, intermittent pain that radiates from the flank to the groin or to the inner thigh.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> This is due to the transfer of referred pain signals from the lower thoracic splanchnic nerves to the lumbar splanchnic nerves as the stone passes down from the kidney or proximal ureter to the distal ureter. This pain, known as <span class="inline text-[1em] leading-7">renal colic</span>, is often described as one of the strongest pain sensations known.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Renal colic caused by kidney stones is commonly accompanied by <span class="inline text-[1em] leading-7">urinary urgency</span>, restlessness, frequent urination, <span class="inline text-[1em] leading-7">blood in the urine</span>, sweating, <span class="inline text-[1em] leading-7">nausea</span>, and <span class="inline text-[1em] leading-7">vomiting</span>. It typically comes in waves lasting 20 to 60 minutes caused by <span class="inline text-[1em] leading-7">peristaltic</span> contractions of the ureter as it attempts to expel the stone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_284abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The <span class="inline text-[1em] leading-7">embryological</span> link between the urinary tract, the <span class="inline text-[1em] leading-7">genital system</span>, and the <span class="inline text-[1em] leading-7">gastrointestinal tract</span> is the basis of the radiation of pain to the <span class="inline text-[1em] leading-7">gonads</span>, as well as the nausea and vomiting that are also common in urolithiasis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_184qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> <span class="inline text-[1em] leading-7">Postrenal azotemia</span> and hydronephrosis can be observed following the obstruction of urine flow through one or both ureters.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1o4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pain in the lower-left quadrant can sometimes be confused with <span class="inline text-[1em] leading-7">diverticulitis</span> because the <span class="inline text-[1em] leading-7">sigmoid colon</span> overlaps the ureter, and the exact location of the pain may be difficult to isolate due to the proximity of these two structures.</span>
<h1 id="risk-factors" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Risk factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Dehydration</span> from low fluid intake is a factor in stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Individuals living in warm climates are at higher risk due to increased fluid loss.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Obesity, immobility, and sedentary lifestyles are other leading risk factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_106abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Type 2 diabetes is associated with increased risk due to altered urinary chemistry, including reduced citrate excretion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_186abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">High dietary intake of animal <span class="inline text-[1em] leading-7">protein</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> <span class="inline text-[1em] leading-7">sodium</span>, sugars including honey, refined <span class="inline text-[1em] leading-7">sugars</span>, <span class="inline text-[1em] leading-7">fructose</span> and <span class="inline text-[1em] leading-7">high fructose corn syrup</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1o6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> and excessive consumption of fruit juices may increase the risk of kidney stone formation due to increased <span class="inline text-[1em] leading-7">uric acid</span> excretion and elevated <span class="inline text-[1em] leading-7">urinary oxalate</span> levels (whereas tea, coffee, wine and beer may decrease the risk).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2g6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2k6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Kidney stones can result from an underlying metabolic condition, such as <span class="inline text-[1em] leading-7">distal renal tubular acidosis</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> <span class="inline text-[1em] leading-7">Dent&#x27;s disease</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_107abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup> <span class="inline text-[1em] leading-7">hyperparathyroidism</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1g7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> primary <span class="inline text-[1em] leading-7">hyperoxaluria</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_207abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> or <span class="inline text-[1em] leading-7">medullary sponge kidney</span>. 3â€“20% of people who form kidney stones have medullary sponge kidney.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2k7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Kidney stones are more common in people with <span class="inline text-[1em] leading-7">Crohn&#x27;s disease</span>;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> Crohn&#x27;s disease is associated with <span class="inline text-[1em] leading-7">hyperoxaluria</span> and malabsorption of magnesium.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_107qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A person with recurrent kidney stones may be screened for such disorders. This is typically done with a 24-hour urine collection. The urine is analyzed for features that promote stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<h3 id="calcium-oxalate" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Calcium oxalate<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Calcium is one component of the most common type of human kidney stones, <span class="inline text-[1em] leading-7">calcium oxalate</span>. Some studies suggest that people who take calcium or <span class="inline text-[1em] leading-7">vitamin D</span> as a <span class="inline text-[1em] leading-7">dietary supplement</span> have a higher risk of developing kidney stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_149abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> In the <span class="inline text-[1em] leading-7">United States</span>, kidney stone formation was used as an indicator of excess calcium intake by the <span class="inline text-[1em] leading-7">Reference Daily Intake</span> committee for calcium in adults.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In the early 1990s, a study conducted for the <span class="inline text-[1em] leading-7">Women&#x27;s Health Initiative</span> in the US found that postmenopausal women who consumed 1000 mg of supplemental calcium and 400 <span class="inline text-[1em] leading-7">international units</span> of <span class="inline text-[1em] leading-7">vitamin D</span> per day for seven years had a 17% higher risk of developing kidney stones than subjects taking a <span class="inline text-[1em] leading-7">placebo</span>.<!-- --> The <span class="inline text-[1em] leading-7">Nurses&#x27; Health Study</span> also showed an association between supplemental calcium intake and kidney stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1o9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Unlike supplemental calcium, high intakes of dietary calcium do not appear to cause kidney stones and may actually protect against their development.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> This is perhaps related to the role of calcium in binding ingested oxalate in the gastrointestinal tract. As the amount of calcium intake decreases, the amount of oxalate available for absorption into the bloodstream increases; this oxalate is then excreted in greater amounts into the urine by the kidneys. In the urine, oxalate is a very strong promoter of calcium oxalate precipitationâ€”about 15 times stronger than calcium.</span>
<span class="mb-4 block break-words text-[1em] leading-7">A 2004 study found that diets low in calcium are associated with a higher overall risk for kidney stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup> For most individuals, other risk factors for kidney stones, such as high intakes of dietary oxalates and low fluid intake, play a greater role than calcium intake.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span>
<h3 id="other-electrolytes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Other electrolytes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Calcium is not the only <span class="inline text-[1em] leading-7">electrolyte</span> that influences the formation of kidney stones. For example, by increasing urinary calcium excretion, high dietary sodium may increase the risk of stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Drinking <span class="inline text-[1em] leading-7">fluoridated tap water</span> may increase the risk of kidney stone formation by a similar mechanism, though further epidemiologic studies are warranted to determine whether fluoride in drinking water is associated with an increased incidence of kidney stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup> High dietary intake of <span class="inline text-[1em] leading-7">potassium</span> appears to reduce the risk of stone formation because potassium promotes the urinary excretion of <span class="inline text-[1em] leading-7">citrate</span>, an inhibitor of calcium crystal formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Kidney stones are more likely to develop, and to grow larger, if a person has low <span class="inline text-[1em] leading-7">dietary magnesium</span>. Magnesium inhibits stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></span>
<h3 id="animal-protein" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Animal protein<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Diets in Western nations</span> typically contain a large proportion of <span class="inline text-[1em] leading-7">animal protein</span>. Eating animal protein creates an acid load that increases urinary excretion of calcium and uric acid and reduced citrate. Urinary excretion of excess sulfurous <span class="inline text-[1em] leading-7">amino acids</span> (e.g., <span class="inline text-[1em] leading-7">cysteine</span> and <span class="inline text-[1em] leading-7">methionine</span>), uric acid, and other acidic <span class="inline text-[1em] leading-7">metabolites</span> from animal protein acidifies the urine, which promotes the formation of kidney stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1kdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> Low urinary-citrate excretion is also commonly found in those with a high dietary intake of animal protein, whereas vegetarians tend to have higher levels of citrate excretion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1sdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> Low urinary citrate, too, promotes stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_24dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup></span>
<h3 id="vitamins" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Vitamins<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The evidence linking <span class="inline text-[1em] leading-7">vitamin C</span> supplements with an increased rate of kidney stones is inconclusive.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_geqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_keqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> The excess dietary intake of vitamin C might increase the risk of calcium-oxalate stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_seqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> The link between vitamin D intake and kidney stones is also tenuous.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Excessive vitamin D supplementation may increase the risk of stone formation by increasing the intestinal absorption of calcium; correction of a deficiency does not.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<h1 id="pathophysiology" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Pathophysiology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Small crystals formed in the kidney. The most common crystals are made of calcium oxalate and initial stone aggregates are generally 4â€“5 mm. Staghorn kidney stones are considerably larger.</span>
<ol class="marker:text-primary my-4 ml-6 list-decimal space-y-2 text-[1em]">
<li class="text-[1em]">Calcium and oxalate come together to make the crystal nucleus. Supersaturation promotes their combination (as does inhibition.)</li>
<li class="text-[1em]">Continued deposition at the renal papillae leads to the growth of the kidney stones.</li>
<li class="text-[1em]">Kidney stones grow and collect debris. In the case where the kidney stones block all routes to the renal papillae, this can cause extreme discomfort and pain.</li>
<li class="text-[1em]">The complete staghorn stone forms and retention occurs. Smaller solids that break off can become trapped in the urinary glands causing discomfort.</li>
<li class="text-[1em]">Displaced stones travel through the ureter. If they cannot be broken down, they must be physically removed by a surgeon.</li>
</ol>
<h3 id="supersaturation-of-urine" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Supersaturation of urine<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Kidney stones are primarily composed of calcium salts, with 60-80% being calcium oxalate, calcium phosphate, or both; calcium oxalate is the most common, followed by calcium phosphate and uric acid.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The formation of kidney stones occurs in three main phases:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup></span>
<ol class="marker:text-primary my-4 ml-6 list-decimal space-y-2 text-[1em]">
<li class="text-[1em]"><span class="inline text-[1em] leading-7">nucleation</span> (initial crystal formation)</li>
<li class="text-[1em]">growth (expansion of single crystals)</li>
<li class="text-[1em]">aggregation (clumping together of multiple crystals)<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2oiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup></li>
</ol>
<span class="mb-4 block break-words text-[1em] leading-7">When the urine becomes <span class="inline text-[1em] leading-7">supersaturated</span> (when the urine <span class="inline text-[1em] leading-7">solvent</span> contains more <span class="inline text-[1em] leading-7">solutes</span> than it can hold in <span class="inline text-[1em] leading-7">solution</span>) with one or more calculogenic (crystal-forming) substances, initial <span class="inline text-[1em] leading-7">seed crystals</span> may form through the process of <span class="inline text-[1em] leading-7">nucleation</span>.<!-- --> Heterogeneous nucleation (where there is a solid surface present on which a crystal can grow) proceeds more rapidly than homogeneous nucleation (where a crystal must grow in a liquid medium with no such surface), because it requires less energy. Adhering to cells on the surface of a <span class="inline text-[1em] leading-7">renal papilla</span>, a seed crystal can grow and aggregate into an organized mass. Depending on the chemical composition of the crystal, the stone-forming process may proceed more rapidly when the urine pH is unusually high or low.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Supersaturation of the urine with respect to a calculogenic compound is pH-dependent. For example, at a pH of 7.0, the solubility of uric acid in urine is 158 mg/100 mL. Reducing the pH to 5.0 decreases the <span class="inline text-[1em] leading-7">solubility</span> of <span class="inline text-[1em] leading-7">uric acid</span> to less than 8 mg/100 mL. The formation of uric-acid stones requires a combination of <span class="inline text-[1em] leading-7">hyperuricosuria</span> (high urine uric-acid levels) and low urine pH; hyperuricosuria alone is not associated with uric-acid stone formation if the urine pH is alkaline.<!-- --> Supersaturation of the urine is a necessary, but not a sufficient, condition for the development of any urinary calculus.<!-- --> Supersaturation is likely the underlying cause of uric acid and <span class="inline text-[1em] leading-7">cystine</span> stones, but calcium-based stones (especially <span class="inline text-[1em] leading-7">calcium oxalate</span> stones) may have a more complex cause.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_20jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup></span>
<h3 id="randalls-plaque" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Randall&#x27;s plaque<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">While supersaturation of urine may lead to <span class="inline text-[1em] leading-7">crystalluria</span>, it does not necessarily promote the formation of a kidney stone because the particle may not reach the sufficient size needed for renal attachment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup> On the other hand, Randall&#x27;s plaques, which were first identified by Alexander Randall in 1937,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_skqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup> are <span class="inline text-[1em] leading-7">calcium phosphate</span> deposits that form in the papillary interstitium and are thought to be the nidus required for stone development.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ckqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup> In addition to Randall&#x27;s plugs, which form in the <span class="inline text-[1em] leading-7">Duct of Bellini</span>, these structures can generate reactive oxygen species that further enhance stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1skqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup></span>
<h3 id="pathogenic-bacteria" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pathogenic bacteria<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Some <span class="inline text-[1em] leading-7">bacteria</span> have roles in promoting stone formation. Specifically, <span class="inline text-[1em] leading-7">urease-positive</span> bacteria, such as <em><span class="inline text-[1em] leading-7">Proteus mirabilis</span></em> can produce the <span class="inline text-[1em] leading-7">enzyme</span> <span class="inline text-[1em] leading-7">urease</span>, which converts <span class="inline text-[1em] leading-7">urea</span> to <span class="inline text-[1em] leading-7">ammonia</span> and <span class="inline text-[1em] leading-7">carbon dioxide</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> This increases the urinary <span class="inline text-[1em] leading-7">pH</span> and promotes <span class="inline text-[1em] leading-7">struvite</span> stone formation. Additionally, non-urease producing bacteria can provide bacterial components that promote <span class="inline text-[1em] leading-7">calcium oxalate</span> crystallization, though this mechanism is poorly understood.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_38lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3clqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup></span>
<h3 id="inhibitors-of-stone-formation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Inhibitors of stone formation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Normal <span class="inline text-[1em] leading-7">urine</span> contains <span class="inline text-[1em] leading-7">chelating</span> agents, such as <span class="inline text-[1em] leading-7">citrate</span>, that inhibit the <span class="inline text-[1em] leading-7">nucleation</span>, <span class="inline text-[1em] leading-7">growth</span>, and aggregation of calcium-containing crystals. Other <span class="inline text-[1em] leading-7">endogenous</span> inhibitors include <span class="inline text-[1em] leading-7">calgranulin</span> (an <span class="inline text-[1em] leading-7">S-100 calcium-binding protein</span>), <span class="inline text-[1em] leading-7">Tammâ€“Horsfall protein</span>, <span class="inline text-[1em] leading-7">glycosaminoglycans</span>, uropontin (a form of <span class="inline text-[1em] leading-7">osteopontin</span>), <span class="inline text-[1em] leading-7">nephrocalcin</span> (an acidic <span class="inline text-[1em] leading-7">glycoprotein</span>), pro<span class="inline text-[1em] leading-7">thrombin</span> F1 peptide, and <span class="inline text-[1em] leading-7">bikunin</span> (<span class="inline text-[1em] leading-7">uronic acid</span>-rich protein). The biochemical mechanisms of action of these substances have not yet been thoroughly elucidated. However, when these substances fall below their normal proportions, stones can form from an aggregation of crystals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Sufficient dietary intake of <span class="inline text-[1em] leading-7">magnesium</span> and <span class="inline text-[1em] leading-7">citrate</span> inhibits the formation of calcium oxalate and calcium phosphate stones; in addition, magnesium and citrate operate synergistically to inhibit kidney stones. The efficacy of magnesium in subduing stone formation and growth is <span class="inline text-[1em] leading-7">dose-dependent</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_14nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup></span>
<h3 id="hypocitraturia" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Hypocitraturia<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Hypocitraturia or low urinary-citrate excretion (variably defined as less than 320 mg/day) can be a contributing cause of kidney stones in up to 2/3 of cases. The protective role of citrate is linked to several mechanisms; citrate reduces urinary supersaturation of calcium salts by forming soluble complexes with calcium ions and by inhibiting crystal growth and aggregation. Therapy with <span class="inline text-[1em] leading-7">potassium citrate</span> is commonly prescribed in clinical practice to increase urinary citrate and to reduce stone formation rates. <span class="inline text-[1em] leading-7">Alkali citrate</span> is also used to increase urine citrate levels. It can be prescribed or found over-the-counter in pill, liquid or powder form.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ooabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_soabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup></span>
<h1 id="diagnosis" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Diagnosis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Diagnosis of kidney stones is made on the basis of information obtained from the history, physical examination, <span class="inline text-[1em] leading-7">urinalysis</span>, and <span class="inline text-[1em] leading-7">radiographic</span> studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_opabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> <span class="inline text-[1em] leading-7">Clinical diagnosis</span> is usually made on the basis of the location and severity of the pain, which is typically colicky in nature (comes and goes in <span class="inline text-[1em] leading-7">spasmodic</span> waves). Pain in the back occurs when calculi produce an obstruction in the kidney.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1gpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> Physical examination may reveal fever and <span class="inline text-[1em] leading-7">tenderness at the costovertebral angle</span> on the affected side.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_20pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup></span>
<h2 id="imaging-studies" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Imaging studies<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Calcium-containing stones are relatively <span class="inline text-[1em] leading-7">radiodense</span> (opaque to <span class="inline text-[1em] leading-7">X-rays</span>), and they can often be detected by a traditional <span class="inline text-[1em] leading-7">radiography</span> of the <span class="inline text-[1em] leading-7">abdomen</span> that includes the <span class="inline text-[1em] leading-7">kidneys, ureters, and bladder</span> (KUB film).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1gqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> KUB radiography, although useful in monitoring size of stone or passage of stone in stone formers, might not be useful in the acute setting due to low sensitivity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1oqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> Some 60% of all renal stones are radiopaque.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_20qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_24qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup> In general, calcium phosphate stones have the greatest density, followed by calcium oxalate and magnesium ammonium phosphate stones. <span class="inline text-[1em] leading-7">Cystine</span> calculi are only faintly <span class="inline text-[1em] leading-7">radiodense</span>, while <span class="inline text-[1em] leading-7">uric acid</span> stones are usually entirely <span class="inline text-[1em] leading-7">radiolucent</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3cqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In people with a history of stones, those who are less than 50 years of age and are presenting with the symptoms of stones without any concerning signs do not require <span class="inline text-[1em] leading-7">helical CT scan</span> imaging.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup> A <span class="inline text-[1em] leading-7">computed tomography</span> (CT) scan is also not typically recommended in children.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Otherwise a noncontrast helical CT scan with 5 millimeters (0.2 in) sections is the diagnostic method to use to detect kidney stones and confirm the diagnosis of kidney stone disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_crabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_grabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_krabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_orabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> Near all stones are detectable on CT scans with the exception of those composed of certain drug residues in the urine,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> such as from <span class="inline text-[1em] leading-7">indinavir</span>.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Where a CT scan is unavailable, an <span class="inline text-[1em] leading-7">intravenous pyelogram</span> may be performed to help confirm the diagnosis of <span class="inline text-[1em] leading-7">urolithiasis</span>. This involves <span class="inline text-[1em] leading-7">intravenous injection</span> of a <span class="inline text-[1em] leading-7">contrast agent</span> followed by a KUB film. <span class="inline text-[1em] leading-7">Uroliths</span> present in the kidneys, ureters, or bladder may be better defined by the use of this contrast agent. Stones can also be detected by a <span class="inline text-[1em] leading-7">retrograde pyelogram</span>, where a similar contrast agent is injected directly into the distal ostium of the ureter (where the ureter terminates as it enters the bladder).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1orqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Renal ultrasonography</span> can sometimes be useful, because it gives details about the presence of <span class="inline text-[1em] leading-7">hydronephrosis</span>, suggesting that the stone is blocking the outflow of urine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ksabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> Radiolucent stones, which do not appear on KUB, may show up on ultrasound imaging studies. Other advantages of renal ultrasonography include its low cost and absence of <span class="inline text-[1em] leading-7">radiation exposure</span>. Ultrasound imaging is useful for detecting stones in situations where X-rays or CT scans are discouraged, such as in children or pregnant women.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_14sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup> Despite these advantages, renal ultrasonography in 2009 was not considered a substitute for noncontrast helical CT scan in the initial diagnostic evaluation of urolithiasis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1csabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup> The main reason for this is that, compared with CT, renal ultrasonography more often fails to detect small stones (especially ureteral stones) and other serious disorders that could be causing the symptoms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ksabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">On the contrary, a 2014 study suggested that ultrasonography should be used as the initial diagnostic imaging test, with further imaging studies be performed at the discretion of the physician on the basis of clinical judgment, and using <span class="inline text-[1em] leading-7">ultrasonography</span> rather than <span class="inline text-[1em] leading-7">CT</span> as an initial diagnostic test results in less radiation exposure and equally good outcome.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_osqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup></span>
<h2 id="laboratory-examination" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Laboratory examination<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Struvite</span> crystals found on <span class="inline text-[1em] leading-7">microscopic examination</span> of the urine</span>
<span class="mb-4 block break-words text-[1em] leading-7">Laboratory investigations typically carried out include:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_guabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup></span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]"><span class="inline text-[1em] leading-7">microscopic examination</span> of the urine, which may show <span class="inline text-[1em] leading-7">red blood cells</span>, bacteria, <span class="inline text-[1em] leading-7">leukocytes</span>, <span class="inline text-[1em] leading-7">urinary casts</span>, and crystals;</li>
<li class="text-[1em]">urine culture to identify any infecting organisms present in the urinary tract and <span class="inline text-[1em] leading-7">sensitivity</span> to determine the susceptibility of these organisms to specific antibiotics;</li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">complete blood count</span>, looking for <span class="inline text-[1em] leading-7">neutrophilia</span> (increased <span class="inline text-[1em] leading-7">neutrophil granulocyte</span> count) suggestive of bacterial infection, as seen in the setting of struvite stones;</li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">renal function</span> tests to look for abnormally high blood calcium levels (<span class="inline text-[1em] leading-7">hypercalcemia</span>);</li>
<li class="text-[1em]">24 hour urine collection to measure total daily urinary volume, magnesium, sodium, uric acid, calcium, citrate, oxalate, and <span class="inline text-[1em] leading-7">phosphate</span>;</li>
<li class="text-[1em]">collection of stones (by urinating through a StoneScreen kidney stone collection cup or a simple <span class="inline text-[1em] leading-7">tea strainer</span>) is useful. Chemical analysis of collected stones can establish their composition, which in turn can help to guide future preventive and therapeutic management.</li>
</ul>
<h2 id="composition" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Composition<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>





























































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Kidney stone type</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Relative incidence (adults)</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Circumstances</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Color and microscopy appearance</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Radio-density</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Details</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="inline text-[1em] leading-7">Calcium oxalate</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">60%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">when urine is acidic (decreased pH)</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2covqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Black/dark brown</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Radio-opaque</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Some of the oxalate in urine is produced by the body. Calcium and oxalate in the diet play a part but are not the only factors that affect the formation of calcium oxalate stones. Dietary oxalate is found in many vegetables, fruits, and nuts. Calcium from bone may also play a role in kidney stone formation.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="inline text-[1em] leading-7">Calcium phosphate</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">10â€“20%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">when urine is alkaline (high pH)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Dirty white</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Radio-opaque</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Tends to grow in alkaline urine especially when *</span><span class="inline text-[1em] leading-7">Proteus* bacteria</span><span class="text-[1em] leading-7"> are present. The most common type among pregnant women.</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4p8vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="inline text-[1em] leading-7">Uric acid</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">10â€“20%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">when urine is persistently acidic</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Yellow/reddish brown</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Radio-lucent</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Diets rich in animal proteins and purines: substances found naturally in all food but especially in organ meats, fish, and shellfish.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="inline text-[1em] leading-7">Struvite</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">10â€“15%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">infections in the kidney and when urine is alkaline (high pH)</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Dirty white</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Radio-opaque</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Prevention of struvite stones depends on staying infection-free. Diet has not been shown to affect struvite stone formation.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="inline text-[1em] leading-7">Cystine</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">01â€“2%</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aovqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rare genetic disorder</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Pink/yellow</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Radio-opaque</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Cystine, an amino acid (a dimer of cysteine, of the building blocks of protein), leaks through the kidneys and into the urine to form crystals.</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="inline text-[1em] leading-7">Xanthine</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">extremely rare</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Brick red</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Radio-lucent</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"></td></tr></tbody></table></div>
<h3 id="calcium-containing-stones" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Calcium-containing stones<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">By far, the most common type of kidney stones worldwide contains calcium. For example, calcium-containing stones represent about 80% of all cases in the United States; these typically contain <span class="inline text-[1em] leading-7">calcium oxalate</span> either alone or in combination with <span class="inline text-[1em] leading-7">calcium phosphate</span> in the form of <span class="inline text-[1em] leading-7">apatite</span> or <span class="inline text-[1em] leading-7">brushite</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1d0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup> Factors that promote the <span class="inline text-[1em] leading-7">precipitation</span> of oxalate crystals in the urine, such as <span class="inline text-[1em] leading-7">primary hyperoxaluria</span>, are associated with the development of calcium oxalate stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_250qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> The formation of calcium phosphate stones is associated with conditions such as <span class="inline text-[1em] leading-7">hyperparathyroidism</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2h0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> and <span class="inline text-[1em] leading-7">renal tubular acidosis</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_310qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Oxaluria</span> is increased in patients with certain gastrointestinal disorders including inflammatory bowel disease such as <span class="inline text-[1em] leading-7">Crohn&#x27;s disease</span> or in patients who have undergone resection of the small bowel or small-bowel bypass procedures. Oxaluria is also increased in patients who consume increased amounts of oxalate (found in vegetables and nuts). Primary hyperoxaluria is a rare autosomal recessive condition that usually presents in childhood.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Calcium oxalate crystals can come in two varieties. Calcium oxalate monohydrate can appear as &#x27;dumbbells&#x27; or as long ovals that resemble the individual posts in a picket fence. Calcium oxalate dihydrate have a tetragonal &quot;envelope&quot; appearance.</span>
<h3 id="struvite-stones" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Struvite stones<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">About 10â€“15% of urinary calculi are composed of <span class="inline text-[1em] leading-7">struvite</span> (hexa-hydrated <span class="inline text-[1em] leading-7">ammonium magnesium phosphate</span>, NH4MgPO4Â·6H2O).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup> Struvite stones (also known as &quot;infection stones,&quot; <span class="inline text-[1em] leading-7">urease</span>, or triple-phosphate stones) form most often in the presence of infection by urea-splitting <span class="inline text-[1em] leading-7">bacteria</span>. Using the enzyme urease, these organisms <span class="inline text-[1em] leading-7">metabolize</span> <span class="inline text-[1em] leading-7">urea</span> into <span class="inline text-[1em] leading-7">ammonia</span> and <span class="inline text-[1em] leading-7">carbon dioxide</span>. This <span class="inline text-[1em] leading-7">alkalinizes</span> the urine, resulting in favorable conditions for the formation of struvite stones. <em><span class="inline text-[1em] leading-7">Proteus mirabilis</span></em> , <em><span class="inline text-[1em] leading-7">Proteus vulgaris</span></em> , and <em><span class="inline text-[1em] leading-7">Morganella morganii</span></em> are the most common organisms isolated; less common organisms include <em><span class="inline text-[1em] leading-7">Ureaplasma urealyticum</span></em> and some species of <em><span class="inline text-[1em] leading-7">Providencia</span></em> , <em><span class="inline text-[1em] leading-7">Klebsiella</span></em> , <em><span class="inline text-[1em] leading-7">Serratia</span></em> , and <em><span class="inline text-[1em] leading-7">Enterobacter</span></em>. These infection stones are commonly observed in people who have factors that predispose them to <span class="inline text-[1em] leading-7">urinary tract infections</span>, such as those with <span class="inline text-[1em] leading-7">spinal cord injury</span> and other forms of <span class="inline text-[1em] leading-7">neurogenic bladder</span>, <span class="inline text-[1em] leading-7">ileal conduit urinary diversion</span>, <span class="inline text-[1em] leading-7">vesicoureteral reflux</span>, and <span class="inline text-[1em] leading-7">obstructive uropathies</span>. They are also commonly seen in people with underlying metabolic disorders, such as <span class="inline text-[1em] leading-7">idiopathic</span> <span class="inline text-[1em] leading-7">hypercalciuria</span>, <span class="inline text-[1em] leading-7">hyperparathyroidism</span>, and <span class="inline text-[1em] leading-7">gout</span>. Infection stones can grow rapidly, forming large calyceal staghorn (<span class="inline text-[1em] leading-7">antler</span>-shaped) calculi requiring invasive surgery such as percutaneous nephrolithotomy for definitive treatment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7h2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Struvite stones (triple-phosphate/magnesium ammonium phosphate) have a &#x27;coffin lid&#x27; morphology by microscopy.</span>
<h3 id="uric-acid-stones" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Uric acid stones<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">About 5â€“10% of all stones are formed from <span class="inline text-[1em] leading-7">uric acid</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> People with certain metabolic abnormalities, including <span class="inline text-[1em] leading-7">obesity</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_114abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> may produce uric acid stones. They also may form in association with conditions that cause <span class="inline text-[1em] leading-7">hyperuricosuria</span> (an excessive amount of uric acid in the urine) with or without <span class="inline text-[1em] leading-7">hyperuricemia</span> (an excessive amount of uric acid in the <span class="inline text-[1em] leading-7">serum</span>). They may also form in association with disorders of acid/base metabolism where the urine is excessively acidic (low <span class="inline text-[1em] leading-7">pH</span>), resulting in precipitation of uric acid crystals. A diagnosis of uric acid <span class="inline text-[1em] leading-7">urolithiasis</span> is supported by the presence of a <span class="inline text-[1em] leading-7">radiolucent</span> stone in the face of persistent urine acidity, in conjunction with the finding of uric acid crystals in fresh urine samples.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2p4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">As noted above (section on calcium oxalate stones), people with <span class="inline text-[1em] leading-7">inflammatory bowel disease</span> (<span class="inline text-[1em] leading-7">Crohn&#x27;s disease</span>, <span class="inline text-[1em] leading-7">ulcerative colitis</span>) tend to have <span class="inline text-[1em] leading-7">hyperoxaluria</span> and form oxalate stones. They also have a tendency to form urate stones. Urate stones are especially common after <span class="inline text-[1em] leading-7">colon resection</span>.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Uric acid stones appear as <span class="inline text-[1em] leading-7">pleomorphic</span> crystals, usually diamond-shaped. They may also look like squares or rods which are polarizable.</span>
<h3 id="other-types" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Other types<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Microscopic <span class="inline text-[1em] leading-7">cystine</span> crystals have a distinctive hexagonal shape and are present in the urine of people with kidney stones composed of cystine</span>
<span class="mb-4 block break-words text-[1em] leading-7">People with certain rare <span class="inline text-[1em] leading-7">inborn errors of metabolism</span> have a propensity to accumulate crystal-forming substances in their urine. For example, those with <span class="inline text-[1em] leading-7">cystinuria</span>, <span class="inline text-[1em] leading-7">cystinosis</span>, and <span class="inline text-[1em] leading-7">Fanconi syndrome</span> may form stones composed of <span class="inline text-[1em] leading-7">cystine</span>. Cystine stone formation can be treated with urine alkalinization and dietary protein restriction. People affected by <span class="inline text-[1em] leading-7">xanthinuria</span> often produce stones composed of <span class="inline text-[1em] leading-7">xanthine</span>. People affected by <span class="inline text-[1em] leading-7">adenine phosphoribosyltransferase deficiency</span> may produce <span class="inline text-[1em] leading-7">2,8-dihydroxyadenine</span> stones,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2h6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup> <span class="inline text-[1em] leading-7">alkaptonurics</span> produce <span class="inline text-[1em] leading-7">homogentisic acid</span> stones, and <span class="inline text-[1em] leading-7">iminoglycinurics</span> produce stones of <span class="inline text-[1em] leading-7">glycine</span>, <span class="inline text-[1em] leading-7">proline</span>, and <span class="inline text-[1em] leading-7">hydroxyproline</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_496qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4d6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> Urolithiasis has also been noted to occur in the setting of therapeutic drug use, with crystals of drug forming within the renal tract in some people currently being treated with agents such as <span class="inline text-[1em] leading-7">indinavir</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4t6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> <span class="inline text-[1em] leading-7">sulfadiazine</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5d6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup> and <span class="inline text-[1em] leading-7">triamterene</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5t6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup></span>
<h2 id="location" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Location<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Urolithiasis refers to stones originating anywhere in the urinary system, including the kidneys and bladder.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> Nephrolithiasis refers to the presence of such stones in the kidneys. Calyceal calculi are aggregations in either the <span class="inline text-[1em] leading-7">minor</span> or <span class="inline text-[1em] leading-7">major calyx</span>, parts of the kidney that pass urine into the ureter (the tube connecting the kidneys to the urinary bladder). The condition is called ureterolithiasis when a calculus is located in the ureter. Stones may also form or pass into the bladder, a condition referred to as <span class="inline text-[1em] leading-7">bladder stones</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_197qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup></span>
<h2 id="size" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Size<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Stones less than 5 mm (0.2 in) in diameter pass spontaneously in up to 98% of cases, while those measuring 5 to 10 mm (0.2 to 0.4 in) in diameter pass spontaneously in less than 53% of cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Stones that are large enough to fill out the renal calyces are called <em>staghorn stones</em> and are composed of <span class="inline text-[1em] leading-7">struvite</span> in a vast majority of cases, which forms only in the presence of <span class="inline text-[1em] leading-7">urease-forming bacteria</span>. Other forms that can possibly grow to become staghorn stones are those composed of cystine, calcium oxalate monohydrate, and uric acid.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_119abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup></span>
<h2 id="prevention" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Prevention<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Preventative measures depend on the type of stones. In those with calcium stones, drinking plenty of fluids, <span class="inline text-[1em] leading-7">thiazide</span> <span class="inline text-[1em] leading-7">diuretics</span> and citrate are effective as is allopurinol in those with high uric acid levels in urine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_paabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_taabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup></span>
<h3 id="dietary-measures" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Dietary measures<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Specific therapy should be tailored to the type of stones involved. Diet can have an effect on the development of kidney stones. Preventive strategies include some combination of dietary modifications and medications with the goal of reducing the excretory load of calculogenic compounds on the kidneys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup> Dietary recommendations to minimize the formation of kidney stones include:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">increasing total fluid intake to achieve more than two liters per day of urine output;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup></li>
<li class="text-[1em]">limiting consumption of cola and sugar-sweetened soft drinks, as daily intake increases stone risk by about 23%;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4hbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6hbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8hbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[91]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ahbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup></li>
<li class="text-[1em]">limiting animal protein intake to about 0.8-1 g per kg of body weight per day (e.g., 50-70 g for most adults; an association between animal <span class="inline text-[1em] leading-7">protein</span> and recurrence of kidney stones has been shown in men);<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[93]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_apbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[94]</sup></li>
<li class="text-[1em]">increasing citrate, including from lemon and <span class="inline text-[1em] leading-7">lime juice</span>;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup> citric acid in its natural form, such as from citrus fruits, &quot;prevents small stones from becoming &#x27;problem stones&#x27; by coating them and preventing other material from attaching and building onto the stones&quot;;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d1bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup> citrate inhibits the formation of kidney stones on all phases<span class="inline text-[1em] leading-7">â€”nucleation</span>, growth and aggregationâ€”by raising the limit at which oxalate remain stable, slowing oxalate crystal growth, and notably, reducing crystal aggregation within the <span class="inline text-[1em] leading-7">kidney tubules</span>;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p1bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup></li>
<li class="text-[1em]">increase alkaline load by consuming more fruits and vegetables (because uric acid crystals form in acidic environment);<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_59bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup></li>
<li class="text-[1em]">reducing sodium intake is associated with a reduction in urine calcium excretion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5hbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup></li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">Maintenance of dilute urine by means of vigorous fluid therapy is beneficial in all forms of kidney stones, so increasing urine volume is a key principle for the prevention of kidney stones. Fluid intake should be sufficient to maintain a urine output of at least 2 <span class="inline text-[1em] leading-7">litres</span> (68 <span class="inline text-[1em] leading-7">US fl oz</span>) per day.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup> A high fluid intake may reduce the likelihood of kidney stone recurrence or may increase the time between stone development without unwanted effects.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Calcium binds with available oxalate in the <span class="inline text-[1em] leading-7">gastrointestinal tract</span>, thereby preventing its absorption into the <span class="inline text-[1em] leading-7">bloodstream</span>. Reducing oxalate absorption decreases kidney stone risk in susceptible people.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[98]</sup> Because of this, some doctors recommend increasing dairy intake so that its calcium content will serve as an oxalate binder. Taking calcium citrate tablets during or after meals containing high oxalate foods<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> may be useful if dietary calcium cannot be increased by other means as in those with lactose intolerance. The preferred calcium supplement for people at risk of stone formation is calcium citrate, as opposed to calcium carbonate, because it helps to increase urinary citrate excretion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Aside from vigorous oral hydration and eating more dietary calcium, other prevention strategies include avoidance of higher doses of supplemental vitamin C (since <span class="inline text-[1em] leading-7">ascorbate</span> is metabolized to oxalate) and restriction of oxalate-rich foods such as <span class="inline text-[1em] leading-7">leaf vegetables</span>, <span class="inline text-[1em] leading-7">rhubarb</span>, <span class="inline text-[1em] leading-7">soy products</span> and <span class="inline text-[1em] leading-7">chocolate</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1hdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup> However, no randomized, controlled trial of oxalate restriction has been performed to test the hypothesis that oxalate restriction reduces stone formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1pdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> Some evidence indicates <span class="inline text-[1em] leading-7">magnesium</span> intake decreases the risk of symptomatic kidney stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup></span>
<h3 id="urine-alkalinization" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Urine alkalinization<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The mainstay for medical management of uric acid stones is <span class="inline text-[1em] leading-7">alkalinization</span> (increasing the <span class="inline text-[1em] leading-7">pH</span>) of the urine. Uric acid stones are among the few types amenable to dissolution therapy, referred to as <span class="inline text-[1em] leading-7">chemolysis</span>. Chemolysis is usually achieved through the use of oral medications, although in some cases, intravenous agents or even instillation of certain irrigating agents directly onto the stone can be performed, using antegrade <span class="inline text-[1em] leading-7">nephrostomy</span> or <span class="inline text-[1em] leading-7">retrograde ureteral</span> catheters.<!-- --> <span class="inline text-[1em] leading-7">Acetazolamide</span> is a medication that alkalinizes the urine. In addition to acetazolamide or as an alternative, certain dietary supplements are available that produce a similar alkalinization of the urine. These include <span class="inline text-[1em] leading-7">alkali citrate</span>, <span class="inline text-[1em] leading-7">sodium bicarbonate</span>, <span class="inline text-[1em] leading-7">potassium citrate</span>, <span class="inline text-[1em] leading-7">magnesium citrate</span>, and <span class="inline text-[1em] leading-7">bicitrate</span> (a combination of citric acid monohydrate and sodium citrate dihydrate).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_39eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup> Aside from alkalinization of the urine, these supplements have the added advantage of increasing the urinary citrate level, which helps to reduce the aggregation of calcium oxalate stones.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Increasing the urine pH to around 6.5 provides optimal conditions for <span class="inline text-[1em] leading-7">dissolution</span> of uric acid stones. Increasing the urine pH to a value higher than 7.0 may increase the risk of calcium phosphate stone formation, though this concept is controversial since citrate does inhibit calcium phosphate crystallization. Testing the urine periodically with <span class="inline text-[1em] leading-7">nitrazine</span> paper can help to ensure the urine pH remains in this optimal range. Using this approach, stone dissolution rate can be expected to be around 10 mm (0.4 in) of stone radius per month.</span>
<h3 id="diuretics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Diuretics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">One of the recognized medical therapies for prevention of stones is the <span class="inline text-[1em] leading-7">thiazide</span> and <span class="inline text-[1em] leading-7">thiazide-like diuretics</span>, such as <span class="inline text-[1em] leading-7">chlorthalidone</span> or <span class="inline text-[1em] leading-7">indapamide</span>. These drugs inhibit the formation of calcium-containing stones by reducing urinary calcium excretion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> Sodium restriction is necessary for clinical effect of thiazides, as sodium excess promotes calcium excretion. Thiazides work best for renal leak hypercalciuria (high urine calcium levels), a condition in which high urinary calcium levels are caused by a primary kidney defect. Thiazides are useful for treating absorptive hypercalciuria, a condition in which high urinary calcium is a result of excess absorption from the gastrointestinal tract.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1hfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span>
<h3 id="allopurinol" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Allopurinol<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">For people with <span class="inline text-[1em] leading-7">hyperuricosuria</span> and calcium stones, <span class="inline text-[1em] leading-7">allopurinol</span> is one of the few treatments that have been shown to reduce kidney stone recurrences. Allopurinol interferes with the production of uric acid in the <span class="inline text-[1em] leading-7">liver</span>. The drug is also used in people with <span class="inline text-[1em] leading-7">gout</span> or hyperuricemia (high <span class="inline text-[1em] leading-7">serum</span> uric acid levels).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1hgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[102]</sup> Dosage is adjusted to maintain a reduced urinary excretion of uric acid. Serum uric acid level at or below 6 mg/100 mL is often a therapeutic goal. Hyperuricemia is not necessary for the formation of uric acid stones; hyperuricosuria can occur in the presence of normal or even <span class="inline text-[1em] leading-7">low serum uric acid</span>. Some practitioners advocate adding allopurinol only in people in whom hyperuricosuria and hyperuricemia persist, despite the use of a urine-<span class="inline text-[1em] leading-7">alkalinizing agent</span> such as <span class="inline text-[1em] leading-7">sodium bicarbonate</span> or <span class="inline text-[1em] leading-7">potassium citrate</span>.</span>
<h1 id="treatment" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Treatment<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Stone size influences the rate of spontaneous stone passage. For example, up to 98% of small stones (less than 5 mm (0.2 in) in diameter) may pass spontaneously through urination within four weeks of the onset of symptoms,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> but for larger stones (5 to 10 mm (0.2 to 0.4 in) in diameter), the rate of spontaneous passage decreases to less than 53%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> Initial stone location also influences the likelihood of spontaneous stone passage. Rates increase from 48% for stones located in the proximal ureter to 79% for stones located at the vesicoureteric junction, regardless of stone size.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_phqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> Assuming no high-grade obstruction or associated infection is found in the urinary tract, and symptoms are relatively mild, various nonsurgical measures can be used to encourage the passage of a stone.<!-- --> Repeat stone formers benefit from more intense management, including proper fluid intake and use of certain medications, as well as careful monitoring.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[103]</sup></span>
<h2 id="pain-management" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Pain management<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Management of pain often requires intravenous administration of <span class="inline text-[1em] leading-7">NSAIDs</span> or opioids.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> NSAIDs appear somewhat better than opioids or <span class="inline text-[1em] leading-7">paracetamol</span> in those with normal kidney function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[104]</sup> Medications by mouth are often effective for less severe discomfort.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup> The use of <span class="inline text-[1em] leading-7">antispasmodics</span> does not have further benefit.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1piqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<h2 id="medical-expulsive-therapy" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Medical expulsive therapy<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The use of medications to speed the spontaneous passage of stones in the ureter is referred to as medical expulsive therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_djqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup> Several agents, including <span class="inline text-[1em] leading-7">alpha adrenergic blockers</span> (such as <span class="inline text-[1em] leading-7">tamsulosin</span>) and <span class="inline text-[1em] leading-7">calcium channel blockers</span> (such as <span class="inline text-[1em] leading-7">nifedipine</span>), may be effective.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ljqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup> Alpha-blockers likely result in more people passing their stones, and they may pass their stones in a shorter time.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1tjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup> People taking alpha-blockers may also use less pain medication and may not need to visit the hospital.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup> Alpha-blockers appear to be more effective for larger stones (over 5 mm in size) than smaller stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2djqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup> However, use of alpha-blockers may be associated with a slight increase in serious, unwanted effects from this medication.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2ljqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup> A combination of tamsulosin and a <span class="inline text-[1em] leading-7">corticosteroid</span> may be better than tamsulosin alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_35jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup> These treatments also appear to be useful in addition to lithotripsy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3djqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<h2 id="lithotripsy" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Lithotripsy<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Extracorporeal shock wave lithotripsy</span> (ESWL) is a <span class="inline text-[1em] leading-7">noninvasive</span> technique for the removal of kidney stones. Most ESWL is carried out when the stone is present near the <span class="inline text-[1em] leading-7">renal pelvis</span>. ESWL involves the use of a <span class="inline text-[1em] leading-7">lithotriptor</span> machine to deliver externally applied, focused, high-intensity pulses of <span class="inline text-[1em] leading-7">ultrasonic energy</span> to cause fragmentation of a stone over a period of around 30â€“60 minutes. Following its introduction in the United States in February 1984, ESWL was rapidly and widely accepted as a treatment alternative for renal and ureteral stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1dkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup> It is currently used in the treatment of uncomplicated stones located in the kidney and upper ureter, provided the aggregate stone burden (stone size and number) is less than 20 mm (0.8 in) and the anatomy of the involved kidney is normal.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1pkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For a stone greater than 10 millimetres (0.39 in), ESWL may not help break the stone in one treatment; instead, two or three treatments may be needed. Some 80-85% of simple renal calculi can be effectively treated with ESWL.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> A number of factors can influence its efficacy, including chemical composition of the stone, presence of anomalous renal anatomy and the specific location of the stone within the kidney, presence of hydronephrosis, <span class="inline text-[1em] leading-7">body mass index</span>, and distance of the stone from the surface of the skin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_plabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Common adverse effects of ESWL include acute <span class="inline text-[1em] leading-7">trauma</span>, such as <span class="inline text-[1em] leading-7">bruising</span> at the site of shock administration, and damage to blood vessels of the kidney.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_plqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup> In fact, the vast majority of people who are treated with a typical dose of shock waves using currently accepted treatment settings are likely to experience some degree of <span class="inline text-[1em] leading-7">acute kidney injury</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1dlqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup> ESWL-induced acute kidney injury is dose-dependent (increases with the total number of shock waves administered and with the power setting of the lithotriptor) and can be severe,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1llqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup> including <span class="inline text-[1em] leading-7">internal bleeding</span> and subcapsular <span class="inline text-[1em] leading-7">hematomas</span>. On rare occasions, such cases may require <span class="inline text-[1em] leading-7">blood transfusion</span> and even lead to acute <span class="inline text-[1em] leading-7">kidney failure</span>. Hematoma rates may be related to the type of lithotriptor used; hematoma rates of less than 1% and up to 13% have been reported for different lithotriptor machines.<!-- --> Recent studies show reduced acute tissue injury when the treatment protocol includes a brief pause following the initiation of treatment, and both improved stone breakage and a reduction in injury when ESWL is carried out at slow shock wave rate.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_35lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In addition to the aforementioned potential for acute kidney injury, animal studies suggest these acute injuries may progress to scar formation, resulting in loss of functional renal volume.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup> Recent <span class="inline text-[1em] leading-7">prospective studies</span> also indicate elderly people are at increased risk of developing new-onset hypertension following ESWL. In addition, a <span class="inline text-[1em] leading-7">retrospective case-control study</span> published by researchers from the <span class="inline text-[1em] leading-7">Mayo Clinic</span> in 2006 has found an increased risk of developing <span class="inline text-[1em] leading-7">diabetes mellitus</span> and <span class="inline text-[1em] leading-7">hypertension</span> in people who had undergone ESWL, compared with age and gender-matched people who had undergone nonsurgical treatment. Whether or not acute trauma progresses to long-term effects probably depends on multiple factors that include the shock wave dose (i.e., the number of shock waves delivered, rate of delivery, power setting, acoustic characteristics of the particular lithotriptor, and frequency of retreatment), as well as certain intrinsic predisposing pathophysiologic risk factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1tmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">To address these concerns, the <span class="inline text-[1em] leading-7">American Urological Association</span> established the Shock Wave Lithotripsy Task Force to provide an expert opinion on the safety and <span class="inline text-[1em] leading-7">risk-benefit ratio</span> of ESWL. The task force published a <span class="inline text-[1em] leading-7">white paper</span> outlining their conclusions in 2009. They concluded the risk-benefit ratio remains favorable for many people.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup> The advantages of ESWL include its noninvasive nature, the fact that it is technically easy to treat most upper urinary tract calculi, and that, at least acutely, it is a well-tolerated, low-<span class="inline text-[1em] leading-7">morbidity</span> treatment for the vast majority of people. However, they recommended slowing the shock wave firing rate from 120 pulses per minute to 60 pulses per minute to reduce the risk of renal injury and increase the degree of stone fragmentation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1hmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Alpha-blockers</span> are sometimes prescribed after shock wave lithotripsy to help the pieces of the stone leave the person&#x27;s body.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup> By relaxing muscles and helping to keep blood vessels open, alpha blockers may relax the ureter muscles to allow the kidney stone fragments to pass. When compared to usual care or placebo treatment, alpha blockers may lead to faster clearing of stones, a reduced need for extra treatment and fewer unwanted effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup> They may also clear kidney stones in more adults than the standard shock wave lithotripsy procedure. The unwanted effects associated with alpha blockers are hospital emergency visits and return to hospital for stone-related issues, but these effects were more common in adults who did not receive <span class="inline text-[1em] leading-7">alpha-blockers</span> as a part of their treatment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup></span>
<h2 id="surgery" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Surgery<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Most stones under 5 mm (0.2 in) pass spontaneously.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_doabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> Prompt surgery may, nonetheless, be required in persons with only one working kidney, bilateral obstructing stones, a urinary tract infection and thus, it is presumed, an infected kidney, or intractable pain.<!-- --> Beginning in the mid-1980s, less invasive treatments such as extracorporeal shock wave lithotripsy, <span class="inline text-[1em] leading-7">ureteroscopy</span>, and <span class="inline text-[1em] leading-7">percutaneous nephrolithotomy</span> began to replace open surgery as the modalities of choice for the surgical management of urolithiasis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1doabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> More recently, flexible ureteroscopy has been adapted to facilitate retrograde nephrostomy creation for percutaneous nephrolithotomy. This approach is still under investigation, though early results are favorable.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1loabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[114]</sup> Percutaneous nephrolithotomy or, rarely, <span class="inline text-[1em] leading-7">anatrophic nephrolithotomy</span>, is the treatment of choice for large or complicated stones (such as calyceal staghorn calculi) or stones that cannot be extracted using less invasive procedures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<h3 id="ureteroscopic-surgery" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Ureteroscopic surgery<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Ureteroscopy</span> has become increasingly popular as flexible and rigid <span class="inline text-[1em] leading-7">fiberoptic</span> ureteroscopes have become smaller. One ureteroscopic technique involves the placement of a <span class="inline text-[1em] leading-7">ureteral stent</span> (a small tube extending from the bladder, up the ureter and into the kidney) to provide immediate relief of an obstructed kidney. Stent placement can be useful for saving a kidney at risk for <span class="inline text-[1em] leading-7">postrenal acute kidney failure</span> due to the increased hydrostatic pressure, <span class="inline text-[1em] leading-7">swelling</span> and infection (<span class="inline text-[1em] leading-7">pyelonephritis</span> and <span class="inline text-[1em] leading-7">pyonephrosis</span>) caused by an obstructing stone. Ureteral stents vary in length from 24 to 30 cm (9.4 to 11.8 in) and most have a shape commonly referred to as a &quot;double-J&quot; or &quot;double pigtail&quot;, because of the curl at both ends. They are designed to allow urine to flow past an obstruction in the ureter. They may be retained in the ureter for days to weeks as infections resolve and as stones are dissolved or fragmented by ESWL or by some other treatment. The stents dilate the ureters, which can facilitate instrumentation, and they also provide a clear landmark to aid in the visualization of the ureters and any associated stones on radiographic examinations. The presence of indwelling ureteral stents may cause minimal to moderate discomfort, frequency or urgency incontinence, and infection, which in general resolves on removal. Most ureteral stents can be removed cystoscopically during an office visit under <span class="inline text-[1em] leading-7">topical anesthesia</span> after resolution of urolithiasis.<!-- --> Research is currently uncertain if placing a temporary stent during ureteroscopy leads to different outcomes than not placing a stent in terms of number of hospital visits for post operative problems, short or long term pain, need for narcotic pain medication, risk of UTI, need for a repeat procedure or narrowing of the ureter from scarring.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2dpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[116]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">More definitive ureteroscopic techniques for stone extraction (rather than simply bypassing the obstruction) include basket extraction and ultrasound ureterolithotripsy. <span class="inline text-[1em] leading-7">Laser lithotripsy</span> is another technique, which involves the use of a <span class="inline text-[1em] leading-7">holmium</span>:<span class="inline text-[1em] leading-7">yttrium aluminium garnet</span> (Ho:YAG) laser to fragment stones in the bladder, ureters, and kidneys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[117]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Ureteroscopic techniques are generally more effective than ESWL for treating stones located in the lower ureter, with success rates of 93â€“100% using Ho:YAG laser lithotripsy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> Although ESWL has been traditionally preferred by many practitioners for treating stones located in the upper ureter, more recent experience suggests ureteroscopic techniques offer distinct advantages in the treatment of upper ureteral stones. Specifically, the overall success rate is higher, fewer repeat interventions and postoperative visits are needed, and treatment costs are lower after ureteroscopic treatment when compared with ESWL. These advantages are especially apparent with stones greater than 10 mm (0.4 in) in diameter. However, because ureteroscopy of the upper ureter is much more challenging than ESWL, many urologists still prefer to use ESWL as a first-line treatment for stones of less than 10 mm, and ureteroscopy for those greater than 10 mm in diameter.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> Ureteroscopy is the preferred treatment in pregnant and morbidly obese people, as well as those with <span class="inline text-[1em] leading-7">bleeding disorders</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<h2 id="epidemiology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Epidemiology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>









































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Country</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Prevalence (%)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Year</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Source</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">United States</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">9.9</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2017â€“2020</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gprabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[118]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Italy</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~2</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h9rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Scotland</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2000s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hprabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Spain</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~5â€“10</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i9rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Turkey</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~15</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iprabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup></td></tr></tbody></table></div>









































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Country</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Incidence (per 100,000/year)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Year</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Trend</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">United States</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~180</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">stable/increasing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Germany</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~700</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">increasing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Japan</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~120</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">increasing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Spain</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~300</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">stable</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Sweden</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~200</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2010s</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">increasing</span></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">Kidney stones affect all geographical, cultural, and racial groups. The lifetime risk is about 8â€“15% in developed countries, but can be as high as 20% in the Middle East and parts of Asia due to hot climates and dietary factors such as lower calcium intake (approximately 50% less) and higher oxalate consumption (up to 250% more) compared to Western diets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[120]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dsabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> In the Middle East, uric acid stones are more common than calcium-containing stones.<!-- --> Globally, there were approximately 106 million incident cases of urolithiasis in 2021, with about 2,900 deaths, reflecting low direct mortality but significant morbidity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tsabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[121]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[122]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[123]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In North America and Europe, the annual incidence of kidney stones is approximately 0.5â€“1%. In the United States, the prevalence of urolithiasis increased from 3.2% in the mid-1970s to 5.2% in the mid-1990s, reaching about 9.9% by 2017â€“2020.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dsqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hsqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[118]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The total cost for treating urolithiasis in the United States exceeds $2 billion annually as of the 2020s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dtabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[124]</sup> About 65â€“80% of those with kidney stones are men, though the gap is narrowing with increasing prevalence among women; most stones in women are due to either metabolic defects (such as cystinuria) or infections in the case of struvite stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ltabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ptabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[125]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ttabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Urinary tract calculi disorders are more common in men than in women. Men most commonly experience their first episode between 30 and 40 years of age, whereas for women, the age at first presentation is somewhat later.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup> The age of onset shows a bimodal distribution in women, with episodes peaking at 35 and 55 years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1dtabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> Recurrence rates are estimated at 50% over a 10-year and 75% over 20-year period,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ltabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> with some people experiencing ten or more episodes over the course of a lifetime.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ttabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Recent analyses indicate that while age-standardized incidence rates have decreased globally (by 17.5% from 1990 to 2021), the absolute number of cases continues to rise due to population growth and aging, particularly in low- and middle-income countries.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dtqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[122]</sup></span>
<h1 id="kidney-stones" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Kidney Stones<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="history" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">History<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The existence of kidney stones was first recorded thousands of years ago, with various explanations given; Joseph Glanville&#x27;s <em><span class="inline text-[1em] leading-7">Saducismus Triumphatus</span></em>, for example, gives a detailed description of Abraham Mechelburg&#x27;s voiding of small stones through his penis&#x27; virga, attributing the issue to witchcraft.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[126]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In 1901, English archaeologist E. Smith discovered a bladder stone in the pelvis of an ancient Egyptian mummy dated to around 4800 BC, representing one of the earliest known urinary calculi.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[127]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Medical texts from ancient <span class="inline text-[1em] leading-7">Mesopotamia</span>, <span class="inline text-[1em] leading-7">India</span>, <span class="inline text-[1em] leading-7">China</span>, <span class="inline text-[1em] leading-7">Persia</span>, <span class="inline text-[1em] leading-7">Greece</span>, and <span class="inline text-[1em] leading-7">Rome</span> all mentioned calculous disease. Descriptions of surgery to remove urinary stones date to as early as 600 BC in ancient India by Sushruta.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1q0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Part of the <span class="inline text-[1em] leading-7">Hippocratic Oath</span> suggests there were practicing surgeons in ancient Greece to whom physicians were to defer for <span class="inline text-[1em] leading-7">lithotomies</span>, or the surgical removal of stones. The Roman medical treatise <em><span class="inline text-[1em] leading-7">De Medicina</span></em> by <span class="inline text-[1em] leading-7">Aulus Cornelius Celsus</span> contained a description of lithotomy,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_320abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[128]</sup> and this work served as the basis for this procedure until the 18th century.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3a0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[129]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In 1980, <span class="inline text-[1em] leading-7">Dornier MedTech</span> introduced extracorporeal shock wave lithotripsy for breaking up kidney stones via acoustical pulses, and this technique has since come into widespread use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup></span>
<h3 id="etymology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Etymology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The term <em>renal calculus</em> is from the <span class="inline text-[1em] leading-7">Latin</span> <em>rÄ“nÄ“s</em> , meaning &quot;kidneys&quot;, and <em><span class="inline text-[1em] leading-7">calculus</span></em> , meaning &quot;pebble&quot;. Lithiasis (stone formation) in the kidneys is called nephrolithiasis (/ËŒnÉ›froÊŠlÉªËˆÎ¸aÉªÉ™sÉªs/), from <em><span class="inline text-[1em] leading-7">nephro</span>-</em>, meaning kidney, + <em><span class="inline text-[1em] leading-7">-lith</span></em> , meaning stone, and <em><span class="inline text-[1em] leading-7">-iasis</span></em> , meaning disorder. A distinction between nephrolithiasis and urolithiasis can be made because not all urinary stones (uroliths) form in the kidney; they can also form in the bladder. But the distinction is often clinically irrelevant (with similar disease process and treatment either way) and the words are thus often used loosely as synonyms.</span>
<h2 id="children" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Children<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Although kidney stones do not often occur in children, the incidence is increasing, with annual rises of 4-10% reported in recent decades.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[130]</sup> The increase is attributed to factors such as rising childhood obesity, increased consumption of sugary beverages, and dietary changes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[131]</sup> Stones are most commonly located in the kidney (approximately 70-80% of cases), with 10-40% in the ureter depending on the study population.[web:6][web:7] Older children are at greater risk independent of sex.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[132]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">As with adults, most pediatric kidney stones are predominantly composed of calcium oxalate; struvite and calcium phosphate stones are less common. Calcium oxalate stones in children are associated with high amounts of calcium, oxalate, and magnesium in acidic urine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[133]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Treatment of kidney stones in children is similar to treatments for adults, including shock wave lithotripsy, medication, and treatment using scope through the bladder, kidney or skin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[134]</sup> Of these treatments, research is uncertain if shock waves are more effective than medication or a scope through the bladder, but it is likely less successful than a scope through skin into the kidney.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[134]</sup> When going in with a scope through the kidney, a regular and a mini-sized scope likely have similar success rates of stone removal. Alpha-blockers, a type of medication, may increase the successful removal of kidney stones when compared with a placebo.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[134]</sup></span>
<h2 id="research" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Research<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Metabolic syndrome</span> and its associated conditions of obesity and diabetes are established risk factors for kidney stone disease. Recent studies as of 2025 confirm modest but significant genetic correlations between kidney stones and obesity, type 2 diabetes, and hypertension, with higher prevalence observed in metabolically unhealthy obese individuals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[135]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[136]</sup> Ongoing research investigates whether urinary excretion of calcium, oxalate, and urate is elevated in these groups compared to those with normal or low weight, and the roles of diet and physical activity in mitigation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[137]</sup> Dietary, fluid intake, and lifestyle factors continue as major topics for research on prevention of kidney stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_124qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[138]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_164qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[139]</sup></span>
<h3 id="gut-microbiota" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Gut microbiota<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The <span class="inline text-[1em] leading-7">gut microbiota</span> has been explored as a contributing factor for stone disease, indicating that some bacteria may be different in people forming kidney stones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[140]</sup> One bacterium, <span class="inline text-[1em] leading-7"><em>Oxalobacter formigenes</em></span>, is potentially beneficial for mitigating calcium oxalate stones because of its ability to metabolize oxalate as its sole carbon source,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_125qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[141]</sup> but 2018 research suggests that it is instead part of a network of oxalate degrading bacteria.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1a5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[142]</sup> Recent studies as of 2025 highlight probiotics and engineered gut bacteria (e.g., modified <em>Phocaeicola vulgatus</em>) to enhance oxalate degradation and reduce stone risk, with clinical trials showing <em>O. formigenes</em> colonization lowers urinary oxalate but yields mixed efficacy in primary hyperoxaluria.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_225qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[143]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_265qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[144]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2a5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[145]</sup> Additionally, one study found that oral <span class="inline text-[1em] leading-7">antibiotic</span> use, which alters the gut microbiota,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2q5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[146]</sup> can increase the odds of a person developing a kidney stone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_325qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[147]</sup> Dysbiosis in both gut and urinary microbiota is linked to stone formation via the gut-kidney axis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3a5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[148]</sup></span>
<h2 id="in-other-animals" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">In other animals<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Among <span class="inline text-[1em] leading-7">ruminants</span>, uroliths more commonly cause problems in males than in females; the sigmoid flexure of the ruminant male urinary tract is more likely to obstruct passage. Early-castrated males are at greater risk, because of lesser urethral diameter.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Low Ca:P intake ratio is conducive to phosphatic (e.g. struvite) urolith formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup> Incidence among wether lambs can be minimized by maintaining a dietary Ca:P intake ratio of 2:1.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[150]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Alkaline (higher) <span class="inline text-[1em] leading-7">pH</span> favors formation of carbonate and phosphate calculi. For domestic ruminants, dietary cation: anion balance is sometimes adjusted to assure a slightly acidic urine pH, for prevention of calculus formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Differing generalizations regarding effects of pH on formation of silicate uroliths may be found.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[151]</sup> In this connection, it may be noted that under some circumstances, calcium carbonate accompanies silica in siliceous uroliths.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[152]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pelleted feeds may be conducive to formation of phosphate uroliths, because of increased urinary phosphorus excretion. This is attributable to lower saliva production where pelleted rations containing finely ground constituents are fed. With less blood phosphate partitioned into saliva, more tends to be excreted in urine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[153]</sup> (Most saliva phosphate is fecally excreted.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[154]</sup>)</span>
<span class="mb-4 block break-words text-[1em] leading-7">Oxalate uroliths can occur in ruminants, although such problems from oxalate ingestion may be relatively uncommon. Ruminant urolithiasis associated with oxalate ingestion has been reported.<!-- --> However, no renal tubular damage or visible deposition of calcium oxalate crystals in kidneys was found in yearling wether sheep fed diets containing soluble oxalate at 6.5 percent of dietary dry matter for about 100 days.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[156]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Conditions limiting water intake can result in stone formation.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Various surgical interventions, e.g. amputation of the urethral process at its base near the glans penis in male ruminants, perineal <span class="inline text-[1em] leading-7">urethrostomy</span>, or tube <span class="inline text-[1em] leading-7">cystostomy</span> may be considered for relief of obstructive urolithiasis.</span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Schulsinger DA (2014). <a href="https://books.google.com/books?id=2ADRBQAAQBAJ&amp;pg=PA27" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Kidney Stone Disease: Say NO to Stones!</em></a>. Springer. p. 27. <span class="inline text-[1em] leading-7">ISBN</span> 978-3-319-12105-5. <a href="https://web.archive.org/web/20170908221053/https://books.google.com/books?id=2ADRBQAAQBAJ&amp;pg=PA27" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 8 September 2017.</span></div></li><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones?dkrd=hispt0421" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney Stones in Adults&quot;</a>. February 2013. <a href="https://web.archive.org/web/20150511192215/http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/kidney-stones-in-adults/Pages/facts.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 11 May 2015. Retrieved 22 May 2015.</span></div></li><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Knoll T, Pearle MS (2012). <a href="https://books.google.com/books?id=A2uak6SVgBUC&amp;pg=PA21" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Clinical Management of Urolithiasis</em></a>. Springer Science &amp; Business Media. p. 21. <span class="inline text-[1em] leading-7">ISBN</span> 978-3-642-28732-9. <a href="https://web.archive.org/web/20170908221053/https://books.google.com/books?id=A2uak6SVgBUC&amp;pg=PA21" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 8 September 2017.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Qaseem A, Dallas P, Forciea MA, et al. (November 2014). <a href="https://doi.org/10.7326%2FM13-2908" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians&quot;</a>. <em>Annals of Internal Medicine</em>. <strong>161</strong> (9): 659â€“67. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7326%2FM13-2908" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7326/M13-2908</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25364887" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25364887</a>.</span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/</a></span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Miller NL, Lingeman JE (March 2007). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808123" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Management of kidney stones&quot;</a>. <em>BMJ</em>. <strong>334</strong> (7591): 468â€“72. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fbmj.39113.480185.80" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/bmj.39113.480185.80</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808123" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1808123</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17332586" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17332586</a>.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Morgan MS, Pearle MS (March 2016). &quot;Medical management of renal stones&quot;. <em>BMJ</em>. <strong>352</strong> : i52. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fbmj.i52" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/bmj.i52</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26977089" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26977089</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:28313474" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28313474</a>.</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Afshar K, Jafari S, Marks AJ, et al. (June 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981792" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>2015</strong> (6): CD006027. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD006027.pub2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD006027.pub2</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981792" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10981792</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26120804" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26120804</a>.</span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wang RC, Smith-Bindman R, Whitaker E, et al. (March 2017). <a href="https://doi.org/10.1016%2Fj.annemergmed.2016.06.044" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis&quot;</a>. <em>Annals of Emergency Medicine</em>. <strong>69</strong> (3): 353â€“361.e3. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.annemergmed.2016.06.044" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.annemergmed.2016.06.044</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/27616037" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27616037</a>.</span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Abufaraj M, Xu T, Cao C, et al. (November 2021). <a href="https://doi.org/10.1016%2Fj.euf.2020.08.011" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data&quot;</a>. <em>European Urology Focus</em>. <strong>7</strong> (6): 1468â€“1475. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.euf.2020.08.011" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.euf.2020.08.011</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/32900675" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">32900675</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:221572651" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">221572651</a>.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stamatelou KK, Francis ME, Jones CA, et al. (May 2003). <a href="https://doi.org/10.1046%2Fj.1523-1755.2003.00917.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Time trends in reported prevalence of kidney stones in the United States: 1976â€“199411.See Editorial by Goldfarb, p. 1951&quot;</a>. <em>Kidney International</em>. <strong>63</strong> (5): 1817â€“1823. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.1523-1755.2003.00917.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.1523-1755.2003.00917.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12675858" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12675858</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stamatelou K, Goldfarb DS (January 2023). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914194" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Epidemiology of Kidney Stones&quot;</a>. <em>Healthcare</em>. <strong>11</strong> (3): 424. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3390%2Fhealthcare11030424" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3390/healthcare11030424</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/2227-9032" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2227-9032</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914194" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9914194</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/36766999" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">36766999</a>.<em><a href="https://creativecommons.org/licenses/by/4.0/" title="creativecommons:by/4.0/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"></a>  This article incorporates text from this source, which is available under the <a href="https://creativecommons.org/licenses/by/4.0/" title="creativecommons:by/4.0/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">CC BY 4.0</a> license.</em></span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Preminger GM (2007). <a href="http://www.merckmanuals.com/home/sec12/ch148/ch148a.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chapter 148: Stones in the Urinary Tract&quot;</a>. In Cutler RE (ed.). <span class="inline text-[1em] leading-7"><em>The Merck Manual of Medical Information Home Edition</em></span> (3rd ed.). Whitehouse Station, New Jersey: <span class="inline text-[1em] leading-7">Merck Sharp and Dohme Corporation</span>. <a href="https://web.archive.org/web/20141208070004/http://www.merckmanuals.com/home/sec12/ch148/ch148a.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 8 December 2014. Retrieved 7 August 2011.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><em><a href="https://emedicine.medscape.com/article/437096-Overview" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Nephrolithiasis~Overview</a></em> at <span class="inline text-[1em] leading-7">eMedicine</span> Â§ Background.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pearle MS, Calhoun EA, Curhan GC (2007). <a href="http://kidney.niddk.nih.gov/statistics/uda/Urologic_Diseases_in_America.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Ch. 8: Urolithiasis&quot;</a> (PDF). In Litwin MS, Saigal CS (eds.). <em>Urologic Diseases in America (NIH Publication No. 07â€“5512)</em>. Bethesda, Maryland: <span class="inline text-[1em] leading-7">National Institute of Diabetes and Digestive and Kidney Diseases</span>, <span class="inline text-[1em] leading-7">National Institutes of Health</span>, <span class="inline text-[1em] leading-7">United States Public Health Service</span>, <span class="inline text-[1em] leading-7">United States Department of Health and Human Services</span>. pp. 283â€“319. <a href="https://web.archive.org/web/20111018023922/http://kidney.niddk.nih.gov/statistics/UDA/Urologic_Diseases_in_America.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 18 October 2011.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cavendish M (2008). <a href="https://books.google.com/books?id=L5fGm_7ThKEC&amp;q=0761477721&amp;pg=PA507" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney disorders&quot;</a>. <em>Diseases and Disorders</em>. Vol. 2 (1st ed.). Tarrytown, New York: Marshall Cavendish Corporation. pp. 490â€“3. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-7614-7772-3. <a href="https://web.archive.org/web/20210414055706/https://books.google.com/books?id=L5fGm_7ThKEC&amp;q=0761477721&amp;pg=PA507" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 14 April 2021. Retrieved 6 November 2020.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Curhan GC, Willett WC, Rimm EB, et al. (February 1996). <a href="https://doi.org/10.1093%2Foxfordjournals.aje.a008734" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Prospective study of beverage use and the risk of kidney stones&quot;</a>. <em>American Journal of Epidemiology</em>. <strong>143</strong> (3): 240â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Foxfordjournals.aje.a008734" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/oxfordjournals.aje.a008734</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8561157" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8561157</a>.</span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lewis SM (2017). <em>Medical-surgical nursing  : assessment and management of clinical problems</em>. Elsevier. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-323-32852-4. <span class="inline text-[1em] leading-7">OCLC</span> <a href="https://search.worldcat.org/oclc/944472408" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">944472408</a>.</span></div></li><li id="38" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Goodwin JS, Tangum MR (November 1998). &quot;Battling quackery: attitudes about micronutrient supplements in American academic medicine&quot;. <em>Archives of Internal Medicine</em>. <strong>158</strong> (20): 2187â€“91. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchinte.158.20.2187" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archinte.158.20.2187</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9818798" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9818798</a>.</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Knight J, Assimos DG, Easter L, et al. (November 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139422" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Metabolism of fructose to oxalate and glycolate&quot;</a>. <em>Hormone and Metabolic Research</em>. <strong>42</strong> (12): 868â€“73. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1055%2Fs-0030-1265145" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1055/s-0030-1265145</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139422" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3139422</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20842614" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20842614</a>.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Moe OW (January 2006). <a href="http://emed.chris-barton.com/PDF/kidney%20stones%20pathophys%20and%20rx.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney stones: pathophysiology and medical management&quot;</a> (PDF). <em>Lancet</em>. <strong>367</strong> (9507): 333â€“44. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0140-6736%2806%2968071-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0140-6736(06)68071-9</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16443041" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16443041</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:26581831" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26581831</a>. <a href="https://web.archive.org/web/20110815154001/http://emed.chris-barton.com/PDF/kidney%20stones%20pathophys%20and%20rx.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 15 August 2011.</span></div></li><li id="22" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Thakker RV (March 2000). <a href="http://www.nature.com/ki/journal/v57/n3/pdf/4491399a.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pathogenesis of Dent&#x27;s disease and related syndromes of X-linked nephrolithiasis&quot;</a> (PDF). <em>Kidney International</em>. <strong>57</strong> (3): 787â€“93. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.1523-1755.2000.00916.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.1523-1755.2000.00916.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10720930" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10720930</a>. <a href="https://web.archive.org/web/20121105121823/http://www.nature.com/ki/journal/v57/n3/pdf/4491399a.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 5 November 2012.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">National Endocrine and Metabolic Diseases Information Service</span> (2006). <a href="https://web.archive.org/web/20110524101254/http://www.endocrine.niddk.nih.gov/pubs/hyper/hyper.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Hyperparathyroidism (NIH Publication No. 6â€“3425)&quot;</a>. <em>Information about Endocrine and Metabolic Diseases: A-Z list of Topics and Titles</em>. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from <a href="http://www.endocrine.niddk.nih.gov/pubs/hyper/hyper.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 24 May 2011. Retrieved 27 July 2011.</span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hoppe B, Langman CB (October 2003). &quot;A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria&quot;. <em>Pediatric Nephrology</em>. <strong>18</strong> (10): 986â€“91. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs00467-003-1234-x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s00467-003-1234-x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12920626" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12920626</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:23503869" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23503869</a>.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Reilly RF, <strong>Ch. 13: &quot;Nephrolithiasis&quot;</strong>. In Reilly &amp; Perazella 2005, pp. 192â€“207.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">National Kidney and Urologic Diseases Information Clearinghouse (2008). <a href="https://web.archive.org/web/20110807163748/http://kidney.niddk.nih.gov/kudiseases/pubs/medullaryspongekidney/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Medullary Sponge Kidney (NIH Publication No. 08â€“6235)&quot;</a>. <em>Kidney &amp; Urologic Diseases: A-Z list of Topics and Titles</em>. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from <a href="http://kidney.niddk.nih.gov/kudiseases/pubs/medullaryspongekidney/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 7 August 2011. Retrieved 27 July 2011.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">National Digestive Diseases Information Clearinghouse</span> (2006). <a href="https://web.archive.org/web/20140609002323/http://digestive.niddk.nih.gov/ddISeases/pubs/crohns/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Crohn&#x27;s Disease (NIH Publication No. 06â€“3410)&quot;</a>. <em>Digestive Diseases: A-Z List of Topics and Titles</em>. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States Public Health Service, United States Department of Health and Human Services. Archived from <a href="http://digestive.niddk.nih.gov/ddiseases/pubs/crohns/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 9 June 2014. Retrieved 27 July 2011.</span></div></li><li id="28" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). <a href="http://www.ccjm.org/content/41/3/109.short" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease&quot;</a>. <em>Cleveland Clinic Quarterly</em>. <strong>41</strong> (3): 109â€“17. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3949%2Fccjm.41.3.109" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3949/ccjm.41.3.109</a> (inactive 12 July 2025). <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/4416806" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4416806</a>. <a href="https://web.archive.org/web/20200320210418/https://www.ccjm.org/content/41/3/109.short" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 20 March 2020. Retrieved 1 November 2013.<code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">{{cite journal}}</code>: CS1 maint: DOI inactive as of July 2025 (link)</span></div></li><li id="29" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">&quot;Tolerable upper intake levels: Calcium and vitamin D&quot;. In Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2011, pp. 403â€“56.</span></div></li><li id="30" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Johri N, Cooper B, Robertson W, et al. (2010). <a href="https://www.karger.com/Article/PDF/000317196" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;An update and practical guide to renal stone management&quot;</a>. <em>Nephron Clinical Practice</em>. <strong>116</strong> (3): c159-71. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1159%2F000317196" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1159/000317196</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20606476" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20606476</a>. <a href="https://web.archive.org/web/20210131093917/https://www.karger.com/Article/PDF/000317196" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 31 January 2021. Retrieved 18 May 2019.</span></div></li><li id="31" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">&quot;Summary&quot;. In Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2011, pp. 1â€“14.</span></div></li><li id="32" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Parmar MS (June 2004). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421787" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney stones&quot;</a>. <em>BMJ</em>. <strong>328</strong> (7453): 1420â€“4. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fbmj.328.7453.1420" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/bmj.328.7453.1420</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421787" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">421787</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15191979" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15191979</a>.</span></div></li><li id="33" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Liebman M, Al-Wahsh IA (May 2011). <a href="http://advances.nutrition.org/content/2/3/254.full.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Probiotics and other key determinants of dietary oxalate absorption&quot;</a> (PDF). <em>Advances in Nutrition</em>. <strong>2</strong> (3): 254â€“60. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3945%2Fan.111.000414" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3945/an.111.000414</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090165" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3090165</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22332057" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22332057</a>. <a href="https://web.archive.org/web/20160116135506/http://advances.nutrition.org/content/2/3/254.full.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 16 January 2016.</span></div></li><li id="34" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Committee on Fluoride in Drinking Water of the National Academy of Sciences (2006). <a href="http://www.nap.edu/openbook.php?record_id=11571&amp;page=268" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chapter 9: Effects on the Renal System&quot;</a>. <em>Fluoride in Drinking Water: A Scientific Review of EPA&#x27;s Standards</em>. Washington, DC: The National Academies Press. pp. 236â€“48. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-309-65799-0. <a href="https://web.archive.org/web/20110730220401/http://www.nap.edu/openbook.php?record_id=11571&amp;page=268" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 30 July 2011.</span></div></li><li id="35" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ferraro PM, Mandel EI, Curhan GC, et al. (October 2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053786" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones&quot;</a>. <em>Clinical Journal of the American Society of Nephrology</em>. <strong>11</strong> (10): 1834â€“1844. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2215%2FCJN.01520216" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2215/CJN.01520216</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053786" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5053786</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/27445166" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27445166</a>.</span></div></li><li id="36" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Riley JM, Kim H, Averch TD, et al. (December 2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883082" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Effect of magnesium on calcium and oxalate ion binding&quot;</a>. <em>Journal of Endourology</em>. <strong>27</strong> (12): 1487â€“92. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1089%2Fend.2013.0173" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1089/end.2013.0173</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883082" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3883082</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24127630" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24127630</a>.</span></div></li><li id="37" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Negri AL, Spivacow FR, Del Valle EE (2013). &quot;[Diet in the treatment of renal lithiasis. Pathophysiological basis]&quot;. <em>Medicina</em>. <strong>73</strong> (3): 267â€“71. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23732207" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23732207</a>.</span></div></li><li id="39" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Traxer O, Pearle MS, Gattegno B, et al. (December 2003). &quot;[Vitamin C and stone risk. Review of the literature]&quot;. <em>Progres en Urologie</em>. <strong>13</strong> (6): 1290â€“4. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15000301" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15000301</a>.</span></div></li><li id="40" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ferraro PM, Curhan GC, Gambaro G, et al. (March 2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769668" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones&quot;</a>. <em>American Journal of Kidney Diseases</em>. <strong>67</strong> (3): 400â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1053%2Fj.ajkd.2015.09.005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1053/j.ajkd.2015.09.005</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769668" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4769668</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26463139" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26463139</a>.</span></div></li><li id="41" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Phillips R, Hanchanale VS, Myatt A, et al. (October 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Citrate salts for preventing and treating calcium containing kidney stones in adults&quot;</a>. <em>Cochrane Database Syst Rev</em>. <strong>2015</strong> (10): CD010057. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD010057.pub2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD010057.pub2</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9578669</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26439475" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26439475</a>.</span></div></li><li id="42" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Perazella MA, <strong>Ch. 14: &quot;Urinalysis&quot;</strong>. In Reilly &amp; Perazella 2005, pp. 209â€“26.</span></div></li><li id="43" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Knudsen BE, Beiko DT, Denstedt JD, <strong>Ch. 16: &quot;Uric Acid Urolithiasis&quot;</strong>. In Stoller &amp; Meng 2007, pp. 299â€“308.</span></div></li><li id="44" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><em><a href="https://emedicine.medscape.com/article/437096-Overview" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Nephrolithiasis~Overview</a></em> at <span class="inline text-[1em] leading-7">eMedicine</span> Â§ Pathophysiology.</span></div></li><li id="45" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Robertson WG, Peacock M, Nordin BE (July 1969). &quot;Calcium crystalluria in recurrent renal-stone formers&quot;. <em>Lancet</em>. <strong>2</strong> (7610): 21â€“24. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0140-6736%2869%2992598-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0140-6736(69)92598-7</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/4182793" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4182793</a>.</span></div></li><li id="46" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Elliot JS, Rabinowitz IN (March 1980). &quot;Calcium oxalate crystalluria: crystal size in urine&quot;. <em>The Journal of Urology</em>. <strong>123</strong> (3): 324â€“327. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0022-5347%2817%2955918-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0022-5347(17)55918-2</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7359628" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7359628</a>.</span></div></li><li id="47" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Randall A (June 1937). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1390483" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The Origin and Growth of Renal Calculi&quot;</a>. <em>Annals of Surgery</em>. <strong>105</strong> (6): 1009â€“1027. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1097%2F00000658-193706000-00014" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1097/00000658-193706000-00014</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1390483" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1390483</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17856988" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17856988</a>.</span></div></li><li id="48" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ratkalkar VN, Kleinman JG (December 2011). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252394" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Mechanisms of Stone Formation&quot;</a>. <em>Clinical Reviews in Bone and Mineral Metabolism</em>. <strong>9</strong> (3â€“4): 187â€“197. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs12018-011-9104-8" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s12018-011-9104-8</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252394" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3252394</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22229020" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22229020</a>.</span></div></li><li id="49" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Khan SR (September 2014). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220551" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis&quot;</a>. <em>Translational Andrology and Urology</em>. <strong>3</strong> (3): 256â€“276. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3978%2Fj.issn.2223-4683.2014.06.04" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3978/j.issn.2223-4683.2014.06.04</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220551" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4220551</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25383321" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25383321</a>.</span></div></li><li id="50" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Jones BD, Mobley HL (August 1988). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC211300" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes&quot;</a>. <em>Journal of Bacteriology</em>. <strong>170</strong> (8): 3342â€“3349. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1128%2Fjb.170.8.3342-3349.1988" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1128/jb.170.8.3342-3349.1988</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC211300" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">211300</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/2841283" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2841283</a>.</span></div></li><li id="51" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chmiel JA, Stuivenberg GA, Alathel A, et al. (December 2021). &quot;High-Throughput in vitro Gel-Based Plate Assay to Screen for Calcium Oxalate Stone Inhibitors&quot;. <em>Urologia Internationalis</em>. <strong>106</strong> (6): 616â€“622. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1159%2F000519842" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1159/000519842</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/34883484" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">34883484</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:245012979" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">245012979</a>.</span></div></li><li id="52" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kanlaya R, Naruepantawart O, Thongboonkerd V (5 November 2019). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848068" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Flagellum Is Responsible for Promoting Effects of Viable <em>Escherichia coli</em> on Calcium Oxalate Crystallization, Crystal Growth, and Crystal Aggregation&quot;</a>. <em>Frontiers in Microbiology</em>. <strong>10</strong> : 2507. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3389%2Ffmicb.2019.02507" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3389/fmicb.2019.02507</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848068" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6848068</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31749785" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31749785</a>.</span></div></li><li id="53" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Coe FL, Evan A, Worcester E (October 2005). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236703" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney stone disease&quot;</a>. <em>The Journal of Clinical Investigation</em>. <strong>115</strong> (10): 2598â€“608. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1172%2FJCI26662" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1172/JCI26662</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236703" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1236703</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16200192" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16200192</a>.</span></div></li><li id="54" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">del Valle EE, Spivacow FR, Negri AL (2013). &quot;[Citrate and renal stones]&quot;. <em>Medicina</em>. <strong>73</strong> (4): 363â€“8. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23924538" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23924538</a>.</span></div></li><li id="55" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.kidney.org/sites/default/files/moonstone-professional-education-teaching-card-final.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Educate Your Patients about Kidney Stones&quot;</a> (PDF). <em>kidney.org</em>. <a href="https://web.archive.org/web/20201026133550/https://www.kidney.org/sites/default/files/moonstone-professional-education-teaching-card-final.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 26 October 2020.</span></div></li><li id="56" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Caudarella R, Vescini F (September 2009). <a href="https://www.researchgate.net/publication/38087757" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment&quot;</a>. <em>Archivio Italiano di Urologia, Andrologia</em>. <strong>81</strong> (3): 182â€“7. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19911682" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19911682</a>.</span></div></li><li id="57" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Anoia EJ, Paik ML, Resnick MI (2009). <a href="https://books.google.com/books?id=GahMzaKgMKAC&amp;q=nephrolithiasis+diagnosis+radiographic&amp;pg=PA45" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Ch. 7: Anatrophic Nephrolithomy&quot;</a>. In Graham SD, Keane TE (eds.). <em>Glenn&#x27;s Urologic Surgery</em> (7th ed.). Philadelphia: Lippincott Williams &amp; Wilkins. pp. 45â€“50. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-7817-9141-0. <a href="https://web.archive.org/web/20210414030139/https://books.google.com/books?id=GahMzaKgMKAC&amp;q=nephrolithiasis+diagnosis+radiographic&amp;pg=PA45" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 14 April 2021. Retrieved 6 November 2020.</span></div></li><li id="58" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Weaver SH, Jenkins P (2002). <a href="https://archive.org/details/illustratedmanua0000unse" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Ch. 14: Renal and Urological Care&quot;</a>. <em>Illustrated Manual of Nursing Practice</em> (3rd ed.). Lippincott Williams &amp; Wilkins. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-58255-082-4.</span></div></li><li id="59" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pietrow PK, Karellas ME (July 2006). <a href="http://www.aafp.org/afp/2006/0701/p86.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Medical management of common urinary calculi&quot;</a> (PDF). <em>American Family Physician</em>. <strong>74</strong> (1): 86â€“94. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16848382" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16848382</a>. <a href="https://web.archive.org/web/20111123060406/http://www.aafp.org/afp/2006/0701/p86.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 23 November 2011.</span></div></li><li id="60" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Brisbane W, Bailey MR, Sorensen MD (November 2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443345" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;An overview of kidney stone imaging techniques&quot;</a>. <em>Nature Reviews. Urology</em>. <strong>13</strong> (11): 654â€“662. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fnrurol.2016.154" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/nrurol.2016.154</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/1759-4812" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1759-4812</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443345" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5443345</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/27578040" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27578040</a>.</span></div></li><li id="61" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Smith RC, Varanelli M (July 2000). &quot;Diagnosis and management of acute ureterolithiasis: CT is truth&quot;. <em>AJR. American Journal of Roentgenology</em>. <strong>175</strong> (1): 3â€“6. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2214%2Fajr.175.1.1750003" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2214/ajr.175.1.1750003</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10882237" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10882237</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:73387308" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">73387308</a>.</span></div></li><li id="62" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bushinsky D, Coe FL, Moe OW (2007). <a href="https://web.archive.org/web/20111008090923/http://www.expertconsultbook.com/expertconsult/op/book.do?method=display&amp;type=bookPage&amp;decorator=none&amp;eid=4-u1.0-B978-1-4160-3105-5..50039-6&amp;isbn=978-1-4160-3105-5#lpState=open&amp;lpTab=contentsTab&amp;content=4-u1.0-B978-1-4160-3105-5..50039-6%3Bfrom%3Dtoc%3Btype%3DbookPage%3Bisbn%3D978-1-4160-3105-5&amp;search=none" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Ch. 37: Nephrolithiasis&quot;</a>. In Brenner BM (ed.). <em>Brenner and Rector&#x27;s The Kidney</em>. Vol. 1 (8th ed.). Philadelphia: WB Saunders. pp. 1299â€“349. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-4160-3105-5. Archived from <a href="http://www.expertconsultbook.com/expertconsult/op/book.do?method=display&amp;type=bookPage&amp;decorator=none&amp;eid=4-u1.0-B978-1-4160-3105-5..50039-6&amp;isbn=978-1-4160-3105-5#lpState=open&amp;lpTab=contentsTab&amp;content=4-u1.0-B978-1-4160-3105-5..50039-6%3Bfrom%3Dtoc%3Btype%3DbookPage%3Bisbn%3D978-1-4160-3105-5&amp;search=none" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 8 October 2011.</span></div></li><li id="63" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Smith RC, Levine J, Rosenfeld AT (September 1999). <a href="https://doi.org/10.1016%2FS0033-8389%2805%2970138-X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Helical CT of urinary tract stones. Epidemiology, origin, pathophysiology, diagnosis, and management&quot;</a>. <em>Radiologic Clinics of North America</em>. <strong>37</strong> (5): 911â€“52, v. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0033-8389%2805%2970138-X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0033-8389(05)70138-X</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10494278" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10494278</a>.</span></div></li><li id="64" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">American College of Emergency Physicians (27 October 2014). <a href="http://www.choosingwisely.org/doctor-patient-lists/american-college-of-emergency-physicians/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Ten Things Physicians and Patients Should Question&quot;</a>. <em>Choosing Wisely</em>. <a href="https://web.archive.org/web/20140307012443/http://www.choosingwisely.org/doctor-patient-lists/american-college-of-emergency-physicians/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 7 March 2014. Retrieved 14 January 2015.</span></div></li><li id="65" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20170223133729/http://www.choosingwisely.org/societies/american-urological-association/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;American Urological Association | Choosing Wisely&quot;</a>. <em><a href="http://www.choosingwisely.org" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">www.choosingwisely.org</a></em>. Archived from <a href="http://www.choosingwisely.org/societies/american-urological-association/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 23 February 2017. Retrieved 28 May 2017.</span></div></li><li id="66" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fang LS (2009). <a href="https://books.google.com/books?id=bIZvJPcSEXMC&amp;q=nephrolithiasis+%22physical+examination%22&amp;pg=PA964" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chapter 135: Approach to the Paient with Nephrolithiasis&quot;</a>. In Goroll AH, Mulley AG (eds.). <em>Primary care medicine: office evaluation and management of the adult patient</em> (6th ed.). Philadelphia: Lippincott Williams &amp; Wilkins. pp. 962â€“7. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-7817-7513-7. <a href="https://web.archive.org/web/20210321183305/https://books.google.com/books?id=bIZvJPcSEXMC&amp;q=nephrolithiasis+%22physical+examination%22&amp;pg=PA964" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 21 March 2021. Retrieved 6 November 2020.</span></div></li><li id="67" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Semins MJ, Matlaga BR (September 2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792830" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Management of urolithiasis in pregnancy&quot;</a>. <em>International Journal of Women&#x27;s Health</em>. <strong>5</strong> : 599â€“604. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2147%2Fijwh.s51416" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2147/ijwh.s51416</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792830" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3792830</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24109196" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24109196</a>.</span></div></li><li id="68" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Smith-Bindman R, Aubin C, Bailitz J, et al. (September 2014). <a href="https://escholarship.org/content/qt1cm5f8cd/qt1cm5f8cd.pdf?t=nwl44w" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Ultrasonography versus computed tomography for suspected nephrolithiasis&quot;</a> (PDF). <em>The New England Journal of Medicine</em>. <strong>371</strong> (12): 1100â€“10. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMoa1404446" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMoa1404446</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25229916" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25229916</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:4511678" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4511678</a>. <a href="https://web.archive.org/web/20200314051953/https://escholarship.org/content/qt1cm5f8cd/qt1cm5f8cd.pdf?t=nwl44w" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 14 March 2020. Retrieved 25 September 2019.</span></div></li><li id="69" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">National Kidney and Urologic Diseases Information Clearinghouse (2007). <a href="https://web.archive.org/web/20110726181803/http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney Stones in Adults (NIH Publication No. 08â€“2495)&quot;</a>. <em>Kidney &amp; Urologic Diseases: A-Z list of Topics and Titles</em>. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from <a href="http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 26 July 2011. Retrieved 27 July 2011.</span></div></li><li id="70" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Frassetto L, Kohlstadt I (2011). &quot;Treatment and prevention of kidney stones: an update&quot;. <em>Am Fam Physician</em>. <strong>84</strong> (11): 1234â€“42. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22150656" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22150656</a>.</span></div></li><li id="71" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Becker KL (2001). <a href="https://books.google.com/books?id=FVfzRvaucq8C&amp;pg=PA684" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Principles and practice of endocrinology and metabolism</em></a> (3 ed.). Philadelphia, Pa. [u.a.]: Lippincott, Williams &amp; Wilkins. p. 684. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-7817-1750-2. <a href="https://web.archive.org/web/20170908221053/https://books.google.com/books?id=FVfzRvaucq8C&amp;pg=PA684" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 8 September 2017.</span></div></li><li id="72" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.uptodate.com/contents/cystine-stones" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystine stones&quot;</a>. <em><span class="inline text-[1em] leading-7">UpToDate</span></em>. <a href="https://web.archive.org/web/20140226110022/http://www.uptodate.com/contents/cystine-stones" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 26 February 2014. Retrieved 20 February 2014.</span></div></li><li id="73" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bailey &amp; Love&#x27;s/25th/1296</span></div></li><li id="74" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">National Endocrine and Metabolic Diseases Information Service (2008). <a href="https://web.archive.org/web/20110728025351/http://kidney.niddk.nih.gov/kudiseases/pubs/tubularacidosis/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Renal Tubular Acidosis (NIH Publication No. 09â€“4696)&quot;</a>. <em>Kidney &amp; Urologic Diseases: A-Z list of Topics and Titles</em>. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from <a href="http://kidney.niddk.nih.gov/kudiseases/pubs/tubularacidosis/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 28 July 2011. Retrieved 27 July 2011.</span></div></li><li id="75" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">De Mais D (2009). <em>ASCP Quick Compendium of Clinical Pathology</em> (2nd ed.). Chicago: ASCP Press.</span></div></li><li id="76" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Weiss M, Liapis H, Tomaszewski JE, et al. (2007). <a href="https://books.google.com/books?id=oWymx2hp1OoC&amp;q=%22AA+amyloidosis%22+pyelonephritis&amp;pg=PA886" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Chapter 22: Pyelonephritis and Other Infections, Reflux Nephropathy, Hydronephrosis, and Nephrolithiasis&quot;</a>. In Jennette JC, Olson JL, Schwartz MM, Silva FG (eds.). <em>Heptinstall&#x27;s Pathology of the Kidney</em>. Vol. 2 (6th ed.). Philadelphia: Lippincott Williams &amp; Wilkins. pp. 991â€“1082. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-7817-4750-9. <a href="https://web.archive.org/web/20210320231125/https://books.google.com/books?id=oWymx2hp1OoC&amp;q=%22AA+amyloidosis%22+pyelonephritis&amp;pg=PA886" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 20 March 2021. Retrieved 6 November 2020.</span></div></li><li id="77" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Halabe A, Sperling O (1994). &quot;Uric acid nephrolithiasis&quot;. <em>Mineral and Electrolyte Metabolism</em>. <strong>20</strong> (6): 424â€“31. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7783706" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7783706</a>.</span></div></li><li id="78" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kamatani N (December 1996). &quot;[Adenine phosphoribosyltransferase(APRT) deficiency]&quot;. <em>Nihon Rinsho. Japanese Journal of Clinical Medicine</em> (in Japanese). <strong>54</strong> (12): 3321â€“7. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8976113" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8976113</a>.</span></div></li><li id="79" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Rosenberg LE, Durant JL, Elsas LJ (June 1968). &quot;Familial iminoglycinuria. An inborn error of renal tubular transport&quot;. <em>The New England Journal of Medicine</em>. <strong>278</strong> (26): 1407â€“13. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJM196806272782601" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJM196806272782601</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/5652624" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5652624</a>.</span></div></li><li id="80" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">CoÅŸkun T, Ozalp I, Tokatli A (1993). &quot;Iminoglycinuria: a benign type of inherited aminoaciduria&quot;. <em>The Turkish Journal of Pediatrics</em>. <strong>35</strong> (2): 121â€“5. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7504361" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7504361</a>.</span></div></li><li id="81" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_ppi.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Patient Information about Crixivan for HIV (Human Immunodeficiency Virus) Infection&quot;</a> (PDF). <em>CrixivanÂ® (indinavir sulfate) Capsules</em>. Whitehouse Station, New Jersey: Merck Sharp &amp; Dohme Corporation. 2010. <a href="https://web.archive.org/web/20110815003924/http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_ppi.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 15 August 2011. Retrieved 27 July 2011.</span></div></li><li id="82" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Schlossberg D, Samuel R (2011). <a href="https://books.google.com/books?id=sCXn0xOVKNoC" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Sulfadiazine&quot;</a>. <em>Antibiotic Manual: A Guide to Commonly Used Antimicrobials</em> (1st ed.). Shelton, Connecticut: People&#x27;s Medical Publishing House. pp. 411â€“12. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-60795-084-4. <a href="https://web.archive.org/web/20210320092903/https://books.google.com/books?id=sCXn0xOVKNoC" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 20 March 2021. Retrieved 25 August 2020.</span></div></li><li id="83" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Carr MC, Prien EL, Babayan RK (December 1990). &quot;Triamterene nephrolithiasis: renewed attention is warranted&quot;. <em>The Journal of Urology</em>. <strong>144</strong> (6): 1339â€“40. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0022-5347%2817%2939734-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0022-5347(17)39734-3</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/2231920" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2231920</a>.</span></div></li><li id="84" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">McNutt WF (1893). <a href="https://books.google.com/books?id=RP0oAAAAYAAJ&amp;q=cystolithiasis+symptoms&amp;pg=PA185" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Section IV: Diseases of the Bladder, Chapter VII: Vesical Calculi (Cysto-lithiasis)&quot;</a>. <em>Diseases of the Kidneys and Bladder: A Text-Book for Students of Medicine</em>. Philadelphia: J.B. Lippincott Company. pp. 185â€“6. <a href="https://web.archive.org/web/20210414030140/https://books.google.com/books?id=RP0oAAAAYAAJ&amp;q=cystolithiasis+symptoms&amp;pg=PA185" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 14 April 2021. Retrieved 6 November 2020.</span></div></li><li id="85" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gettman MT, Segura JW (March 2005). &quot;Management of ureteric stones: issues and controversies&quot;. <em>BJU International</em>. <strong>95</strong> (Suppl 2): 85â€“93. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1464-410X.2005.05206.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1464-410X.2005.05206.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15720341" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15720341</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:36265416" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">36265416</a>.</span></div></li><li id="86" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Segura JW (February 1997). &quot;Staghorn calculi&quot;. <em>The Urologic Clinics of North America</em>. <strong>24</strong> (1): 71â€“80. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0094-0143%2805%2970355-4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0094-0143(05)70355-4</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9048853" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9048853</a>.</span></div></li><li id="87" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fink HA, Wilt TJ, Eidman KE, et al. (April 2013). <a href="https://doi.org/10.7326%2F0003-4819-158-7-201304020-00005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline&quot;</a>. <em>Annals of Internal Medicine</em>. <strong>158</strong> (7): 535â€“43. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7326%2F0003-4819-158-7-201304020-00005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7326/0003-4819-158-7-201304020-00005</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23546565" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23546565</a>.</span></div></li><li id="88" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Qaseem A, Dallas P, Forciea MA, et al. (November 2014). <a href="https://doi.org/10.7326%2Fm13-2908" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians&quot;</a>. <em>Annals of Internal Medicine</em>. <strong>161</strong> (9): 659â€“67. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7326%2Fm13-2908" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7326/m13-2908</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25364887" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25364887</a>.</span></div></li><li id="89" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Goldfarb DS, Coe FL (November 1999). <a href="http://www.aafp.org/afp/991115ap/2269.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Prevention of recurrent nephrolithiasis&quot;</a>. <em>American Family Physician</em>. <strong>60</strong> (8): 2269â€“76. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10593318" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10593318</a>. <a href="https://web.archive.org/web/20050822183805/http://www.aafp.org/afp/991115ap/2269.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 22 August 2005.</span></div></li><li id="90" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Finkielstein VA, Goldfarb DS (May 2006). <a href="http://www.cmaj.ca/cgi/reprint/174/10/1407" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Strategies for preventing calcium oxalate stones&quot;</a>. <em>CMAJ</em>. <strong>174</strong> (10): 1407â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1503%2Fcmaj.051517" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1503/cmaj.051517</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1455427" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1455427</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16682705" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16682705</a>. <a href="https://web.archive.org/web/20081015202450/http://www.cmaj.ca/cgi/reprint/174/10/1407" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 15 October 2008.</span></div></li><li id="91" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fink HA, Wilt TJ, Eidman KE, et al. (July 2012). &quot;Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies&quot;. <em>Comparative Effectiveness Reviews</em> (61). Rockvill, MD: Agency for Healthcare Research and Quality. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22896859" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22896859</a>.</span></div></li><li id="92" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ferraro PM, Taylor EN, Gambaro G, et al. (August 2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731916" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Soda and other beverages and the risk of kidney stones&quot;</a>. <em>Clinical Journal of the American Society of Nephrology</em>. <strong>8</strong> (8): 1389â€“95. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2215%2FCJN.11661112" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2215/CJN.11661112</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731916" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3731916</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23676355" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23676355</a>.</span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3731916/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3731916/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3731916/</a></span></div></li><li id="94" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Taylor EN, Curhan GC (September 2006). <a href="https://doi.org/10.1038%2Fsj.ki.5001656" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Diet and fluid prescription in stone disease&quot;</a>. <em>Kidney International</em>. <strong>70</strong> (5): 835â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fsj.ki.5001656" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/sj.ki.5001656</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16837923" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16837923</a>.</span></div></li><li id="https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones/eating-diet-nutrition" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones/eating-diet-nutrition" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones/eating-diet-nutrition</a></span></div></li><li id="95" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gul Z, Monga M (December 2014). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Medical and dietary therapy for kidney stone prevention&quot;</a>. <em>Korean Journal of Urology</em>. <strong>55</strong> (12): 775â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.4111%2Fkju.2014.55.12.775" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.4111/kju.2014.55.12.775</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4265710</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25512810" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25512810</a>.</span></div></li><li id="96" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uwhealth.org/files/uwhealth/docs/pdf/kidney_citric_acid.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Citric Acid and Kidney Stones&quot;</a> (PDF). <em>uwhealth.org</em>. <a href="https://web.archive.org/web/20100705033118/http://www.uwhealth.org/files/uwhealth/docs/pdf/kidney_citric_acid.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 5 July 2010.</span></div></li><li id="97" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Balawender K, Åuszczki E, Mazur A, et al. (June 2024). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11206918" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The Multidisciplinary Approach in the Management of Patients with Kidney Stone Disease-A State-of-the-Art Review&quot;</a>. <em>Nutrients</em>. <strong>16</strong> (12): 1932. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3390%2Fnu16121932" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3390/nu16121932</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11206918" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11206918</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/38931286" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">38931286</a>.</span></div></li><li id="98" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Heaney RP (March 2006). <a href="https://doi.org/10.4065%2F81.3.297" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Nutrition and chronic disease&quot;</a>. <em>Mayo Clinic Proceedings</em>. <strong>81</strong> (3): 297â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.4065%2F81.3.297" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.4065/81.3.297</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16529131" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16529131</a>.</span></div></li><li id="99" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tiselius HG (May 2003). &quot;Epidemiology and medical management of stone disease&quot;. <em>BJU International</em>. <strong>91</strong> (8): 758â€“67. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.1464-410X.2003.04208.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.1464-410X.2003.04208.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12709088" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12709088</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:28256459" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28256459</a>.</span></div></li><li id="100" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Taylor EN, Stampfer MJ, Curhan GC (December 2004). <a href="http://jasn.asnjournals.org/content/15/12/3225.full.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up&quot;</a> (PDF). <em>Journal of the American Society of Nephrology</em>. <strong>15</strong> (12): 3225â€“32. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1097%2F01.ASN.0000146012.44570.20" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1097/01.ASN.0000146012.44570.20</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15579526" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15579526</a>. <a href="https://web.archive.org/web/20170921054542/http://jasn.asnjournals.org/content/15/12/3225.full.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 21 September 2017. Retrieved 3 June 2011.</span></div></li><li id="101" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cicerello E, Merlo F, Maccatrozzo L (September 2010). &quot;Urinary alkalization for the treatment of uric acid nephrolithiasis&quot;. <em>Archivio Italiano di Urologia, Andrologia</em>. <strong>82</strong> (3): 145â€“8. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21121431" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21121431</a>.</span></div></li><li id="103" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cameron JS, Simmonds HA (June 1987). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246665" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Use and abuse of allopurinol&quot;</a>. <em>British Medical Journal</em>. <strong>294</strong> (6586): 1504â€“5. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fbmj.294.6586.1504" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/bmj.294.6586.1504</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246665" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1246665</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/3607420" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3607420</a>.</span></div></li><li id="104" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Macaluso JN (November 1996). &quot;Management of stone disease--bearing the burden&quot;. <em>The Journal of Urology</em>. <strong>156</strong> (5): 1579â€“80. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0022-5347%2801%2965452-1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0022-5347(01)65452-1</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8863542" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8863542</a>.</span></div></li><li id="105" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pathan SA, Mitra B, Cameron PA (April 2018). &quot;A Systematic Review and Meta-analysis Comparing the Efficacy of Nonsteroidal Anti-inflammatory Drugs, Opioids, and Paracetamol in the Treatment of Acute Renal Colic&quot;. <em>European Urology</em>. <strong>73</strong> (4): 583â€“595. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.eururo.2017.11.001" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.eururo.2017.11.001</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29174580" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29174580</a>.</span></div></li><li id="106" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Seitz C, Liatsikos E, Porpiglia F, et al. (September 2009). &quot;Medical therapy to facilitate the passage of stones: what is the evidence?&quot;. <em>European Urology</em>. <strong>56</strong> (3): 455â€“71. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.eururo.2009.06.012" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.eururo.2009.06.012</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19560860" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19560860</a>.</span></div></li><li id="107" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Campschroer T, Zhu X, Vernooij RW, et al. (April 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494465" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Alpha-blockers as medical expulsive therapy for ureteral stones&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>2018</strong> (4): CD008509. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD008509.pub3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD008509.pub3</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494465" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6494465</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29620795" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29620795</a>.</span></div></li><li id="108" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Shock Wave Lithotripsy Task Force (2009). <a href="https://web.archive.org/web/20130718072759/http://www.auanet.org/common/pdf/education/clinical-guidance/Shock-Wave-Therapy-WP.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Current Perspective on Adverse Effects in Shock Wave Lithotripsy&quot;</a> (PDF). <em>Clinical Guidelines</em>. Linthicum, Maryland: <span class="inline text-[1em] leading-7">American Urological Association</span>. Archived from <a href="https://www.auanet.org/common/pdf/education/clinical-guidance/Shock-Wave-Therapy-WP.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 18 July 2013. Retrieved 13 October 2015.</span></div></li><li id="109" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lingeman JE, Matlaga BR, Evan AP (2007). &quot;Surgical Management of Urinary Lithiasis&quot;. In Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds.). <em>Campbell-Walsh Urology</em>. Philadelphia: W. B. Saunders. pp. 1431â€“1507.</span></div></li><li id="110" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Preminger GM, Tiselius HG, Assimos DG, et al. (December 2007). &quot;2007 guideline for the management of ureteral calculi&quot;. <em>The Journal of Urology</em>. <strong>178</strong> (6): 2418â€“34. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.juro.2007.09.107" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.juro.2007.09.107</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17993340" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17993340</a>.</span></div></li><li id="111" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Evan AP, McAteer JA (1996). &quot;Ch. 28: Q-effects of Shock Wave Lithotripsy&quot;. In Coe FL, Favus MJ, Pak CY, Parks JH, Preminger GM (eds.). <a href="https://archive.org/details/kidneystonesmedi0000unse" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Kidney Stones: Medical and Surgical Management</em></a>. Philadelphia: Lippincott-Raven. pp. <a href="https://archive.org/details/kidneystonesmedi0000unse/page/549" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">549</a>â€“60. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-7817-0263-8.</span></div></li><li id="112" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Evan AP, Willis LR (2007). &quot;Ch. 41: Extracorporeal Shock Wave Lithotripsy: Complications&quot;. In Smith AD, Badlani GH, Bagley DH, Clayman RV, Docimo SG (eds.). <em>Smith&#x27;s Textbook on Endourology</em>. Hamilton, Ontario, Canada: B C Decker, Inc. pp. 353â€“65.</span></div></li><li id="113" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Oestreich MC, Vernooij RW, Sathianathen NJ, et al. (Cochrane Urology Group) (November 2020). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092672" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>2020</strong> (11): CD013393. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD013393.pub2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD013393.pub2</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092672" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8092672</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/33179245" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">33179245</a>.</span></div></li><li id="114" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Young JG, Keeley FX, __Ch. 38: &quot;Indications for Surgical Removal, Including Asymptomatic Stones&quot;__inRao, Preminger &amp; Kavanagh 2011, pp. 441â€“454.</span></div></li><li id="115" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wynberg JB, Borin JF, Vicena JZ, et al. (October 2012). &quot;Flexible ureteroscopy-directed retrograde nephrostomy for percutaneous nephrolithotomy: description of a technique&quot;. <em>Journal of Endourology</em>. <strong>26</strong> (10): 1268â€“74. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1089%2Fend.2012.0160" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1089/end.2012.0160</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22563900" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22563900</a>.</span></div></li><li id="116" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lam JS, Gupta M, <strong>Ch. 25: &quot;Ureteral Stents&quot;</strong>. In Stoller &amp; Meng 2007, pp. 465â€“83.</span></div></li><li id="117" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ordonez M, Hwang EC, Borofsky M, et al. (Cochrane Urology Group) (February 2019). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365118" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>2019</strong> (2): CD012703. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD012703.pub2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD012703.pub2</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365118" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6365118</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30726554" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30726554</a>.</span></div></li><li id="118" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Marks AJ, Qiu J, Milner TE, et al. (6 January 2011), <a href="https://books.google.com/books?id=LlJy5XJOkSkC&amp;pg=PA302" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><strong>Ch. 26: &quot;Laser Lithotripsy Physics&quot;</strong></a>, Springer,<span class="inline text-[1em] leading-7">ISBN</span> 978-1-84800-362-0, <a href="https://web.archive.org/web/20210220110253/https://books.google.com/books?id=LlJy5XJOkSkC&amp;pg=PA302" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">archived</a> from the original on 20 February 2021, retrieved 6 November 2020 in Rao, Preminger &amp; Kavanagh 2011, pp. 301â€“310.</span></div></li><li id="https://journals.lww.com/juop/fulltext/2024/11000/kidney_stone_prevalence_among_us_population_.3.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.lww.com/juop/fulltext/2024/11000/kidney_stone_prevalence_among_us_population_.3.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.lww.com/juop/fulltext/2024/11000/kidney_stone_prevalence_among_us_population_.3.aspx</a></span></div></li><li id="119" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Romero V, Akpinar H, Assimos DG (2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931286" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Kidney stones: a global picture of prevalence, incidence, and associated risk factors&quot;</a>. <em>Reviews in Urology</em>. <strong>12</strong> (2â€“3): e86-96. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931286" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2931286</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20811557" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20811557</a>.</span></div></li><li id="120" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lieske JC, Segura JW (2004). &quot;Ch. 7: Evaluation and Medical Management of Kidney Stones&quot;. In Potts JM (ed.). <a href="https://archive.org/details/essentialurology0000unse" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Essential Urology: A Guide to Clinical Practice</em></a> (1st ed.). Totowa, New Jersey: Humana Press. pp. <a href="https://archive.org/details/essentialurology0000unse/page/117" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">117</a>â€“52. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-58829-109-7.</span></div></li><li id="121" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lozano R, Naghavi M, Foreman K, et al. (December 2012). <a href="https://web.archive.org/web/20200519152712/https://zenodo.org/record/2557786" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010&quot;</a>. <em>Lancet</em>. <strong>380</strong> (9859): 2095â€“128. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0140-6736%2812%2961728-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0140-6736(12)61728-0</a>. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/10536%2FDRO%2FDU%3A30050819" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10536/DRO/DU:30050819</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10790329" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10790329</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23245604" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23245604</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:1541253" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1541253</a>. Archived from <a href="https://zenodo.org/record/2557786" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 19 May 2020.</span></div></li><li id="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext</a></span></div></li><li id="https://mednexus.org/doi/10.1097/CM9.0000000000003622" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://mednexus.org/doi/10.1097/CM9.0000000000003622" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://mednexus.org/doi/10.1097/CM9.0000000000003622</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/full/10.1002/uro2.94" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/uro2.94" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/full/10.1002/uro2.94</a></span></div></li><li id="122" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Windus D (2008). <a href="https://books.google.com/books?id=sPgGqotdzqAC&amp;pg=PA235" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>The Washington manual nephrology subspecialty consult</em></a> (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins Health. p. 235. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-7817-9149-6. <a href="https://web.archive.org/web/20160909114412/https://books.google.com/books?id=sPgGqotdzqAC&amp;pg=PA235" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 9 September 2016.</span></div></li><li id="123" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Glanvill J (December 2010). <em>Saducismus triumphatus, or, Full and plain evidence concerning witches and apparitions  : in two parts, the first treating of their possibility, the second of their real existence</em>. BiblioBazaar. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-171-33286-2. <span class="inline text-[1em] leading-7">OCLC</span> <a href="https://search.worldcat.org/oclc/943229347" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">943229347</a>.</span></div></li><li id="https://www.kidneystoners.org/information/history-of-stones/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.kidneystoners.org/information/history-of-stones/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.kidneystoners.org/information/history-of-stones/</a></span></div></li><li id="124" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Celsus AC</span> (1831). <a href="https://books.google.com/books?id=p2kFAAAAQAAJ&amp;pg=PA311" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Book VII, Chapter XXVI: Of the operation necessary in a suppression of urine, and lithotomy&quot;</a>. In Collier GF (ed.). <em>A translation of the eight books of Aul. Corn. Celsus on medicine</em> (2nd ed.). London: Simpkin and Marshall. pp. 306â€“14. <a href="https://web.archive.org/web/20140708104311/http://books.google.com/books?id=p2kFAAAAQAAJ&amp;pg=PA311" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 8 July 2014.</span></div></li><li id="125" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Shah J, Whitfield HN (May 2002). &quot;Urolithiasis through the ages&quot;. <em>BJU International</em>. <strong>89</strong> (8): 801â€“10. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.1464-410X.2002.02769.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.1464-410X.2002.02769.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11972501" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11972501</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:44311421" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">44311421</a>.</span></div></li><li id="128" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dwyer ME, Krambeck AE, Bergstralh EJ, et al. (July 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482509" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Temporal trends in incidence of kidney stones among children: a 25-year population based study&quot;</a>. <em>The Journal of Urology</em>. <strong>188</strong> (1): 247â€“52. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.juro.2012.03.021" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.juro.2012.03.021</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482509" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3482509</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22595060" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22595060</a>.</span></div></li><li id="https://consultqd.clevelandclinic.org/why-more-children-are-getting-kidney-stones-and-the-best-way-to-manage-them" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://consultqd.clevelandclinic.org/why-more-children-are-getting-kidney-stones-and-the-best-way-to-manage-them" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://consultqd.clevelandclinic.org/why-more-children-are-getting-kidney-stones-and-the-best-way-to-manage-them</a></span></div></li><li id="129" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20071117030318/http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/Diet_diseases/diet_for_renal.asp" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Diet and Definition of Kidney Stones, Renal Calculi&quot;</a>. Archived from <a href="http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/Diet_diseases/diet_for_renal.asp" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 17 November 2007. Retrieved 11 October 2013.</span></div></li><li id="130" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kirejczyk JK, Porowski T, Filonowicz R, et al. (February 2014). <a href="https://doi.org/10.1016%2Fj.jpurol.2013.07.010" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;An association between kidney stone composition and urinary metabolic disturbances in children&quot;</a>. <em>Journal of Pediatric Urology</em>. <strong>10</strong> (1): 130â€“5. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.jpurol.2013.07.010" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.jpurol.2013.07.010</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23953243" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23953243</a>.</span></div></li><li id="131" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Barreto L, Jung JH, Abdelrahim A, et al. (Cochrane Urology Group) (June 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513049" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Medical and surgical interventions for the treatment of urinary stones in children&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>6</strong> (6): CD010784. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD010784.pub2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD010784.pub2</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513049" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6513049</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29859007" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29859007</a>.</span></div></li><li id="https://www.mayoclinicproceedings.org/article/S0025-6196%2825%2900243-5/abstract" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinicproceedings.org/article/S0025-6196%2825%2900243-5/abstract" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinicproceedings.org/article/S0025-6196%2825%2900243-5/abstract</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12230011/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12230011/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12230011/</a></span></div></li><li id="https://bmjopen.bmj.com/content/bmjopen/15/5/e096533.full.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmjopen.bmj.com/content/bmjopen/15/5/e096533.full.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmjopen.bmj.com/content/bmjopen/15/5/e096533.full.pdf</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11975591/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11975591/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11975591/</a></span></div></li><li id="https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1612347/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1612347/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1612347/full</a></span></div></li><li id="135" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stanford J, Charlton K, Stefoska-Needham A, et al. (5 June 2020). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275316" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature&quot;</a>. <em>BMC Nephrology</em>. <strong>21</strong> (1): 215. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1186%2Fs12882-020-01805-w" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1186/s12882-020-01805-w</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/1471-2369" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1471-2369</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275316" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7275316</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/32503496" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">32503496</a>.</span></div></li><li id="136" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Duncan SH, Richardson AJ, Kaul P, et al. (1 August 2002). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124017" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Oxalobacter formigenes and Its Potential Role in Human Health&quot;</a>. <em>Applied and Environmental Microbiology</em>. <strong>68</strong> (8): 3841â€“3847. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2002ApEnM..68.3841D" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2002ApEnM..68.3841D</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1128%2FAEM.68.8.3841-3847.2002" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1128/AEM.68.8.3841-3847.2002</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0099-2240" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0099-2240</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124017" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">124017</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12147479" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12147479</a>.</span></div></li><li id="137" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ticinesi A, Milani C, Guerra A, et al. (28 April 2018). <a href="https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2017-315734" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Understanding the gutâ€“kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers&quot;</a>. <em>Gut</em>. <strong>67</strong> (12): 2097â€“2106. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fgutjnl-2017-315734" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/gutjnl-2017-315734</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0017-5749" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0017-5749</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29705728" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29705728</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:14055215" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">14055215</a>.</span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12528112/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12528112/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12528112/</a></span></div></li><li id="https://www.news-medical.net/news/20250718/Microbial-therapy-uses-modified-bacteria-to-target-oxalate-in-the-gut.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.news-medical.net/news/20250718/Microbial-therapy-uses-modified-bacteria-to-target-oxalate-in-the-gut.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.news-medical.net/news/20250718/Microbial-therapy-uses-modified-bacteria-to-target-oxalate-in-the-gut.aspx</a></span></div></li><li id="https://clinicaltrials.gov/study/NCT06330246" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://clinicaltrials.gov/study/NCT06330246" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://clinicaltrials.gov/study/NCT06330246</a></span></div></li><li id="138" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ramirez J, Guarner F, Bustos Fernandez L, et al. (24 November 2020). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732679" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Antibiotics as Major Disruptors of Gut Microbiota&quot;</a>. <em>Frontiers in Cellular and Infection Microbiology</em>. <strong>10</strong> : 572912. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3389%2Ffcimb.2020.572912" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3389/fcimb.2020.572912</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/2235-2988" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2235-2988</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732679" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7732679</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/33330122" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">33330122</a>.</span></div></li><li id="139" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tasian GE, Jemielita T, Goldfarb DS, et al. (1 June 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054354" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Oral Antibiotic Exposure and Kidney Stone Disease&quot;</a>. <em>Journal of the American Society of Nephrology</em>. <strong>29</strong> (6): 1731â€“1740. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1681%2FASN.2017111213" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1681/ASN.2017111213</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/1046-6673" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1046-6673</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054354" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6054354</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29748329" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29748329</a>.</span></div></li><li id="https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1602413/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1602413/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1602413/full</a></span></div></li><li id="140" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pugh DG, Baird N (27 May 2012). <a href="https://books.google.com/books?id=s-Z311q6CIcC" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Sheep &amp; Goat Medicine - E-Book</em></a>. Elsevier Health Sciences. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-4377-2354-0. <a href="https://web.archive.org/web/20210414055355/https://books.google.com/books?id=s-Z311q6CIcC" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 14 April 2021. Retrieved 17 June 2018.</span></div></li><li id="141" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bushman DH, Emerick RJ, Embry LB (December 1965). &quot;Experimentally induced ovine phosphatic urolithiasis: relationships involving dietary calcium, phosphorus and magnesium&quot;. <em>The Journal of Nutrition</em>. <strong>87</strong> (4): 499â€“504. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fjn%2F87.4.499" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/jn/87.4.499</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/5841867" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5841867</a>.</span></div></li><li id="142" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stewart SR, Emerick RJ, Pritchard RH (May 1991). <a href="https://web.archive.org/web/20190302075532/http://pdfs.semanticscholar.org/b1f1/b2a896e57ed8350fe826cffcb23496d2be2c.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Effects of dietary ammonium chloride and variations in calcium to phosphorus ratio on silica urolithiasis in sheep&quot;</a> (PDF). <em>Journal of Animal Science</em>. <strong>69</strong> (5): 2225â€“9. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2527%2F1991.6952225x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2527/1991.6952225x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/1648554" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1648554</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:10130833" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10130833</a>. Archived from <a href="http://pdfs.semanticscholar.org/b1f1/b2a896e57ed8350fe826cffcb23496d2be2c.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 2 March 2019.</span></div></li><li id="143" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Forman SA, Whiting F, Connell R (May 1959). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581990" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Silica Urolithiasis In Beef Cattle : 3. Chemical and Physical Composition of the Uroliths&quot;</a>. <em>Canadian Journal of Comparative Medicine and Veterinary Science</em>. <strong>23</strong> (5): 157â€“62. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581990" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1581990</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17649146" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17649146</a>.</span></div></li><li id="144" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Scott D, Buchan W (May 1988). <a href="https://doi.org/10.1113%2Fexpphysiol.1988.sp003148" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The effects of feeding pelleted diets made from either coarsely or finely ground hay on phosphorus balance and on the partition of phosphorus excretion between urine and faeces in the sheep&quot;</a>. <em>Quarterly Journal of Experimental Physiology</em>. <strong>73</strong> (3): 315â€“22. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1113%2Fexpphysiol.1988.sp003148" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1113/expphysiol.1988.sp003148</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/3399614" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3399614</a>.</span></div></li><li id="145" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bravo D, Sauvant D, Bogaert C, et al. (2003). <a href="https://hal.archives-ouvertes.fr/hal-00900449/file/hal-00900449.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;III. Quantitative aspects of phosphorus excretion in ruminants&quot;</a> (PDF). <em>Reproduction, Nutrition, Development</em>. <strong>43</strong> (3): 285â€“300. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1051%2Frnd%3A2003021" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1051/rnd:2003021</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/14620634" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">14620634</a>. <a href="https://web.archive.org/web/20210416000942/https://hal.archives-ouvertes.fr/hal-00900449/file/hal-00900449.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> (PDF) from the original on 16 April 2021. Retrieved 29 August 2019.</span></div></li><li id="146" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Waltner-Toews, D. and D. H. Meadows. 1980. Case report: Urolithiasis in a herd of beef cattle associated with oxalate ingestion. Can. Vet. J. 21: 61-62</span></div></li><li id="147" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">James LF, Butcher JE (December 1972). &quot;Halogeton poisoning of sheep: effect of high level oxalate intake&quot;. <em>Journal of Animal Science</em>. <strong>35</strong> (6): 1233â€“1238. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2527%2Fjas1972.3561233x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2527/jas1972.3561233x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/4647453" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4647453</a>.</span></div></li><li id="148" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kahn CM, ed. (2005). <em>Merck veterinary manual</em> (9th ed.). Whitehouse Station: Merck &amp; Co., Inc.</span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Kidney_stone_disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw" id="_R_" async=""></script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Kidney_stone_disease\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Kidney_stone_disease\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Kidney_stone_disease\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"23:I[6367,[],\"IconMark\"]\n1f:T422,"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"_**a**_ _**b**_ _**c**_ Pearle MS, Calhoun EA, Curhan GC (2007). [\"Ch. 8: Urolithiasis\"](http://kidney.niddk.nih.gov/statistics/uda/Urologic_Diseases_in_America.pdf) (PDF). In Litwin MS, Saigal CS (eds.). _Urologic Diseases in America (NIH Publication No. 07â€“5512)_. Bethesda, Maryland: [National Institute of Diabetes and Digestive and Kidney Diseases](National_Institute_of_Diabetes_and_Digestive_and_Kidney_Diseases \"National Institute of Diabetes and Digestive and Kidney Diseases\"), [National Institutes of Health](National_Institutes_of_Health \"National Institutes of Health\"), [United States Public Health Service](United_States_Public_Health_Service \"United States Public Health Service\"), [United States Department of Health and Human Services](United_States_Department_of_Health_and_Human_Services \"United States Department of Health and Human Services\"). pp. 283â€“319\\. [Archived](https://web.archive.org/web/20111018023922/http://kidney.niddk.nih.gov/statistics/UDA/Urologic_Diseases_in_America.pdf) (PDF) from the original on 18 October 2011."])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"20:T428,"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"16. ^ _**a**_ _**b**_ _**c**_ Pearle MS, Calhoun EA, Curhan GC (2007). [\"Ch. 8: Urolithiasis\"](http://kidney.niddk.nih.gov/statistics/uda/Urologic_Diseases_in_America.pdf) (PDF). In Litwin MS, Saigal CS (eds.). _Urologic Diseases in America (NIH Publication No. 07â€“5512)_. Bethesda, Maryland: [National Institute of Diabetes and Digestive and Kidney Diseases](National_Institute_of_Diabetes_and_Digestive_and_Kidney_Diseases \"National Institute of Diabetes and Digestive and Kidney Diseases\"), [National Institutes of Health](National_Institutes_of_Health \"National Institutes of Health\"), [United States Public Health Service](United_States_Public_Health_Service \"United States Public Health Service\"), [United States Department of Health and Human Services](United_States_Department_of_Health_and_Human_Services \"United States Department of Health and Human Services\"). pp. 283â€“319\\. [Archived](https://web.archive.org/web/20111018023922/http://kidney.niddk.nih.gov/statistics/UDA/Urologic_Diseases_in_America.pdf) (PDF) from the original on 18 October 2011."])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"21:T11fac,"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"# Kidney stone disease\n\n| **Attribute** | **Details** |\n|---------------|-------------|\n| Other names | Urolithiasis, kidney stone, renal calculus, nephrolithiasis, kidney stone disease,[1] |\n| Specialty | [Urology](Urology \"Urology\"), [nephrology](Nephrology \"Nephrology\") |\n| Symptoms | Severe pain in the lower back or abdomen, blood in the urine, vomiting, nausea[2] |\n| Causes | [Genetic](Genetics \"Genetics\") and environmental factors[2] |\n| Diagnostic method | Based on symptoms, [urine testing](Urinalysis \"Urinalysis\"), [medical imaging](Medical_imaging \"Medical imaging\")[2] |\n| Differential diagnosis | [Abdominal aortic aneurysm](Abdominal_aortic_aneurysm \"Abdominal aortic aneurysm\"), [diverticulitis](Diverticulitis \"Diverticulitis\"), [appendicitis](Appendicitis \"Appendicitis\"), [pyelonephritis](Pyelonephritis \"Pyelonephritis\")[3] |\n| Prevention | Drinking fluids such that more than two liters of urine are produced per day[4] |\n| Treatment | [Pain medication](Analgesic \"Analgesic\"), [extracorporeal shockwave therapy](Extracorporeal_shockwave_therapy \"Extracorporeal shockwave therapy\"), [laser lithotripsy](Laser_lithotripsy \"Laser lithotripsy\"), [percutaneous nephrolithotomy](Percutaneous_nephrolithotomy \"Percutaneous nephrolithotomy\")[2] |\n| Frequency | 115 million incident cases (2019)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/) |\n| Deaths | 13,300 (2019)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/) |\n\n**Kidney stone disease** (known as **nephrolithiasis** , **renal calculus disease** or **urolithiasis**) is a [crystallopathy](Crystallopathy \"Crystallopathy\") and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper [urinary tract](Urinary_tract \"Urinary tract\").[2] Because renal calculi typically form in the [kidney](Kidney \"Kidney\"), if small enough, they are able to leave the urinary tract via the urine stream.[2] A small calculus may pass without causing [symptoms](Signs_and_symptoms \"Signs and symptoms\").[2] However, if a stone grows to more than 5 millimeters (0.2 inches), it can cause a blockage of the [ureter](Ureter \"Ureter\"), resulting in extremely sharp and severe pain ([renal colic](Renal_colic \"Renal colic\")) in the lower back that often radiates downward to the groin.[2][7] A calculus may also result in [blood in the urine](Hematuria \"Hematuria\"), vomiting (due to severe pain), [swelling of the kidney](Hydronephrosis \"Hydronephrosis\"), or [painful urination](Dysuria \"Dysuria\").[2] About half of all people who have had a kidney stone are likely to develop another within ten years.[8]\n\n_Renal_ is Latin for \"kidney\", while _nephro_ is the Greek equivalent. _Lithiasis_ (Gr.) and _calculus_ (Lat.- pl. calculi) both mean stone. \n\nMost calculi form by a combination of [genetics](Genetics \"Genetics\") and environmental factors.[2] Risk factors include [high urine calcium levels](Hypercalciuria \"Hypercalciuria\"), [obesity](Obesity \"Obesity\"), certain foods, some medications, [calcium supplements](Calcium_supplement \"Calcium supplement\"), [gout](Gout \"Gout\"), [hyperparathyroidism](Hyperparathyroidism \"Hyperparathyroidism\") and not drinking enough fluids.[2][8] Calculi form in the kidney when [minerals](Mineral \"Mineral\") in [urine](Urine \"Urine\") are at high concentrations.[2] The [diagnosis](Medical_diagnosis \"Medical diagnosis\") is usually based on symptoms, [urine testing](Urinalysis \"Urinalysis\"), and [medical imaging](Medical_imaging \"Medical imaging\").[2] [Blood tests](Blood_test \"Blood test\") may also be useful.[2] Calculi are typically classified by their location, being referred to medically as nephrolithiasis (in the kidney), [ureterolithiasis](Ureterolithiasis \"Ureterolithiasis\") (in the [ureter](Ureter \"Ureter\")), or [cystolithiasis](Bladder_stone \"Bladder stone\") (in the [bladder](Urinary_bladder \"Urinary bladder\")). Calculi are also classified by [what they are made of](Chemical_composition \"Chemical composition\"), such as from [calcium oxalate](Calcium_oxalate \"Calcium oxalate\"), [uric acid](Uric_acid \"Uric acid\"), [struvite](Struvite \"Struvite\"), or [cystine](Cystine \"Cystine\").[2]\n\nIn those who have had renal calculi, drinking fluids, especially water, is a way to prevent them. Drinking fluids such that more than two liters of urine are produced per day is recommended.[4] If fluid intake alone is not effective to prevent renal calculi, the medications [thiazide diuretic](Thiazide_diuretic \"Thiazide diuretic\"), [citrate](Citrate \"Citrate\"), or [allopurinol](Allopurinol \"Allopurinol\") may be suggested.[4] Soft drinks containing [phosphoric acid](Phosphoric_acid \"Phosphoric acid\") (typically [colas](Cola \"Cola\")) should be avoided.[4] When a calculus causes no symptoms, [no treatment](Watchful_waiting \"Watchful waiting\") is needed.[2] For those with symptoms, [pain control](Analgesic \"Analgesic\") is usually the first measure, using medications such as [nonsteroidal anti-inflammatory drugs](Nonsteroidal_anti-inflammatory_drug \"Nonsteroidal anti-inflammatory drug\") or [opioids](Opioid \"Opioid\").[7][9] Larger calculi may be helped to pass with the medication [tamsulosin](Tamsulosin \"Tamsulosin\"),[10] or may require procedures for removal such as [extracorporeal shockwave therapy](Extracorporeal_shockwave_therapy \"Extracorporeal shockwave therapy\") (ESWT), [laser lithotripsy](Laser_lithotripsy \"Laser lithotripsy\") (LL), or a [percutaneous nephrolithotomy](Percutaneous_nephrolithotomy \"Percutaneous nephrolithotomy\") (PCNL).[2]\n\nRenal calculi have affected humans throughout history with a description of surgery to remove them dating from as early as 600 BC in ancient India by [Sushruta](Sushruta \"Sushruta\").[1] Between 1% and 15% of people globally are affected by renal calculi at some point in their lives.[8][11] In 2019, approximately 115 million incident cases occurred, resulting in about 13,300 deaths.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/) They have become more common in the [Western world](Western_world \"Western world\") since the 1970s.[8][12] Generally, more men are affected than women.[2][11] The prevalence and incidence of the disease rises worldwide and continues to be challenging for patients, physicians, and healthcare systems alike. In this context, epidemiological studies are striving to elucidate the worldwide changes in the patterns and the burden of the disease and identify modifiable risk factors that contribute to the development of renal calculi.[13]\n## Signs and symptoms\n\nThe hallmark of a stone that obstructs the ureter or renal pelvis is excruciating, intermittent pain that radiates from the flank to the groin or to the inner thigh.[14] This is due to the transfer of referred pain signals from the lower thoracic splanchnic nerves to the lumbar splanchnic nerves as the stone passes down from the kidney or proximal ureter to the distal ureter. This pain, known as [renal colic](Renal_colic \"Renal colic\"), is often described as one of the strongest pain sensations known.[15] Renal colic caused by kidney stones is commonly accompanied by [urinary urgency](Urinary_urgency \"Urinary urgency\"), restlessness, frequent urination, [blood in the urine](Blood_in_the_urine \"Blood in the urine\"), sweating, [nausea](Nausea \"Nausea\"), and [vomiting](Vomiting \"Vomiting\"). It typically comes in waves lasting 20 to 60 minutes caused by [peristaltic](Peristalsis \"Peristalsis\") contractions of the ureter as it attempts to expel the stone.[14]\n\nThe [embryological](Embryology \"Embryology\") link between the urinary tract, the [genital system](Reproductive_system \"Reproductive system\"), and the [gastrointestinal tract](Human_gastrointestinal_tract \"Human gastrointestinal tract\") is the basis of the radiation of pain to the [gonads](Gonad \"Gonad\"), as well as the nausea and vomiting that are also common in urolithiasis.[16] [Postrenal azotemia](Postrenal_azotemia \"Postrenal azotemia\") and hydronephrosis can be observed following the obstruction of urine flow through one or both ureters.[17]\n\nPain in the lower-left quadrant can sometimes be confused with [diverticulitis](Diverticulitis \"Diverticulitis\") because the [sigmoid colon](Sigmoid_colon \"Sigmoid colon\") overlaps the ureter, and the exact location of the pain may be difficult to isolate due to the proximity of these two structures.\n# Risk factors\n\n[Dehydration](https://en.wikipedia.org/wiki/Dehydration) from low fluid intake is a factor in stone formation.[14][18] Individuals living in warm climates are at higher risk due to increased fluid loss.[19] Obesity, immobility, and sedentary lifestyles are other leading risk factors.[19] Type 2 diabetes is associated with increased risk due to altered urinary chemistry, including reduced citrate excretion.[38]\n\nHigh dietary intake of animal [protein](https://en.wikipedia.org/wiki/Protein),[14] [sodium](https://en.wikipedia.org/wiki/Sodium), sugars including honey, refined [sugars](https://en.wikipedia.org/wiki/Sugar), [fructose](https://en.wikipedia.org/wiki/Fructose) and [high fructose corn syrup](https://en.wikipedia.org/wiki/High_fructose_corn_syrup),[20] and excessive consumption of fruit juices may increase the risk of kidney stone formation due to increased [uric acid](https://en.wikipedia.org/wiki/Uric_acid) excretion and elevated [urinary oxalate](https://en.wikipedia.org/wiki/Oxalate) levels (whereas tea, coffee, wine and beer may decrease the risk).[19][18]\n\nKidney stones can result from an underlying metabolic condition, such as [distal renal tubular acidosis](https://en.wikipedia.org/wiki/Distal_renal_tubular_acidosis),[21] [Dent's disease](https://en.wikipedia.org/wiki/Dent%27s_disease),[22] [hyperparathyroidism](https://en.wikipedia.org/wiki/Hyperparathyroidism),[23] primary [hyperoxaluria](https://en.wikipedia.org/wiki/Hyperoxaluria),[24] or [medullary sponge kidney](https://en.wikipedia.org/wiki/Medullary_sponge_kidney). 3â€“20% of people who form kidney stones have medullary sponge kidney.[25][26]\n\nKidney stones are more common in people with [Crohn's disease](https://en.wikipedia.org/wiki/Crohn%27s_disease);[27] Crohn's disease is associated with [hyperoxaluria](https://en.wikipedia.org/wiki/Hyperoxaluria) and malabsorption of magnesium.[28]\n\nA person with recurrent kidney stones may be screened for such disorders. This is typically done with a 24-hour urine collection. The urine is analyzed for features that promote stone formation.[17]\n\n### Calcium oxalate\n\nCalcium is one component of the most common type of human kidney stones, [calcium oxalate](https://en.wikipedia.org/wiki/Calcium_oxalate). Some studies suggest that people who take calcium or [vitamin D](https://en.wikipedia.org/wiki/Vitamin_D) as a [dietary supplement](https://en.wikipedia.org/wiki/Dietary_supplement) have a higher risk of developing kidney stones.[29][30] In the [United States](https://en.wikipedia.org/wiki/United_States), kidney stone formation was used as an indicator of excess calcium intake by the [Reference Daily Intake](https://en.wikipedia.org/wiki/Reference_Daily_Intake) committee for calcium in adults.[31]\n\nIn the early 1990s, a study conducted for the [Women's Health Initiative](https://en.wikipedia.org/wiki/Women%27s_Health_Initiative) in the US found that postmenopausal women who consumed 1000 mg of supplemental calcium and 400 [international units](https://en.wikipedia.org/wiki/International_unit) of [vitamin D](https://en.wikipedia.org/wiki/Vitamin_D) per day for seven years had a 17% higher risk of developing kidney stones than subjects taking a [placebo](https://en.wikipedia.org/wiki/Placebo).[29] The [Nurses' Health Study](https://en.wikipedia.org/wiki/Nurses%27_Health_Study) also showed an association between supplemental calcium intake and kidney stone formation.[30]\n\nUnlike supplemental calcium, high intakes of dietary calcium do not appear to cause kidney stones and may actually protect against their development.[30][29] This is perhaps related to the role of calcium in binding ingested oxalate in the gastrointestinal tract. As the amount of calcium intake decreases, the amount of oxalate available for absorption into the bloodstream increases; this oxalate is then excreted in greater amounts into the urine by the kidneys. In the urine, oxalate is a very strong promoter of calcium oxalate precipitationâ€”about 15 times stronger than calcium. \n\nA 2004 study found that diets low in calcium are associated with a higher overall risk for kidney stone formation.[32] For most individuals, other risk factors for kidney stones, such as high intakes of dietary oxalates and low fluid intake, play a greater role than calcium intake.[33]\n\n### Other electrolytes\n\nCalcium is not the only [electrolyte](https://en.wikipedia.org/wiki/Electrolyte) that influences the formation of kidney stones. For example, by increasing urinary calcium excretion, high dietary sodium may increase the risk of stone formation.[30]\n\nDrinking [fluoridated tap water](https://en.wikipedia.org/wiki/Water_fluoridation) may increase the risk of kidney stone formation by a similar mechanism, though further epidemiologic studies are warranted to determine whether fluoride in drinking water is associated with an increased incidence of kidney stones.[34] High dietary intake of [potassium](https://en.wikipedia.org/wiki/Potassium) appears to reduce the risk of stone formation because potassium promotes the urinary excretion of [citrate](https://en.wikipedia.org/wiki/Citrate), an inhibitor of calcium crystal formation.[35]\n\nKidney stones are more likely to develop, and to grow larger, if a person has low [dietary magnesium](https://en.wikipedia.org/wiki/Magnesium_in_biology). Magnesium inhibits stone formation.[36]\n\n### Animal protein\n\n[Diets in Western nations](https://en.wikipedia.org/wiki/Western_pattern_diet) typically contain a large proportion of [animal protein](https://en.wikipedia.org/wiki/Protein#nutrition). Eating animal protein creates an acid load that increases urinary excretion of calcium and uric acid and reduced citrate. Urinary excretion of excess sulfurous [amino acids](https://en.wikipedia.org/wiki/Amino_acid) (e.g., [cysteine](https://en.wikipedia.org/wiki/Cysteine) and [methionine](https://en.wikipedia.org/wiki/Methionine)), uric acid, and other acidic [metabolites](https://en.wikipedia.org/wiki/Metabolite) from animal protein acidifies the urine, which promotes the formation of kidney stones.[37] Low urinary-citrate excretion is also commonly found in those with a high dietary intake of animal protein, whereas vegetarians tend to have higher levels of citrate excretion.[30] Low urinary citrate, too, promotes stone formation.[37]\n\n### Vitamins\n\nThe evidence linking [vitamin C](https://en.wikipedia.org/wiki/Vitamin_C) supplements with an increased rate of kidney stones is inconclusive.[38][39] The excess dietary intake of vitamin C might increase the risk of calcium-oxalate stone formation.[40] The link between vitamin D intake and kidney stones is also tenuous. \n\nExcessive vitamin D supplementation may increase the risk of stone formation by increasing the intestinal absorption of calcium; correction of a deficiency does not.[30]\n# Pathophysiology\n\nSmall crystals formed in the kidney. The most common crystals are made of calcium oxalate and initial stone aggregates are generally 4â€“5 mm. Staghorn kidney stones are considerably larger.\n\n1. Calcium and oxalate come together to make the crystal nucleus. Supersaturation promotes their combination (as does inhibition.)\n2. Continued deposition at the renal papillae leads to the growth of the kidney stones.\n3. Kidney stones grow and collect debris. In the case where the kidney stones block all routes to the renal papillae, this can cause extreme discomfort and pain.\n4. The complete staghorn stone forms and retention occurs. Smaller solids that break off can become trapped in the urinary glands causing discomfort.\n5. Displaced stones travel through the ureter. If they cannot be broken down, they must be physically removed by a surgeon.\n\n### Supersaturation of urine\n\nKidney stones are primarily composed of calcium salts, with 60-80% being calcium oxalate, calcium phosphate, or both; calcium oxalate is the most common, followed by calcium phosphate and uric acid.[41]\n\nThe formation of kidney stones occurs in three main phases:[41]\n\n1. [nucleation](Nucleation \"Nucleation\") (initial crystal formation)\n2. growth (expansion of single crystals)\n3. aggregation (clumping together of multiple crystals)[41]\n\nWhen the urine becomes [supersaturated](Supersaturation \"Supersaturation\") (when the urine [solvent](Solvent \"Solvent\") contains more [solutes](https://en.wiktionary.org/wiki/Special:Search/solute \"wikt:Special:Search/solute\") than it can hold in [solution](Solution_\\(chemistry\\) \"Solution \\(chemistry\\)\")) with one or more calculogenic (crystal-forming) substances, initial [seed crystals](Seed_crystal \"Seed crystal\") may form through the process of [nucleation](Nucleation \"Nucleation\").[25] Heterogeneous nucleation (where there is a solid surface present on which a crystal can grow) proceeds more rapidly than homogeneous nucleation (where a crystal must grow in a liquid medium with no such surface), because it requires less energy. Adhering to cells on the surface of a [renal papilla](Renal_papilla \"Renal papilla\"), a seed crystal can grow and aggregate into an organized mass. Depending on the chemical composition of the crystal, the stone-forming process may proceed more rapidly when the urine pH is unusually high or low.[42]\n\nSupersaturation of the urine with respect to a calculogenic compound is pH-dependent. For example, at a pH of 7.0, the solubility of uric acid in urine is 158 mg/100 mL. Reducing the pH to 5.0 decreases the [solubility](Solubility \"Solubility\") of [uric acid](Uric_acid \"Uric acid\") to less than 8 mg/100 mL. The formation of uric-acid stones requires a combination of [hyperuricosuria](Hyperuricosuria \"Hyperuricosuria\") (high urine uric-acid levels) and low urine pH; hyperuricosuria alone is not associated with uric-acid stone formation if the urine pH is alkaline.[43] Supersaturation of the urine is a necessary, but not a sufficient, condition for the development of any urinary calculus.[25] Supersaturation is likely the underlying cause of uric acid and [cystine](Cystine \"Cystine\") stones, but calcium-based stones (especially [calcium oxalate](Calcium_oxalate \"Calcium oxalate\") stones) may have a more complex cause.[44]\n\n### Randall's plaque\n\nWhile supersaturation of urine may lead to [crystalluria](Crystalluria \"Crystalluria\"), it does not necessarily promote the formation of a kidney stone because the particle may not reach the sufficient size needed for renal attachment.[45][46] On the other hand, Randall's plaques, which were first identified by Alexander Randall in 1937,[47] are [calcium phosphate](Calcium_phosphate \"Calcium phosphate\") deposits that form in the papillary interstitium and are thought to be the nidus required for stone development.[48] In addition to Randall's plugs, which form in the [Duct of Bellini](Duct_of_Bellini \"Duct of Bellini\"), these structures can generate reactive oxygen species that further enhance stone formation.[49]\n\n### Pathogenic bacteria\n\nSome [bacteria](Bacteria \"Bacteria\") have roles in promoting stone formation. Specifically, [urease-positive](Urease-positive \"Urease-positive\") bacteria, such as _[Proteus mirabilis](Proteus_mirabilis \"Proteus mirabilis\")_ can produce the [enzyme](Enzyme \"Enzyme\") [urease](Urease \"Urease\"), which converts [urea](Urea \"Urea\") to [ammonia](Ammonia \"Ammonia\") and [carbon dioxide](Carbon_dioxide \"Carbon dioxide\").[50] This increases the urinary [pH](PH \"PH\") and promotes [struvite](Struvite \"Struvite\") stone formation. Additionally, non-urease producing bacteria can provide bacterial components that promote [calcium oxalate](Calcium_oxalate \"Calcium oxalate\") crystallization, though this mechanism is poorly understood.[51][52]\n\n### Inhibitors of stone formation\n\nNormal [urine](Urine \"Urine\") contains [chelating](Chelation \"Chelation\") agents, such as [citrate](Citric_acid \"Citric acid\"), that inhibit the [nucleation](Nucleation \"Nucleation\"), [growth](Crystal_growth \"Crystal growth\"), and aggregation of calcium-containing crystals. Other [endogenous](Endogenous \"Endogenous\") inhibitors include [calgranulin](Calgranulin \"Calgranulin\") (an [S-100 calcium-binding protein](S-100_protein \"S-100 protein\")), [Tammâ€“Horsfall protein](Tamm%E2%80%93Horsfall_protein \"Tammâ€“Horsfall protein\"), [glycosaminoglycans](Glycosaminoglycan \"Glycosaminoglycan\"), uropontin (a form of [osteopontin](Osteopontin \"Osteopontin\")), [nephrocalcin](Nephrocalcin \"Nephrocalcin\") (an acidic [glycoprotein](Glycoprotein \"Glycoprotein\")), pro[thrombin](Thrombin \"Thrombin\") F1 peptide, and [bikunin](Alpha-1-microglobulin/bikunin_precursor \"Alpha-1-microglobulin/bikunin precursor\") ([uronic acid](Uronic_acid \"Uronic acid\")-rich protein). The biochemical mechanisms of action of these substances have not yet been thoroughly elucidated. However, when these substances fall below their normal proportions, stones can form from an aggregation of crystals.[53]\n\nSufficient dietary intake of [magnesium](Magnesium \"Magnesium\") and [citrate](Citrate \"Citrate\") inhibits the formation of calcium oxalate and calcium phosphate stones; in addition, magnesium and citrate operate synergistically to inhibit kidney stones. The efficacy of magnesium in subduing stone formation and growth is [dose-dependent](Dose-dependent \"Dose-dependent\").[30][36][54]\n\n### Hypocitraturia\n\nHypocitraturia or low urinary-citrate excretion (variably defined as less than 320 mg/day) can be a contributing cause of kidney stones in up to 2/3 of cases. The protective role of citrate is linked to several mechanisms; citrate reduces urinary supersaturation of calcium salts by forming soluble complexes with calcium ions and by inhibiting crystal growth and aggregation. Therapy with [potassium citrate](Potassium_citrate \"Potassium citrate\") is commonly prescribed in clinical practice to increase urinary citrate and to reduce stone formation rates. [Alkali citrate](Alkali_citrate \"Alkali citrate\") is also used to increase urine citrate levels. It can be prescribed or found over-the-counter in pill, liquid or powder form.[55][56]\n# Diagnosis\n\nDiagnosis of kidney stones is made on the basis of information obtained from the history, physical examination, [urinalysis](Urinalysis \"Urinalysis\"), and [radiographic](Radiography \"Radiography\") studies.[57] [Clinical diagnosis](Medical_diagnosis \"Medical diagnosis\") is usually made on the basis of the location and severity of the pain, which is typically colicky in nature (comes and goes in [spasmodic](Spasm \"Spasm\") waves). Pain in the back occurs when calculi produce an obstruction in the kidney.[58] Physical examination may reveal fever and [tenderness at the costovertebral angle](Murphy's_punch_sign \"Murphy's punch sign\") on the affected side.[57]\n\n## Imaging studies\n\nCalcium-containing stones are relatively [radiodense](Radiodensity \"Radiodensity\") (opaque to [X-rays](X-ray \"X-ray\")), and they can often be detected by a traditional [radiography](Radiography \"Radiography\") of the [abdomen](Abdomen \"Abdomen\") that includes the [kidneys, ureters, and bladder](Kidneys%2C_ureters%2C_and_bladder_x-ray \"Kidneys, ureters, and bladder x-ray\") (KUB film).[59] KUB radiography, although useful in monitoring size of stone or passage of stone in stone formers, might not be useful in the acute setting due to low sensitivity.[60] Some 60% of all renal stones are radiopaque.[61][62] In general, calcium phosphate stones have the greatest density, followed by calcium oxalate and magnesium ammonium phosphate stones. [Cystine](Cystine \"Cystine\") calculi are only faintly [radiodense](Radiodense \"Radiodense\"), while [uric acid](Uric_acid \"Uric acid\") stones are usually entirely [radiolucent](Radiolucent \"Radiolucent\").[63]\n\nIn people with a history of stones, those who are less than 50 years of age and are presenting with the symptoms of stones without any concerning signs do not require [helical CT scan](Helical_cone_beam_computed_tomography \"Helical cone beam computed tomography\") imaging.[64] A [computed tomography](CT_scan \"CT scan\") (CT) scan is also not typically recommended in children.[65]\n\nOtherwise a noncontrast helical CT scan with 5 millimeters (0.2 in) sections is the diagnostic method to use to detect kidney stones and confirm the diagnosis of kidney stone disease.[16][57][61][66][7] Near all stones are detectable on CT scans with the exception of those composed of certain drug residues in the urine,[59] such as from [indinavir](Indinavir \"Indinavir\"). \n\nWhere a CT scan is unavailable, an [intravenous pyelogram](Intravenous_pyelogram \"Intravenous pyelogram\") may be performed to help confirm the diagnosis of [urolithiasis](Urolithiasis \"Urolithiasis\"). This involves [intravenous injection](Intravenous_therapy \"Intravenous therapy\") of a [contrast agent](Radiocontrast \"Radiocontrast\") followed by a KUB film. [Uroliths](Urolith \"Urolith\") present in the kidneys, ureters, or bladder may be better defined by the use of this contrast agent. Stones can also be detected by a [retrograde pyelogram](Retrograde_pyelogram \"Retrograde pyelogram\"), where a similar contrast agent is injected directly into the distal ostium of the ureter (where the ureter terminates as it enters the bladder).[61]\n\n[Renal ultrasonography](Renal_ultrasonography \"Renal ultrasonography\") can sometimes be useful, because it gives details about the presence of [hydronephrosis](Hydronephrosis \"Hydronephrosis\"), suggesting that the stone is blocking the outflow of urine.[59] Radiolucent stones, which do not appear on KUB, may show up on ultrasound imaging studies. Other advantages of renal ultrasonography include its low cost and absence of [radiation exposure](Radiology \"Radiology\"). Ultrasound imaging is useful for detecting stones in situations where X-rays or CT scans are discouraged, such as in children or pregnant women.[67] Despite these advantages, renal ultrasonography in 2009 was not considered a substitute for noncontrast helical CT scan in the initial diagnostic evaluation of urolithiasis.[66] The main reason for this is that, compared with CT, renal ultrasonography more often fails to detect small stones (especially ureteral stones) and other serious disorders that could be causing the symptoms.[14]\n\nOn the contrary, a 2014 study suggested that ultrasonography should be used as the initial diagnostic imaging test, with further imaging studies be performed at the discretion of the physician on the basis of clinical judgment, and using [ultrasonography](Ultrasonography \"Ultrasonography\") rather than [CT](CT_scan \"CT scan\") as an initial diagnostic test results in less radiation exposure and equally good outcome.[68]\n\n## Laboratory examination\n\n[Struvite](Struvite \"Struvite\") crystals found on [microscopic examination](Urine_microscopy \"Urine microscopy\") of the urine\n\nLaboratory investigations typically carried out include:[57][66][59][69]\n\n* [microscopic examination](Urine_microscopy \"Urine microscopy\") of the urine, which may show [red blood cells](Red_blood_cell \"Red blood cell\"), bacteria, [leukocytes](Leukocyte \"Leukocyte\"), [urinary casts](Urinary_cast \"Urinary cast\"), and crystals;\n* urine culture to identify any infecting organisms present in the urinary tract and [sensitivity](Kirby-Bauer_antibiotic_testing \"Kirby-Bauer antibiotic testing\") to determine the susceptibility of these organisms to specific antibiotics;\n* [complete blood count](Complete_blood_count \"Complete blood count\"), looking for [neutrophilia](Neutrophilia \"Neutrophilia\") (increased [neutrophil granulocyte](Neutrophil_granulocyte \"Neutrophil granulocyte\") count) suggestive of bacterial infection, as seen in the setting of struvite stones;\n* [renal function](Renal_function \"Renal function\") tests to look for abnormally high blood calcium levels ([hypercalcemia](Hypercalcaemia \"Hypercalcaemia\"));\n* 24 hour urine collection to measure total daily urinary volume, magnesium, sodium, uric acid, calcium, citrate, oxalate, and [phosphate](Phosphate \"Phosphate\");\n* collection of stones (by urinating through a StoneScreen kidney stone collection cup or a simple [tea strainer](Tea_strainer \"Tea strainer\")) is useful. Chemical analysis of collected stones can establish their composition, which in turn can help to guide future preventive and therapeutic management.\n\n## Composition\n\n| Kidney stone type                  | Relative incidence (adults)[70] | Circumstances                          | Color and microscopy appearance | Radio-density | Details |\n|------------------------------------|---------------------------------|---------------------------------------|---------------------------------|---------------|---------|\n| [Calcium oxalate](Calcium_oxalate \"Calcium oxalate\") | 60%                             | when urine is acidic (decreased pH)[71] | Black/dark brown                | Radio-opaque  | Some of the oxalate in urine is produced by the body. Calcium and oxalate in the diet play a part but are not the only factors that affect the formation of calcium oxalate stones. Dietary oxalate is found in many vegetables, fruits, and nuts. Calcium from bone may also play a role in kidney stone formation. |\n| [Calcium phosphate](Calcium_phosphate \"Calcium phosphate\") | 10â€“20%                          | when urine is alkaline (high pH)       | Dirty white                     | Radio-opaque  | Tends to grow in alkaline urine especially when *[Proteus* bacteria](Proteus_\\(bacterium\\) \"Proteus \\(bacterium\\)\") are present. The most common type among pregnant women.[70] |\n| [Uric acid](Uric_acid \"Uric acid\") | 10â€“20%                          | when urine is persistently acidic      | Yellow/reddish brown            | Radio-lucent  | Diets rich in animal proteins and purines: substances found naturally in all food but especially in organ meats, fish, and shellfish. |\n| [Struvite](Struvite \"Struvite\")    | 10â€“15%                          | infections in the kidney and when urine is alkaline (high pH) | Dirty white                     | Radio-opaque  | Prevention of struvite stones depends on staying infection-free. Diet has not been shown to affect struvite stone formation. |\n| [Cystine](Cystine \"Cystine\")       | 01â€“2%[72]                       | rare genetic disorder                  | Pink/yellow                     | Radio-opaque  | Cystine, an amino acid (a dimer of cysteine, of the building blocks of protein), leaks through the kidneys and into the urine to form crystals. |\n| [Xanthine](Xanthine \"Xanthine\")[73]|                                 | extremely rare                         | Brick red                       | Radio-lucent  |  |\n\n### Calcium-containing stones\n\nBy far, the most common type of kidney stones worldwide contains calcium. For example, calcium-containing stones represent about 80% of all cases in the United States; these typically contain [calcium oxalate](Calcium_oxalate \"Calcium oxalate\") either alone or in combination with [calcium phosphate](Calcium_phosphate \"Calcium phosphate\") in the form of [apatite](Apatite \"Apatite\") or [brushite](Brushite \"Brushite\").[25][53] Factors that promote the [precipitation](Precipitation_\\(chemistry\\) \"Precipitation \\(chemistry\\)\") of oxalate crystals in the urine, such as [primary hyperoxaluria](Primary_hyperoxaluria \"Primary hyperoxaluria\"), are associated with the development of calcium oxalate stones.[24] The formation of calcium phosphate stones is associated with conditions such as [hyperparathyroidism](Hyperparathyroidism \"Hyperparathyroidism\")[23] and [renal tubular acidosis](Renal_tubular_acidosis \"Renal tubular acidosis\").[74]\n\n[Oxaluria](Oxaluria \"Oxaluria\") is increased in patients with certain gastrointestinal disorders including inflammatory bowel disease such as [Crohn's disease](Crohn's_disease \"Crohn's disease\") or in patients who have undergone resection of the small bowel or small-bowel bypass procedures. Oxaluria is also increased in patients who consume increased amounts of oxalate (found in vegetables and nuts). Primary hyperoxaluria is a rare autosomal recessive condition that usually presents in childhood.[75]\n\nCalcium oxalate crystals can come in two varieties. Calcium oxalate monohydrate can appear as 'dumbbells' or as long ovals that resemble the individual posts in a picket fence. Calcium oxalate dihydrate have a tetragonal \"envelope\" appearance.[75]\n\n### Struvite stones\n\nAbout 10â€“15% of urinary calculi are composed of [struvite](Struvite \"Struvite\") (hexa-hydrated [ammonium magnesium phosphate](Ammonium_magnesium_phosphate \"Ammonium magnesium phosphate\"), NH4MgPO4Â·6H2O).[76] Struvite stones (also known as \"infection stones,\" [urease](Urease \"Urease\"), or triple-phosphate stones) form most often in the presence of infection by urea-splitting [bacteria](Bacteria \"Bacteria\"). Using the enzyme urease, these organisms [metabolize](Metabolism \"Metabolism\") [urea](Urea \"Urea\") into [ammonia](Ammonia \"Ammonia\") and [carbon dioxide](Carbon_dioxide \"Carbon dioxide\"). This [alkalinizes](Alkalinity \"Alkalinity\") the urine, resulting in favorable conditions for the formation of struvite stones. _[Proteus mirabilis](Proteus_mirabilis \"Proteus mirabilis\")_ , _[Proteus vulgaris](Proteus_vulgaris \"Proteus vulgaris\")_ , and _[Morganella morganii](Morganella_morganii \"Morganella morganii\")_ are the most common organisms isolated; less common organisms include _[Ureaplasma urealyticum](Ureaplasma_urealyticum \"Ureaplasma urealyticum\")_ and some species of _[Providencia](Providencia_\\(bacterium\\) \"Providencia \\(bacterium\\)\")_ , _[Klebsiella](Klebsiella \"Klebsiella\")_ , _[Serratia](Serratia \"Serratia\")_ , and _[Enterobacter](Enterobacter \"Enterobacter\")_. These infection stones are commonly observed in people who have factors that predispose them to [urinary tract infections](Urinary_tract_infection \"Urinary tract infection\"), such as those with [spinal cord injury](Spinal_cord_injury \"Spinal cord injury\") and other forms of [neurogenic bladder](Neurogenic_bladder \"Neurogenic bladder\"), [ileal conduit urinary diversion](Ileal_conduit_urinary_diversion \"Ileal conduit urinary diversion\"), [vesicoureteral reflux](Vesicoureteral_reflux \"Vesicoureteral reflux\"), and [obstructive uropathies](Obstructive_uropathy \"Obstructive uropathy\"). They are also commonly seen in people with underlying metabolic disorders, such as [idiopathic](Idiopathic \"Idiopathic\") [hypercalciuria](Hypercalciuria \"Hypercalciuria\"), [hyperparathyroidism](Hyperparathyroidism \"Hyperparathyroidism\"), and [gout](Gout \"Gout\"). Infection stones can grow rapidly, forming large calyceal staghorn ([antler](Antler \"Antler\")-shaped) calculi requiring invasive surgery such as percutaneous nephrolithotomy for definitive treatment.[76]\n\nStruvite stones (triple-phosphate/magnesium ammonium phosphate) have a 'coffin lid' morphology by microscopy.[75]\n\n### Uric acid stones\n\nAbout 5â€“10% of all stones are formed from [uric acid](Uric_acid \"Uric acid\").[21] People with certain metabolic abnormalities, including [obesity](Obesity \"Obesity\"),[30] may produce uric acid stones. They also may form in association with conditions that cause [hyperuricosuria](Hyperuricosuria \"Hyperuricosuria\") (an excessive amount of uric acid in the urine) with or without [hyperuricemia](Hyperuricemia \"Hyperuricemia\") (an excessive amount of uric acid in the [serum](Blood_serum \"Blood serum\")). They may also form in association with disorders of acid/base metabolism where the urine is excessively acidic (low [pH](PH \"PH\")), resulting in precipitation of uric acid crystals. A diagnosis of uric acid [urolithiasis](Urolithiasis \"Urolithiasis\") is supported by the presence of a [radiolucent](Radiodensity \"Radiodensity\") stone in the face of persistent urine acidity, in conjunction with the finding of uric acid crystals in fresh urine samples.[77]\n\nAs noted above (section on calcium oxalate stones), people with [inflammatory bowel disease](Inflammatory_bowel_disease \"Inflammatory bowel disease\") ([Crohn's disease](Crohn's_disease \"Crohn's disease\"), [ulcerative colitis](Ulcerative_colitis \"Ulcerative colitis\")) tend to have [hyperoxaluria](Hyperoxaluria \"Hyperoxaluria\") and form oxalate stones. They also have a tendency to form urate stones. Urate stones are especially common after [colon resection](Colectomy \"Colectomy\"). \n\nUric acid stones appear as [pleomorphic](Pleomorphism_\\(cytology\\) \"Pleomorphism \\(cytology\\)\") crystals, usually diamond-shaped. They may also look like squares or rods which are polarizable.[75]\n\n### Other types\n\nMicroscopic [cystine](Cystine \"Cystine\") crystals have a distinctive hexagonal shape and are present in the urine of people with kidney stones composed of cystine\n\nPeople with certain rare [inborn errors of metabolism](Inborn_error_of_metabolism \"Inborn error of metabolism\") have a propensity to accumulate crystal-forming substances in their urine. For example, those with [cystinuria](Cystinuria \"Cystinuria\"), [cystinosis](Cystinosis \"Cystinosis\"), and [Fanconi syndrome](Fanconi_syndrome \"Fanconi syndrome\") may form stones composed of [cystine](Cystine \"Cystine\"). Cystine stone formation can be treated with urine alkalinization and dietary protein restriction. People affected by [xanthinuria](Xanthinuria \"Xanthine\") often produce stones composed of [xanthine](Xanthine \"Xanthine\"). People affected by [adenine phosphoribosyltransferase deficiency](Adenine_phosphoribosyltransferase_deficiency \"Adenine phosphoribosyltransferase deficiency\") may produce [2,8-dihydroxyadenine](2%2C8-dihydroxyadenine \"2,8-dihydroxyadenine\") stones,[78] [alkaptonurics](Alkaptonuria \"Alkaptonuria\") produce [homogentisic acid](Homogentisic_acid \"Homogentisic acid\") stones, and [iminoglycinurics](Iminoglycinuria \"Iminoglycinuria\") produce stones of [glycine](Glycine \"Glycine\"), [proline](Proline \"Proline\"), and [hydroxyproline](Hydroxyproline \"Hydroxyproline\").[79][80] Urolithiasis has also been noted to occur in the setting of therapeutic drug use, with crystals of drug forming within the renal tract in some people currently being treated with agents such as [indinavir](Indinavir \"Indinavir\"),[81] [sulfadiazine](Sulfadiazine \"Sulfadiazine\"),[82] and [triamterene](Triamterene \"Triamterene\").[83]\n\n## Location\n\nUrolithiasis refers to stones originating anywhere in the urinary system, including the kidneys and bladder.[16] Nephrolithiasis refers to the presence of such stones in the kidneys. Calyceal calculi are aggregations in either the [minor](Minor_calyx \"Minor calyx\") or [major calyx](Major_calyx \"Major calyx\"), parts of the kidney that pass urine into the ureter (the tube connecting the kidneys to the urinary bladder). The condition is called ureterolithiasis when a calculus is located in the ureter. Stones may also form or pass into the bladder, a condition referred to as [bladder stones](Bladder_stone \"Bladder stone\").[84]\n\n## Size\n\nStones less than 5 mm (0.2 in) in diameter pass spontaneously in up to 98% of cases, while those measuring 5 to 10 mm (0.2 to 0.4 in) in diameter pass spontaneously in less than 53% of cases.[85]\n\nStones that are large enough to fill out the renal calyces are called _staghorn stones_ and are composed of [struvite](Struvite \"Struvite\") in a vast majority of cases, which forms only in the presence of [urease-forming bacteria](Urease#As_diagnostic_test \"Urease\"). Other forms that can possibly grow to become staghorn stones are those composed of cystine, calcium oxalate monohydrate, and uric acid.[86]\n## Prevention\n\nPreventative measures depend on the type of stones. In those with calcium stones, drinking plenty of fluids, [thiazide](Thiazide \"Thiazide\") [diuretics](Diuretic \"Diuretic\") and citrate are effective as is allopurinol in those with high uric acid levels in urine.[87][88]\n\n### Dietary measures\n\nSpecific therapy should be tailored to the type of stones involved. Diet can have an effect on the development of kidney stones. Preventive strategies include some combination of dietary modifications and medications with the goal of reducing the excretory load of calculogenic compounds on the kidneys.[32][89][90] Dietary recommendations to minimize the formation of kidney stones include: \n\n- increasing total fluid intake to achieve more than two liters per day of urine output;[91]\n- limiting consumption of cola and sugar-sweetened soft drinks, as daily intake increases stone risk by about 23%;[87][91][92][](https://pmc.ncbi.nlm.nih.gov/articles/PMC3731916/)\n- limiting animal protein intake to about 0.8-1 g per kg of body weight per day (e.g., 50-70 g for most adults; an association between animal [protein](Protein_\\(nutrient\\) \"Protein \\(nutrient\\)\") and recurrence of kidney stones has been shown in men);[94][](https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones/eating-diet-nutrition)\n- increasing citrate, including from lemon and [lime juice](Lime_juice \"Lime juice\");[95] citric acid in its natural form, such as from citrus fruits, \"prevents small stones from becoming 'problem stones' by coating them and preventing other material from attaching and building onto the stones\";[96] citrate inhibits the formation of kidney stones on all phases[â€”nucleation](Nucleation \"Nucleation\"), growth and aggregationâ€”by raising the limit at which oxalate remain stable, slowing oxalate crystal growth, and notably, reducing crystal aggregation within the [kidney tubules](Kidney_tubules \"Kidney tubules\");[41]\n- increase alkaline load by consuming more fruits and vegetables (because uric acid crystals form in acidic environment);[95]\n- reducing sodium intake is associated with a reduction in urine calcium excretion.[97]\n\nMaintenance of dilute urine by means of vigorous fluid therapy is beneficial in all forms of kidney stones, so increasing urine volume is a key principle for the prevention of kidney stones. Fluid intake should be sufficient to maintain a urine output of at least 2 [litres](Litre \"Litre\") (68 [US fl oz](US_fluid_ounce \"US fluid ounce\")) per day.[88] A high fluid intake may reduce the likelihood of kidney stone recurrence or may increase the time between stone development without unwanted effects. \n\nCalcium binds with available oxalate in the [gastrointestinal tract](Gastrointestinal_tract \"Gastrointestinal tract\"), thereby preventing its absorption into the [bloodstream](Circulatory_system \"Circulatory system\"). Reducing oxalate absorption decreases kidney stone risk in susceptible people.[98] Because of this, some doctors recommend increasing dairy intake so that its calcium content will serve as an oxalate binder. Taking calcium citrate tablets during or after meals containing high oxalate foods[99] may be useful if dietary calcium cannot be increased by other means as in those with lactose intolerance. The preferred calcium supplement for people at risk of stone formation is calcium citrate, as opposed to calcium carbonate, because it helps to increase urinary citrate excretion.[90]\n\nAside from vigorous oral hydration and eating more dietary calcium, other prevention strategies include avoidance of higher doses of supplemental vitamin C (since [ascorbate](Ascorbate \"Ascorbate\") is metabolized to oxalate) and restriction of oxalate-rich foods such as [leaf vegetables](List_of_common_leaf_vegetables \"List of common leaf vegetables\"), [rhubarb](Rhubarb \"Rhubarb\"), [soy products](Soybean \"Soybean\") and [chocolate](Chocolate \"Chocolate\").[100] However, no randomized, controlled trial of oxalate restriction has been performed to test the hypothesis that oxalate restriction reduces stone formation.[99] Some evidence indicates [magnesium](Magnesium \"Magnesium\") intake decreases the risk of symptomatic kidney stones.[100]\n\n### Urine alkalinization\n\nThe mainstay for medical management of uric acid stones is [alkalinization](Alkalinity \"Alkalinity\") (increasing the [pH](PH \"PH\")) of the urine. Uric acid stones are among the few types amenable to dissolution therapy, referred to as [chemolysis](Lysis \"Lysis\"). Chemolysis is usually achieved through the use of oral medications, although in some cases, intravenous agents or even instillation of certain irrigating agents directly onto the stone can be performed, using antegrade [nephrostomy](Nephrostomy \"Nephrostomy\") or [retrograde ureteral](Retrograde_ureteral \"Retrograde ureteral\") catheters.[43] [Acetazolamide](Acetazolamide \"Acetazolamide\") is a medication that alkalinizes the urine. In addition to acetazolamide or as an alternative, certain dietary supplements are available that produce a similar alkalinization of the urine. These include [alkali citrate](Alkali_citrate \"Alkali citrate\"), [sodium bicarbonate](Sodium_bicarbonate \"Sodium bicarbonate\"), [potassium citrate](Potassium_citrate \"Potassium citrate\"), [magnesium citrate](Magnesium_citrate \"Magnesium citrate\"), and [bicitrate](Bicitrate \"Bicitrate\") (a combination of citric acid monohydrate and sodium citrate dihydrate).[101] Aside from alkalinization of the urine, these supplements have the added advantage of increasing the urinary citrate level, which helps to reduce the aggregation of calcium oxalate stones.[43]\n\nIncreasing the urine pH to around 6.5 provides optimal conditions for [dissolution](Dissolution_\\(chemistry\\) \"Dissolution \\(chemistry\\)\") of uric acid stones. Increasing the urine pH to a value higher than 7.0 may increase the risk of calcium phosphate stone formation, though this concept is controversial since citrate does inhibit calcium phosphate crystallization. Testing the urine periodically with [nitrazine](Nitrazine \"Nitrazine\") paper can help to ensure the urine pH remains in this optimal range. Using this approach, stone dissolution rate can be expected to be around 10 mm (0.4 in) of stone radius per month.[43]\n\n### Diuretics\n\nOne of the recognized medical therapies for prevention of stones is the [thiazide](Thiazide \"Thiazide\") and [thiazide-like diuretics](Thiazide-like_diuretic \"Thiazide-like diuretic\"), such as [chlorthalidone](Chlortalidone \"Chlortalidone\") or [indapamide](Indapamide \"Indapamide\"). These drugs inhibit the formation of calcium-containing stones by reducing urinary calcium excretion.[14] Sodium restriction is necessary for clinical effect of thiazides, as sodium excess promotes calcium excretion. Thiazides work best for renal leak hypercalciuria (high urine calcium levels), a condition in which high urinary calcium levels are caused by a primary kidney defect. Thiazides are useful for treating absorptive hypercalciuria, a condition in which high urinary calcium is a result of excess absorption from the gastrointestinal tract.[53]\n\n### Allopurinol\n\nFor people with [hyperuricosuria](Hyperuricosuria \"Hyperuricosuria\") and calcium stones, [allopurinol](Allopurinol \"Allopurinol\") is one of the few treatments that have been shown to reduce kidney stone recurrences. Allopurinol interferes with the production of uric acid in the [liver](Liver \"Liver\"). The drug is also used in people with [gout](Gout \"Gout\") or hyperuricemia (high [serum](Serum_\\(blood\\) \"Serum \\(blood\\)\") uric acid levels).[103] Dosage is adjusted to maintain a reduced urinary excretion of uric acid. Serum uric acid level at or below 6 mg/100 mL is often a therapeutic goal. Hyperuricemia is not necessary for the formation of uric acid stones; hyperuricosuria can occur in the presence of normal or even [low serum uric acid](Hypouricemia \"Hypouricemia\"). Some practitioners advocate adding allopurinol only in people in whom hyperuricosuria and hyperuricemia persist, despite the use of a urine-[alkalinizing agent](Alkalinizing_agent \"Alkalinizing agent\") such as [sodium bicarbonate](Sodium_bicarbonate \"Sodium bicarbonate\") or [potassium citrate](Potassium_citrate \"Potassium citrate\").[43]\n# Treatment\n\nStone size influences the rate of spontaneous stone passage. For example, up to 98% of small stones (less than 5 mm (0.2 in) in diameter) may pass spontaneously through urination within four weeks of the onset of symptoms,[7] but for larger stones (5 to 10 mm (0.2 to 0.4 in) in diameter), the rate of spontaneous passage decreases to less than 53%.[85] Initial stone location also influences the likelihood of spontaneous stone passage. Rates increase from 48% for stones located in the proximal ureter to 79% for stones located at the vesicoureteric junction, regardless of stone size.[85] Assuming no high-grade obstruction or associated infection is found in the urinary tract, and symptoms are relatively mild, various nonsurgical measures can be used to encourage the passage of a stone.[43] Repeat stone formers benefit from more intense management, including proper fluid intake and use of certain medications, as well as careful monitoring.[104]\n\n## Pain management\n\nManagement of pain often requires intravenous administration of [NSAIDs](Nonsteroidal_anti-inflammatory_drug \"Nonsteroidal anti-inflammatory drug\") or opioids.[14] NSAIDs appear somewhat better than opioids or [paracetamol](Paracetamol \"Paracetamol\") in those with normal kidney function.[105] Medications by mouth are often effective for less severe discomfort.[67] The use of [antispasmodics](Antispasmodic \"Antispasmodic\") does not have further benefit.[9]\n\n## Medical expulsive therapy\n\nThe use of medications to speed the spontaneous passage of stones in the ureter is referred to as medical expulsive therapy.[106][107] Several agents, including [alpha adrenergic blockers](Alpha_blocker \"Alpha blocker\") (such as [tamsulosin](Tamsulosin \"Tamsulosin\")) and [calcium channel blockers](Calcium_channel_blocker \"Calcium channel blocker\") (such as [nifedipine](Nifedipine \"Nifedipine\")), may be effective.[106] Alpha-blockers likely result in more people passing their stones, and they may pass their stones in a shorter time.[107] People taking alpha-blockers may also use less pain medication and may not need to visit the hospital.[107] Alpha-blockers appear to be more effective for larger stones (over 5 mm in size) than smaller stones.[107] However, use of alpha-blockers may be associated with a slight increase in serious, unwanted effects from this medication.[107] A combination of tamsulosin and a [corticosteroid](Corticosteroid \"Corticosteroid\") may be better than tamsulosin alone.[106] These treatments also appear to be useful in addition to lithotripsy.[7]\n\n## Lithotripsy\n\n[Extracorporeal shock wave lithotripsy](Extracorporeal_shock_wave_lithotripsy \"Extracorporeal shock wave lithotripsy\") (ESWL) is a [noninvasive](Noninvasive \"Noninvasive\") technique for the removal of kidney stones. Most ESWL is carried out when the stone is present near the [renal pelvis](Renal_pelvis \"Renal pelvis\"). ESWL involves the use of a [lithotriptor](Extracorporeal_shockwave_therapy \"Extracorporeal shockwave therapy\") machine to deliver externally applied, focused, high-intensity pulses of [ultrasonic energy](Ultrasound \"Ultrasound\") to cause fragmentation of a stone over a period of around 30â€“60 minutes. Following its introduction in the United States in February 1984, ESWL was rapidly and widely accepted as a treatment alternative for renal and ureteral stones.[108] It is currently used in the treatment of uncomplicated stones located in the kidney and upper ureter, provided the aggregate stone burden (stone size and number) is less than 20 mm (0.8 in) and the anatomy of the involved kidney is normal.[109][110]\n\nFor a stone greater than 10 millimetres (0.39 in), ESWL may not help break the stone in one treatment; instead, two or three treatments may be needed. Some 80-85% of simple renal calculi can be effectively treated with ESWL.[7] A number of factors can influence its efficacy, including chemical composition of the stone, presence of anomalous renal anatomy and the specific location of the stone within the kidney, presence of hydronephrosis, [body mass index](Body_mass_index \"Body mass index\"), and distance of the stone from the surface of the skin.[108]\n\nCommon adverse effects of ESWL include acute [trauma](Trauma_\\(medicine\\) \"Trauma \\(medicine\\)\"), such as [bruising](Bruise \"Bruise\") at the site of shock administration, and damage to blood vessels of the kidney.[111][112] In fact, the vast majority of people who are treated with a typical dose of shock waves using currently accepted treatment settings are likely to experience some degree of [acute kidney injury](Acute_kidney_injury \"Acute kidney injury\").[108] ESWL-induced acute kidney injury is dose-dependent (increases with the total number of shock waves administered and with the power setting of the lithotriptor) and can be severe,[108] including [internal bleeding](Internal_bleeding \"Internal bleeding\") and subcapsular [hematomas](Hematoma \"Hematoma\"). On rare occasions, such cases may require [blood transfusion](Blood_transfusion \"Blood transfusion\") and even lead to acute [kidney failure](Kidney_failure \"Kidney failure\"). Hematoma rates may be related to the type of lithotriptor used; hematoma rates of less than 1% and up to 13% have been reported for different lithotriptor machines.[112] Recent studies show reduced acute tissue injury when the treatment protocol includes a brief pause following the initiation of treatment, and both improved stone breakage and a reduction in injury when ESWL is carried out at slow shock wave rate.[108]\n\nIn addition to the aforementioned potential for acute kidney injury, animal studies suggest these acute injuries may progress to scar formation, resulting in loss of functional renal volume.[111][112] Recent [prospective studies](Prospective_cohort_study \"Prospective cohort study\") also indicate elderly people are at increased risk of developing new-onset hypertension following ESWL. In addition, a [retrospective case-control study](Retrospective_cohort_study \"Retrospective cohort study\") published by researchers from the [Mayo Clinic](Mayo_Clinic \"Mayo Clinic\") in 2006 has found an increased risk of developing [diabetes mellitus](Diabetes_mellitus \"Diabetes mellitus\") and [hypertension](Hypertension \"Hypertension\") in people who had undergone ESWL, compared with age and gender-matched people who had undergone nonsurgical treatment. Whether or not acute trauma progresses to long-term effects probably depends on multiple factors that include the shock wave dose (i.e., the number of shock waves delivered, rate of delivery, power setting, acoustic characteristics of the particular lithotriptor, and frequency of retreatment), as well as certain intrinsic predisposing pathophysiologic risk factors.[108]\n\nTo address these concerns, the [American Urological Association](American_Urological_Association \"American Urological Association\") established the Shock Wave Lithotripsy Task Force to provide an expert opinion on the safety and [risk-benefit ratio](Risk-benefit_analysis \"Risk-benefit analysis\") of ESWL. The task force published a [white paper](White_paper \"White paper\") outlining their conclusions in 2009. They concluded the risk-benefit ratio remains favorable for many people.[108] The advantages of ESWL include its noninvasive nature, the fact that it is technically easy to treat most upper urinary tract calculi, and that, at least acutely, it is a well-tolerated, low-[morbidity](Morbidity \"Morbidity\") treatment for the vast majority of people. However, they recommended slowing the shock wave firing rate from 120 pulses per minute to 60 pulses per minute to reduce the risk of renal injury and increase the degree of stone fragmentation.[108]\n\n[Alpha-blockers](Alpha_blocker \"Alpha blocker\") are sometimes prescribed after shock wave lithotripsy to help the pieces of the stone leave the person's body.[113] By relaxing muscles and helping to keep blood vessels open, alpha blockers may relax the ureter muscles to allow the kidney stone fragments to pass. When compared to usual care or placebo treatment, alpha blockers may lead to faster clearing of stones, a reduced need for extra treatment and fewer unwanted effects.[113] They may also clear kidney stones in more adults than the standard shock wave lithotripsy procedure. The unwanted effects associated with alpha blockers are hospital emergency visits and return to hospital for stone-related issues, but these effects were more common in adults who did not receive [alpha-blockers](Alpha_blocker \"Alpha blocker\") as a part of their treatment.[113]\n\n## Surgery\n\nMost stones under 5 mm (0.2 in) pass spontaneously.[32][7] Prompt surgery may, nonetheless, be required in persons with only one working kidney, bilateral obstructing stones, a urinary tract infection and thus, it is presumed, an infected kidney, or intractable pain.[114] Beginning in the mid-1980s, less invasive treatments such as extracorporeal shock wave lithotripsy, [ureteroscopy](Ureteroscopy \"Ureteroscopy\"), and [percutaneous nephrolithotomy](Percutaneous_nephrolithotomy \"Percutaneous nephrolithotomy\") began to replace open surgery as the modalities of choice for the surgical management of urolithiasis.[7] More recently, flexible ureteroscopy has been adapted to facilitate retrograde nephrostomy creation for percutaneous nephrolithotomy. This approach is still under investigation, though early results are favorable.[115] Percutaneous nephrolithotomy or, rarely, [anatrophic nephrolithotomy](Lithotomy \"Lithotomy\"), is the treatment of choice for large or complicated stones (such as calyceal staghorn calculi) or stones that cannot be extracted using less invasive procedures.[57][7]\n\n### Ureteroscopic surgery\n\n[Ureteroscopy](Ureteroscopy \"Ureteroscopy\") has become increasingly popular as flexible and rigid [fiberoptic](Optical_fiber \"Optical fiber\") ureteroscopes have become smaller. One ureteroscopic technique involves the placement of a [ureteral stent](Ureteric_stent \"Ureteric stent\") (a small tube extending from the bladder, up the ureter and into the kidney) to provide immediate relief of an obstructed kidney. Stent placement can be useful for saving a kidney at risk for [postrenal acute kidney failure](Acute_kidney_injury#Postrenal \"Acute kidney injury\") due to the increased hydrostatic pressure, [swelling](Edema \"Edema\") and infection ([pyelonephritis](Pyelonephritis \"Pyelonephritis\") and [pyonephrosis](Pyonephrosis \"Pyonephrosis\")) caused by an obstructing stone. Ureteral stents vary in length from 24 to 30 cm (9.4 to 11.8 in) and most have a shape commonly referred to as a \"double-J\" or \"double pigtail\", because of the curl at both ends. They are designed to allow urine to flow past an obstruction in the ureter. They may be retained in the ureter for days to weeks as infections resolve and as stones are dissolved or fragmented by ESWL or by some other treatment. The stents dilate the ureters, which can facilitate instrumentation, and they also provide a clear landmark to aid in the visualization of the ureters and any associated stones on radiographic examinations. The presence of indwelling ureteral stents may cause minimal to moderate discomfort, frequency or urgency incontinence, and infection, which in general resolves on removal. Most ureteral stents can be removed cystoscopically during an office visit under [topical anesthesia](Topical_anesthetic \"Topical anesthetic\") after resolution of urolithiasis.[116] Research is currently uncertain if placing a temporary stent during ureteroscopy leads to different outcomes than not placing a stent in terms of number of hospital visits for post operative problems, short or long term pain, need for narcotic pain medication, risk of UTI, need for a repeat procedure or narrowing of the ureter from scarring.[117]\n\nMore definitive ureteroscopic techniques for stone extraction (rather than simply bypassing the obstruction) include basket extraction and ultrasound ureterolithotripsy. [Laser lithotripsy](Laser_lithotripsy \"Laser lithotripsy\") is another technique, which involves the use of a [holmium](Holmium \"Holmium\"):[yttrium aluminium garnet](Yttrium_aluminium_garnet \"Yttrium aluminium garnet\") (Ho:YAG) laser to fragment stones in the bladder, ureters, and kidneys.[118]\n\nUreteroscopic techniques are generally more effective than ESWL for treating stones located in the lower ureter, with success rates of 93â€“100% using Ho:YAG laser lithotripsy.[85] Although ESWL has been traditionally preferred by many practitioners for treating stones located in the upper ureter, more recent experience suggests ureteroscopic techniques offer distinct advantages in the treatment of upper ureteral stones. Specifically, the overall success rate is higher, fewer repeat interventions and postoperative visits are needed, and treatment costs are lower after ureteroscopic treatment when compared with ESWL. These advantages are especially apparent with stones greater than 10 mm (0.4 in) in diameter. However, because ureteroscopy of the upper ureter is much more challenging than ESWL, many urologists still prefer to use ESWL as a first-line treatment for stones of less than 10 mm, and ureteroscopy for those greater than 10 mm in diameter.[85] Ureteroscopy is the preferred treatment in pregnant and morbidly obese people, as well as those with [bleeding disorders](Bleeding_diathesis \"Bleeding diathesis\").[7]\n## Epidemiology\n\n| Country | Prevalence (%) | Year | Source |\n|---------|----------------|------|--------|\n| United States | 9.9 | 2017â€“2020 | [](https://journals.lww.com/juop/fulltext/2024/11000/kidney_stone_prevalence_among_us_population_.3.aspx) |\n| Italy | ~2 | 2010s | [119] |\n| Scotland | ~4 | 2000s | [119] |\n| Spain | ~5â€“10 | 2010s | [119] |\n| Turkey | ~15 | 2010s | [119] |\n\n| Country | Incidence (per 100,000/year) | Year | Trend |\n|---------|------------------------------|------|-------|\n| United States | ~180 | 2010s | stable/increasing |\n| Germany | ~700 | 2010s | increasing |\n| Japan | ~120 | 2010s | increasing |\n| Spain | ~300 | 2010s | stable |\n| Sweden | ~200 | 2010s | increasing |\n\nKidney stones affect all geographical, cultural, and racial groups. The lifetime risk is about 8â€“15% in developed countries, but can be as high as 20% in the Middle East and parts of Asia due to hot climates and dietary factors such as lower calcium intake (approximately 50% less) and higher oxalate consumption (up to 250% more) compared to Western diets.[120][13] In the Middle East, uric acid stones are more common than calcium-containing stones.[25] Globally, there were approximately 106 million incident cases of urolithiasis in 2021, with about 2,900 deaths, reflecting low direct mortality but significant morbidity.[121][](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext)[](https://mednexus.org/doi/10.1097/CM9.0000000000003622)\n\nIn North America and Europe, the annual incidence of kidney stones is approximately 0.5â€“1%. In the United States, the prevalence of urolithiasis increased from 3.2% in the mid-1970s to 5.2% in the mid-1990s, reaching about 9.9% by 2017â€“2020.[21][2][](https://journals.lww.com/juop/fulltext/2024/11000/kidney_stone_prevalence_among_us_population_.3.aspx)\n\nThe total cost for treating urolithiasis in the United States exceeds $2 billion annually as of the 2020s.[59][](https://onlinelibrary.wiley.com/doi/full/10.1002/uro2.94) About 65â€“80% of those with kidney stones are men, though the gap is narrowing with increasing prevalence among women; most stones in women are due to either metabolic defects (such as cystinuria) or infections in the case of struvite stones.[76][122][19] Urinary tract calculi disorders are more common in men than in women. Men most commonly experience their first episode between 30 and 40 years of age, whereas for women, the age at first presentation is somewhat later.[76] The age of onset shows a bimodal distribution in women, with episodes peaking at 35 and 55 years.[59] Recurrence rates are estimated at 50% over a 10-year and 75% over 20-year period,[21] with some people experiencing ten or more episodes over the course of a lifetime.[76]\n\nRecent analyses indicate that while age-standardized incidence rates have decreased globally (by 17.5% from 1990 to 2021), the absolute number of cases continues to rise due to population growth and aging, particularly in low- and middle-income countries.[119][](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext)\n# Kidney Stones\n\n## History\n\nThe existence of kidney stones was first recorded thousands of years ago, with various explanations given; Joseph Glanville's _[Saducismus Triumphatus](Saducismus_Triumphatus \"Saducismus Triumphatus\")_, for example, gives a detailed description of Abraham Mechelburg's voiding of small stones through his penis' virga, attributing the issue to witchcraft.[123]\n\nIn 1901, English archaeologist E. Smith discovered a bladder stone in the pelvis of an ancient Egyptian mummy dated to around 4800 BC, representing one of the earliest known urinary calculi.[](https://www.kidneystoners.org/information/history-of-stones/)\n\nMedical texts from ancient [Mesopotamia](Mesopotamia \"Mesopotamia\"), [India](History_of_India \"History of India\"), [China](History_of_China \"History of China\"), [Persia](Achaemenid_Empire \"Achaemenid Empire\"), [Greece](Ancient_Greece \"Ancient Greece\"), and [Rome](Ancient_Rome \"Ancient Rome\") all mentioned calculous disease. Descriptions of surgery to remove urinary stones date to as early as 600 BC in ancient India by Sushruta.[1] Part of the [Hippocratic Oath](Hippocratic_Oath \"Hippocratic Oath\") suggests there were practicing surgeons in ancient Greece to whom physicians were to defer for [lithotomies](Lithotomy \"Lithotomy\"), or the surgical removal of stones. The Roman medical treatise _[De Medicina](De_Medicina \"De Medicina\")_ by [Aulus Cornelius Celsus](Aulus_Cornelius_Celsus \"Aulus Cornelius Celsus\") contained a description of lithotomy,[124] and this work served as the basis for this procedure until the 18th century.[125]\n\nIn 1980, [Dornier MedTech](Dornier_Flugzeugwerke \"Dornier Flugzeugwerke\") introduced extracorporeal shock wave lithotripsy for breaking up kidney stones via acoustical pulses, and this technique has since come into widespread use.[108]\n\n### Etymology\n\nThe term _renal calculus_ is from the [Latin](Latin \"Latin\") _rÄ“nÄ“s_ , meaning \"kidneys\", and _[calculus](Calculus_\\(medicine\\) \"Calculus \\(medicine\\)\")_ , meaning \"pebble\". Lithiasis (stone formation) in the kidneys is called nephrolithiasis (/ËŒnÉ›froÊŠlÉªËˆÎ¸aÉªÉ™sÉªs/), from _[nephro](https://en.wiktionary.org/wiki/nephro- \"wikt:nephro-\")-_, meaning kidney, + _[-lith](https://en.wiktionary.org/wiki/-lith \"wikt:-lith\")_ , meaning stone, and _[-iasis](https://en.wiktionary.org/wiki/-iasis#Suffix \"wikt:-iasis\")_ , meaning disorder. A distinction between nephrolithiasis and urolithiasis can be made because not all urinary stones (uroliths) form in the kidney; they can also form in the bladder. But the distinction is often clinically irrelevant (with similar disease process and treatment either way) and the words are thus often used loosely as synonyms.\n## Children\n\nAlthough kidney stones do not often occur in children, the incidence is increasing, with annual rises of 4-10% reported in recent decades.[128] The increase is attributed to factors such as rising childhood obesity, increased consumption of sugary beverages, and dietary changes.[](https://consultqd.clevelandclinic.org/why-more-children-are-getting-kidney-stones-and-the-best-way-to-manage-them) Stones are most commonly located in the kidney (approximately 70-80% of cases), with 10-40% in the ureter depending on the study population.[web:6][web:7] Older children are at greater risk independent of sex.[129]\n\nAs with adults, most pediatric kidney stones are predominantly composed of calcium oxalate; struvite and calcium phosphate stones are less common. Calcium oxalate stones in children are associated with high amounts of calcium, oxalate, and magnesium in acidic urine.[130]\n\nTreatment of kidney stones in children is similar to treatments for adults, including shock wave lithotripsy, medication, and treatment using scope through the bladder, kidney or skin.[131] Of these treatments, research is uncertain if shock waves are more effective than medication or a scope through the bladder, but it is likely less successful than a scope through skin into the kidney.[131] When going in with a scope through the kidney, a regular and a mini-sized scope likely have similar success rates of stone removal. Alpha-blockers, a type of medication, may increase the successful removal of kidney stones when compared with a placebo.[131]\n## Research\n\n[Metabolic syndrome](Metabolic_syndrome) and its associated conditions of obesity and diabetes are established risk factors for kidney stone disease. Recent studies as of 2025 confirm modest but significant genetic correlations between kidney stones and obesity, type 2 diabetes, and hypertension, with higher prevalence observed in metabolically unhealthy obese individuals.[](https://www.mayoclinicproceedings.org/article/S0025-6196%2825%2900243-5/abstract)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12230011/) Ongoing research investigates whether urinary excretion of calcium, oxalate, and urate is elevated in these groups compared to those with normal or low weight, and the roles of diet and physical activity in mitigation.[](https://bmjopen.bmj.com/content/bmjopen/15/5/e096533.full.pdf) Dietary, fluid intake, and lifestyle factors continue as major topics for research on prevention of kidney stones.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11975591/)[](https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1612347/full)\n\n### Gut microbiota\n\nThe [gut microbiota](Gut_microbiota) has been explored as a contributing factor for stone disease, indicating that some bacteria may be different in people forming kidney stones.[135] One bacterium, [_Oxalobacter formigenes_](Oxalobacter_formigenes), is potentially beneficial for mitigating calcium oxalate stones because of its ability to metabolize oxalate as its sole carbon source,[136] but 2018 research suggests that it is instead part of a network of oxalate degrading bacteria.[137] Recent studies as of 2025 highlight probiotics and engineered gut bacteria (e.g., modified _Phocaeicola vulgatus_) to enhance oxalate degradation and reduce stone risk, with clinical trials showing _O. formigenes_ colonization lowers urinary oxalate but yields mixed efficacy in primary hyperoxaluria.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12528112/)[](https://www.news-medical.net/news/20250718/Microbial-therapy-uses-modified-bacteria-to-target-oxalate-in-the-gut.aspx)[](https://clinicaltrials.gov/study/NCT06330246) Additionally, one study found that oral [antibiotic](Antibiotic) use, which alters the gut microbiota,[138] can increase the odds of a person developing a kidney stone.[139] Dysbiosis in both gut and urinary microbiota is linked to stone formation via the gut-kidney axis.[](https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1602413/full)\n## In other animals\n\nAmong [ruminants](Ruminant \"Ruminant\"), uroliths more commonly cause problems in males than in females; the sigmoid flexure of the ruminant male urinary tract is more likely to obstruct passage. Early-castrated males are at greater risk, because of lesser urethral diameter.[140]\n\nLow Ca:P intake ratio is conducive to phosphatic (e.g. struvite) urolith formation.[140] Incidence among wether lambs can be minimized by maintaining a dietary Ca:P intake ratio of 2:1.[140][141]\n\nAlkaline (higher) [pH](PH \"PH\") favors formation of carbonate and phosphate calculi. For domestic ruminants, dietary cation: anion balance is sometimes adjusted to assure a slightly acidic urine pH, for prevention of calculus formation.[140]\n\nDiffering generalizations regarding effects of pH on formation of silicate uroliths may be found.[140][142] In this connection, it may be noted that under some circumstances, calcium carbonate accompanies silica in siliceous uroliths.[143]\n\nPelleted feeds may be conducive to formation of phosphate uroliths, because of increased urinary phosphorus excretion. This is attributable to lower saliva production where pelleted rations containing finely ground constituents are fed. With less blood phosphate partitioned into saliva, more tends to be excreted in urine.[144] (Most saliva phosphate is fecally excreted.[145]) \n\nOxalate uroliths can occur in ruminants, although such problems from oxalate ingestion may be relatively uncommon. Ruminant urolithiasis associated with oxalate ingestion has been reported.[146] However, no renal tubular damage or visible deposition of calcium oxalate crystals in kidneys was found in yearling wether sheep fed diets containing soluble oxalate at 6.5 percent of dietary dry matter for about 100 days.[147]\n\nConditions limiting water intake can result in stone formation.[148]\n\nVarious surgical interventions, e.g. amputation of the urethral process at its base near the glans penis in male ruminants, perineal [urethrostomy](Urethrostomy \"Urethrostomy\"), or tube [cystostomy](Suprapubic_cystostomy \"Suprapubic cystostomy\") may be considered for relief of obstructive urolithiasis.[148]"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761886994207,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"_**a**_ _**b**_ Schulsinger DA (2014). [_Kidney Stone Disease: Say NO to Stones!_](https://books.google.com/books?id=2ADRBQAAQBAJ\u0026pg=PA27). Springer. p. 27\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-3-319-12105-5. [Archived](https://web.archive.org/web/20170908221053/https://books.google.com/books?id=2ADRBQAAQBAJ\u0026pg=PA27) from the original on 8 September 2017.\",\"description\":\"1. ^ _**a**_ _**b**_ Schulsinger DA (2014). [_Kidney Stone Disease: Say NO to Stones!_](https://books.google.com/books?id=2ADRBQAAQBAJ\u0026pg=PA27). Springer. p. 27\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-3-319-12105-5. [Archived](https://web.archive.org/web/20170908221053/https://books.google.com/books?id=2ADRBQAAQBAJ\u0026pg=PA27) from the original on 8 September 2017.\",\"url\":\"https://books.google.com/books?id=2ADRBQAAQBAJ\u0026pg=PA27\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ _**l**_ _**m**_ _**n**_ _**o**_ _**p**_ _**q**_ _**r**_ _**s**_ [\\\"Kidney Stones in Adults\\\"](https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones?dkrd=hispt0421). February 2013. [Archived](https://web.archive.org/web/20150511192215/http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/kidney-stones-in-adults/Pages/facts.aspx) from the original on 11 May 2015. Retrieved 22 May 2015.\",\"description\":\"2. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ _**l**_ _**m**_ _**n**_ _**o**_ _**p**_ _**q**_ _**r**_ _**s**_ [\\\"Kidney Stones in Adults\\\"](https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones?dkrd=hispt0421). February 2013. [Archived](https://web.archive.org/web/20150511192215/http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/kidney-stones-in-adults/Pages/facts.aspx) from the original on 11 May 2015. Retrieved 22 May 2015.\",\"url\":\"https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones?dkrd=hispt0421\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"** Knoll T, Pearle MS (2012). [_Clinical Management of Urolithiasis_](https://books.google.com/books?id=A2uak6SVgBUC\u0026pg=PA21). Springer Science \u0026 Business Media. p. 21\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-3-642-28732-9. [Archived](https://web.archive.org/web/20170908221053/https://books.google.com/books?id=A2uak6SVgBUC\u0026pg=PA21) from the original on 8 September 2017.\",\"description\":\"3. **^** Knoll T, Pearle MS (2012). [_Clinical Management of Urolithiasis_](https://books.google.com/books?id=A2uak6SVgBUC\u0026pg=PA21). Springer Science \u0026 Business Media. p. 21\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-3-642-28732-9. [Archived](https://web.archive.org/web/20170908221053/https://books.google.com/books?id=A2uak6SVgBUC\u0026pg=PA21) from the original on 8 September 2017.\",\"url\":\"https://books.google.com/books?id=A2uak6SVgBUC\u0026pg=PA21\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Qaseem A, Dallas P, Forciea MA, et al. (November 2014). [\\\"Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians\\\"](https://doi.org/10.7326%2FM13-2908). _Annals of Internal Medicine_. **161** (9): 659â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/M13-2908](https://doi.org/10.7326%2FM13-2908). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25364887](https://pubmed.ncbi.nlm.nih.gov/25364887).\",\"description\":\"4. ^ _**a**_ _**b**_ _**c**_ _**d**_ Qaseem A, Dallas P, Forciea MA, et al. (November 2014). [\\\"Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians\\\"](https://doi.org/10.7326%2FM13-2908). _Annals of Internal Medicine_. **161** (9): 659â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/M13-2908](https://doi.org/10.7326%2FM13-2908). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25364887](https://pubmed.ncbi.nlm.nih.gov/25364887).\",\"url\":\"https://doi.org/10.7326%2FM13-2908\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"_**a**_ _**b**_ Vos T, Allen C, Arora M, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). [\\\"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577). _Lancet_. **388** (10053): 1545â€“1602\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(16)31678-6](https://doi.org/10.1016%2FS0140-6736%2816%2931678-6). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5055577](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27733282](https://pubmed.ncbi.nlm.nih.gov/27733282).\",\"description\":\"5. ^ _**a**_ _**b**_ Vos T, Allen C, Arora M, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). [\\\"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577). _Lancet_. **388** (10053): 1545â€“1602\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(16)31678-6](https://doi.org/10.1016%2FS0140-6736%2816%2931678-6). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5055577](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27733282](https://pubmed.ncbi.nlm.nih.gov/27733282).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"_**a**_ _**b**_ Wang H, Naghavi M, Allen C, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). [\\\"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903). _Lancet_. **388** (10053): 1459â€“1544\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0140-6736(16)31012-1](https://doi.org/10.1016%2Fs0140-6736%2816%2931012-1). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5388903](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27733281](https://pubmed.ncbi.nlm.nih.gov/27733281).\",\"description\":\"6. ^ _**a**_ _**b**_ Wang H, Naghavi M, Allen C, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). [\\\"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903). _Lancet_. **388** (10053): 1459â€“1544\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0140-6736(16)31012-1](https://doi.org/10.1016%2Fs0140-6736%2816%2931012-1). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5388903](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27733281](https://pubmed.ncbi.nlm.nih.gov/27733281).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ Miller NL, Lingeman JE (March 2007). [\\\"Management of kidney stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808123). _BMJ_. **334** (7591): 468â€“72\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.39113.480185.80](https://doi.org/10.1136%2Fbmj.39113.480185.80). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1808123](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808123). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17332586](https://pubmed.ncbi.nlm.nih.gov/17332586).\",\"description\":\"7. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ Miller NL, Lingeman JE (March 2007). [\\\"Management of kidney stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808123). _BMJ_. **334** (7591): 468â€“72\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.39113.480185.80](https://doi.org/10.1136%2Fbmj.39113.480185.80). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1808123](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808123). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17332586](https://pubmed.ncbi.nlm.nih.gov/17332586).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808123\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Morgan MS, Pearle MS (March 2016). \\\"Medical management of renal stones\\\". _BMJ_. **352** : i52. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.i52](https://doi.org/10.1136%2Fbmj.i52). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26977089](https://pubmed.ncbi.nlm.nih.gov/26977089). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28313474](https://api.semanticscholar.org/CorpusID:28313474).\",\"description\":\"8. ^ _**a**_ _**b**_ _**c**_ _**d**_ Morgan MS, Pearle MS (March 2016). \\\"Medical management of renal stones\\\". _BMJ_. **352** : i52. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.i52](https://doi.org/10.1136%2Fbmj.i52). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26977089](https://pubmed.ncbi.nlm.nih.gov/26977089). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28313474](https://api.semanticscholar.org/CorpusID:28313474).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"_**a**_ _**b**_ Afshar K, Jafari S, Marks AJ, et al. (June 2015). [\\\"Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981792). _The Cochrane Database of Systematic Reviews_. **2015** (6): CD006027. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD006027.pub2](https://doi.org/10.1002%2F14651858.CD006027.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [10981792](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981792). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26120804](https://pubmed.ncbi.nlm.nih.gov/26120804).\",\"description\":\"9. ^ _**a**_ _**b**_ Afshar K, Jafari S, Marks AJ, et al. (June 2015). [\\\"Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981792). _The Cochrane Database of Systematic Reviews_. **2015** (6): CD006027. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD006027.pub2](https://doi.org/10.1002%2F14651858.CD006027.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [10981792](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981792). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26120804](https://pubmed.ncbi.nlm.nih.gov/26120804).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981792\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Wang RC, Smith-Bindman R, Whitaker E, et al. (March 2017). [\\\"Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis\\\"](https://doi.org/10.1016%2Fj.annemergmed.2016.06.044). _Annals of Emergency Medicine_. **69** (3): 353â€“361.e3. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.annemergmed.2016.06.044](https://doi.org/10.1016%2Fj.annemergmed.2016.06.044). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27616037](https://pubmed.ncbi.nlm.nih.gov/27616037).\",\"description\":\"10. **^** Wang RC, Smith-Bindman R, Whitaker E, et al. (March 2017). [\\\"Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis\\\"](https://doi.org/10.1016%2Fj.annemergmed.2016.06.044). _Annals of Emergency Medicine_. **69** (3): 353â€“361.e3. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.annemergmed.2016.06.044](https://doi.org/10.1016%2Fj.annemergmed.2016.06.044). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27616037](https://pubmed.ncbi.nlm.nih.gov/27616037).\",\"url\":\"https://doi.org/10.1016%2Fj.annemergmed.2016.06.044\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"_**a**_ _**b**_ Abufaraj M, Xu T, Cao C, et al. (November 2021). [\\\"Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data\\\"](https://doi.org/10.1016%2Fj.euf.2020.08.011). _European Urology Focus_. **7** (6): 1468â€“1475\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.euf.2020.08.011](https://doi.org/10.1016%2Fj.euf.2020.08.011). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32900675](https://pubmed.ncbi.nlm.nih.gov/32900675). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [221572651](https://api.semanticscholar.org/CorpusID:221572651).\",\"description\":\"11. ^ _**a**_ _**b**_ Abufaraj M, Xu T, Cao C, et al. (November 2021). [\\\"Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data\\\"](https://doi.org/10.1016%2Fj.euf.2020.08.011). _European Urology Focus_. **7** (6): 1468â€“1475\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.euf.2020.08.011](https://doi.org/10.1016%2Fj.euf.2020.08.011). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32900675](https://pubmed.ncbi.nlm.nih.gov/32900675). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [221572651](https://api.semanticscholar.org/CorpusID:221572651).\",\"url\":\"https://doi.org/10.1016%2Fj.euf.2020.08.011\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** Stamatelou KK, Francis ME, Jones CA, et al. (May 2003). [\\\"Time trends in reported prevalence of kidney stones in the United States: 1976â€“199411.See Editorial by Goldfarb, p. 1951\\\"](https://doi.org/10.1046%2Fj.1523-1755.2003.00917.x). _Kidney International_. **63** (5): 1817â€“1823\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2003.00917.x](https://doi.org/10.1046%2Fj.1523-1755.2003.00917.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12675858](https://pubmed.ncbi.nlm.nih.gov/12675858).\",\"description\":\"12. **^** Stamatelou KK, Francis ME, Jones CA, et al. (May 2003). [\\\"Time trends in reported prevalence of kidney stones in the United States: 1976â€“199411.See Editorial by Goldfarb, p. 1951\\\"](https://doi.org/10.1046%2Fj.1523-1755.2003.00917.x). _Kidney International_. **63** (5): 1817â€“1823\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2003.00917.x](https://doi.org/10.1046%2Fj.1523-1755.2003.00917.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12675858](https://pubmed.ncbi.nlm.nih.gov/12675858).\",\"url\":\"https://doi.org/10.1046%2Fj.1523-1755.2003.00917.x\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** Stamatelou K, Goldfarb DS (January 2023). [\\\"Epidemiology of Kidney Stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914194). _Healthcare_. **11** (3): 424. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/healthcare11030424](https://doi.org/10.3390%2Fhealthcare11030424). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2227-9032](https://search.worldcat.org/issn/2227-9032). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9914194](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914194). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [36766999](https://pubmed.ncbi.nlm.nih.gov/36766999)._[![](./_assets_/Creative_Commons_by_small.svg.png)](https://creativecommons.org/licenses/by/4.0/ \\\"creativecommons:by/4.0/\\\")  This article incorporates text from this source, which is available under the [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/ \\\"creativecommons:by/4.0/\\\") license._\",\"description\":\"13. **^** Stamatelou K, Goldfarb DS (January 2023). [\\\"Epidemiology of Kidney Stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914194). _Healthcare_. **11** (3): 424. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/healthcare11030424](https://doi.org/10.3390%2Fhealthcare11030424). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2227-9032](https://search.worldcat.org/issn/2227-9032). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9914194](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914194). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [36766999](https://pubmed.ncbi.nlm.nih.gov/36766999)._[![](./_assets_/Creative_Commons_by_small.svg.png)](https://creativecommons.org/licenses/by/4.0/ \\\"creativecommons:by/4.0/\\\")  This article incorporates text from this source, which is available under the [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/ \\\"creativecommons:by/4.0/\\\") license._\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914194\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ Preminger GM (2007). [\\\"Chapter 148: Stones in the Urinary Tract\\\"](http://www.merckmanuals.com/home/sec12/ch148/ch148a.html). In Cutler RE (ed.). [_The Merck Manual of Medical Information Home Edition_](Merck_Manual_of_Diagnosis_and_Therapy \\\"Merck Manual of Diagnosis and Therapy\\\") (3rd ed.). Whitehouse Station, New Jersey: [Merck Sharp and Dohme Corporation](Merck_%26_Co. \\\"Merck \u0026 Co.\\\"). [Archived](https://web.archive.org/web/20141208070004/http://www.merckmanuals.com/home/sec12/ch148/ch148a.html) from the original on 8 December 2014. Retrieved 7 August 2011.\",\"description\":\"14. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ Preminger GM (2007). [\\\"Chapter 148: Stones in the Urinary Tract\\\"](http://www.merckmanuals.com/home/sec12/ch148/ch148a.html). In Cutler RE (ed.). [_The Merck Manual of Medical Information Home Edition_](Merck_Manual_of_Diagnosis_and_Therapy \\\"Merck Manual of Diagnosis and Therapy\\\") (3rd ed.). Whitehouse Station, New Jersey: [Merck Sharp and Dohme Corporation](Merck_%26_Co. \\\"Merck \u0026 Co.\\\"). [Archived](https://web.archive.org/web/20141208070004/http://www.merckmanuals.com/home/sec12/ch148/ch148a.html) from the original on 8 December 2014. Retrieved 7 August 2011.\",\"url\":\"http://www.merckmanuals.com/home/sec12/ch148/ch148a.html\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** _[Nephrolithiasis~Overview](https://emedicine.medscape.com/article/437096-Overview)_ at [eMedicine](EMedicine \\\"EMedicine\\\") Â§ Background.\",\"description\":\"15. **^** _[Nephrolithiasis~Overview](https://emedicine.medscape.com/article/437096-Overview)_ at [eMedicine](EMedicine \\\"EMedicine\\\") Â§ Background.\",\"url\":\"https://emedicine.medscape.com/article/437096-Overview\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"$1f\",\"description\":\"$20\",\"url\":\"http://kidney.niddk.nih.gov/statistics/uda/Urologic_Diseases_in_America.pdf\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"_**a**_ _**b**_ Cavendish M (2008). [\\\"Kidney disorders\\\"](https://books.google.com/books?id=L5fGm_7ThKEC\u0026q=0761477721\u0026pg=PA507). _Diseases and Disorders_. Vol. 2 (1st ed.). Tarrytown, New York: Marshall Cavendish Corporation. pp. 490â€“3\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7614-7772-3. [Archived](https://web.archive.org/web/20210414055706/https://books.google.com/books?id=L5fGm_7ThKEC\u0026q=0761477721\u0026pg=PA507) from the original on 14 April 2021. Retrieved 6 November 2020.\",\"description\":\"17. ^ _**a**_ _**b**_ Cavendish M (2008). [\\\"Kidney disorders\\\"](https://books.google.com/books?id=L5fGm_7ThKEC\u0026q=0761477721\u0026pg=PA507). _Diseases and Disorders_. Vol. 2 (1st ed.). Tarrytown, New York: Marshall Cavendish Corporation. pp. 490â€“3\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7614-7772-3. [Archived](https://web.archive.org/web/20210414055706/https://books.google.com/books?id=L5fGm_7ThKEC\u0026q=0761477721\u0026pg=PA507) from the original on 14 April 2021. Retrieved 6 November 2020.\",\"url\":\"https://books.google.com/books?id=L5fGm_7ThKEC\u0026q=0761477721\u0026pg=PA507\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"_**a**_ _**b**_ Curhan GC, Willett WC, Rimm EB, et al. (February 1996). [\\\"Prospective study of beverage use and the risk of kidney stones\\\"](https://doi.org/10.1093%2Foxfordjournals.aje.a008734). _American Journal of Epidemiology_. **143** (3): 240â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/oxfordjournals.aje.a008734](https://doi.org/10.1093%2Foxfordjournals.aje.a008734). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8561157](https://pubmed.ncbi.nlm.nih.gov/8561157).\",\"description\":\"18. ^ _**a**_ _**b**_ Curhan GC, Willett WC, Rimm EB, et al. (February 1996). [\\\"Prospective study of beverage use and the risk of kidney stones\\\"](https://doi.org/10.1093%2Foxfordjournals.aje.a008734). _American Journal of Epidemiology_. **143** (3): 240â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/oxfordjournals.aje.a008734](https://doi.org/10.1093%2Foxfordjournals.aje.a008734). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8561157](https://pubmed.ncbi.nlm.nih.gov/8561157).\",\"url\":\"https://doi.org/10.1093%2Foxfordjournals.aje.a008734\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Lewis SM (2017). _Medical-surgical nursing  : assessment and management of clinical problems_. Elsevier. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-323-32852-4. [OCLC](OCLC_\\\\(identifier\\\\) \\\"OCLC \\\\(identifier\\\\)\\\") [944472408](https://search.worldcat.org/oclc/944472408).\",\"description\":\"19. ^ _**a**_ _**b**_ _**c**_ _**d**_ Lewis SM (2017). _Medical-surgical nursing  : assessment and management of clinical problems_. Elsevier. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-323-32852-4. [OCLC](OCLC_\\\\(identifier\\\\) \\\"OCLC \\\\(identifier\\\\)\\\") [944472408](https://search.worldcat.org/oclc/944472408).\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** Knight J, Assimos DG, Easter L, et al. (November 2010). [\\\"Metabolism of fructose to oxalate and glycolate\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139422). _Hormone and Metabolic Research_. **42** (12): 868â€“73\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1055/s-0030-1265145](https://doi.org/10.1055%2Fs-0030-1265145). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3139422](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139422). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20842614](https://pubmed.ncbi.nlm.nih.gov/20842614).\",\"description\":\"20. **^** Knight J, Assimos DG, Easter L, et al. (November 2010). [\\\"Metabolism of fructose to oxalate and glycolate\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139422). _Hormone and Metabolic Research_. **42** (12): 868â€“73\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1055/s-0030-1265145](https://doi.org/10.1055%2Fs-0030-1265145). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3139422](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139422). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20842614](https://pubmed.ncbi.nlm.nih.gov/20842614).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139422\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Moe OW (January 2006). [\\\"Kidney stones: pathophysiology and medical management\\\"](http://emed.chris-barton.com/PDF/kidney%20stones%20pathophys%20and%20rx.pdf) (PDF). _Lancet_. **367** (9507): 333â€“44\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(06)68071-9](https://doi.org/10.1016%2FS0140-6736%2806%2968071-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16443041](https://pubmed.ncbi.nlm.nih.gov/16443041). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26581831](https://api.semanticscholar.org/CorpusID:26581831). [Archived](https://web.archive.org/web/20110815154001/http://emed.chris-barton.com/PDF/kidney%20stones%20pathophys%20and%20rx.pdf) (PDF) from the original on 15 August 2011.\",\"description\":\"21. ^ _**a**_ _**b**_ _**c**_ _**d**_ Moe OW (January 2006). [\\\"Kidney stones: pathophysiology and medical management\\\"](http://emed.chris-barton.com/PDF/kidney%20stones%20pathophys%20and%20rx.pdf) (PDF). _Lancet_. **367** (9507): 333â€“44\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(06)68071-9](https://doi.org/10.1016%2FS0140-6736%2806%2968071-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16443041](https://pubmed.ncbi.nlm.nih.gov/16443041). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [26581831](https://api.semanticscholar.org/CorpusID:26581831). [Archived](https://web.archive.org/web/20110815154001/http://emed.chris-barton.com/PDF/kidney%20stones%20pathophys%20and%20rx.pdf) (PDF) from the original on 15 August 2011.\",\"url\":\"http://emed.chris-barton.com/PDF/kidney%20stones%20pathophys%20and%20rx.pdf\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** Thakker RV (March 2000). [\\\"Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis\\\"](http://www.nature.com/ki/journal/v57/n3/pdf/4491399a.pdf) (PDF). _Kidney International_. **57** (3): 787â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2000.00916.x](https://doi.org/10.1046%2Fj.1523-1755.2000.00916.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10720930](https://pubmed.ncbi.nlm.nih.gov/10720930). [Archived](https://web.archive.org/web/20121105121823/http://www.nature.com/ki/journal/v57/n3/pdf/4491399a.pdf) (PDF) from the original on 5 November 2012.\",\"description\":\"22. **^** Thakker RV (March 2000). [\\\"Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis\\\"](http://www.nature.com/ki/journal/v57/n3/pdf/4491399a.pdf) (PDF). _Kidney International_. **57** (3): 787â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1523-1755.2000.00916.x](https://doi.org/10.1046%2Fj.1523-1755.2000.00916.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10720930](https://pubmed.ncbi.nlm.nih.gov/10720930). [Archived](https://web.archive.org/web/20121105121823/http://www.nature.com/ki/journal/v57/n3/pdf/4491399a.pdf) (PDF) from the original on 5 November 2012.\",\"url\":\"http://www.nature.com/ki/journal/v57/n3/pdf/4491399a.pdf\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"_**a**_ _**b**_ [National Endocrine and Metabolic Diseases Information Service](Endocrine_and_Metabolic_Diseases_Information_Service \\\"Endocrine and Metabolic Diseases Information Service\\\") (2006). [\\\"Hyperparathyroidism (NIH Publication No. 6â€“3425)\\\"](https://web.archive.org/web/20110524101254/http://www.endocrine.niddk.nih.gov/pubs/hyper/hyper.htm). _Information about Endocrine and Metabolic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://www.endocrine.niddk.nih.gov/pubs/hyper/hyper.htm) on 24 May 2011. Retrieved 27 July 2011.\",\"description\":\"23. ^ _**a**_ _**b**_ [National Endocrine and Metabolic Diseases Information Service](Endocrine_and_Metabolic_Diseases_Information_Service \\\"Endocrine and Metabolic Diseases Information Service\\\") (2006). [\\\"Hyperparathyroidism (NIH Publication No. 6â€“3425)\\\"](https://web.archive.org/web/20110524101254/http://www.endocrine.niddk.nih.gov/pubs/hyper/hyper.htm). _Information about Endocrine and Metabolic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://www.endocrine.niddk.nih.gov/pubs/hyper/hyper.htm) on 24 May 2011. Retrieved 27 July 2011.\",\"url\":\"Endocrine_and_Metabolic_Diseases_Information_Service \\\"Endocrine and Metabolic Diseases Information Service\\\"\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"_**a**_ _**b**_ Hoppe B, Langman CB (October 2003). \\\"A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria\\\". _Pediatric Nephrology_. **18** (10): 986â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00467-003-1234-x](https://doi.org/10.1007%2Fs00467-003-1234-x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12920626](https://pubmed.ncbi.nlm.nih.gov/12920626). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [23503869](https://api.semanticscholar.org/CorpusID:23503869).\",\"description\":\"24. ^ _**a**_ _**b**_ Hoppe B, Langman CB (October 2003). \\\"A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria\\\". _Pediatric Nephrology_. **18** (10): 986â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00467-003-1234-x](https://doi.org/10.1007%2Fs00467-003-1234-x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12920626](https://pubmed.ncbi.nlm.nih.gov/12920626). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [23503869](https://api.semanticscholar.org/CorpusID:23503869).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Reilly RF, __Ch. 13: \\\"Nephrolithiasis\\\"__. In Reilly \u0026 Perazella 2005, pp. 192â€“207.\",\"description\":\"25. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Reilly RF, __Ch. 13: \\\"Nephrolithiasis\\\"__. In Reilly \u0026 Perazella 2005, pp. 192â€“207.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** National Kidney and Urologic Diseases Information Clearinghouse (2008). [\\\"Medullary Sponge Kidney (NIH Publication No. 08â€“6235)\\\"](https://web.archive.org/web/20110807163748/http://kidney.niddk.nih.gov/kudiseases/pubs/medullaryspongekidney/). _Kidney \u0026 Urologic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/medullaryspongekidney/) on 7 August 2011. Retrieved 27 July 2011.\",\"description\":\"26. **^** National Kidney and Urologic Diseases Information Clearinghouse (2008). [\\\"Medullary Sponge Kidney (NIH Publication No. 08â€“6235)\\\"](https://web.archive.org/web/20110807163748/http://kidney.niddk.nih.gov/kudiseases/pubs/medullaryspongekidney/). _Kidney \u0026 Urologic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/medullaryspongekidney/) on 7 August 2011. Retrieved 27 July 2011.\",\"url\":\"https://web.archive.org/web/20110807163748/http://kidney.niddk.nih.gov/kudiseases/pubs/medullaryspongekidney/\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** [National Digestive Diseases Information Clearinghouse](National_Digestive_Diseases_Information_Clearinghouse \\\"National Digestive Diseases Information Clearinghouse\\\") (2006). [\\\"Crohn's Disease (NIH Publication No. 06â€“3410)\\\"](https://web.archive.org/web/20140609002323/http://digestive.niddk.nih.gov/ddISeases/pubs/crohns/). _Digestive Diseases: A-Z List of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States Public Health Service, United States Department of Health and Human Services. Archived from [the original](http://digestive.niddk.nih.gov/ddiseases/pubs/crohns/) on 9 June 2014. Retrieved 27 July 2011.\",\"description\":\"27. **^** [National Digestive Diseases Information Clearinghouse](National_Digestive_Diseases_Information_Clearinghouse \\\"National Digestive Diseases Information Clearinghouse\\\") (2006). [\\\"Crohn's Disease (NIH Publication No. 06â€“3410)\\\"](https://web.archive.org/web/20140609002323/http://digestive.niddk.nih.gov/ddISeases/pubs/crohns/). _Digestive Diseases: A-Z List of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States Public Health Service, United States Department of Health and Human Services. Archived from [the original](http://digestive.niddk.nih.gov/ddiseases/pubs/crohns/) on 9 June 2014. Retrieved 27 July 2011.\",\"url\":\"National_Digestive_Diseases_Information_Clearinghouse \\\"National Digestive Diseases Information Clearinghouse\\\"\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"** Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). [\\\"Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease\\\"](http://www.ccjm.org/content/41/3/109.short). _Cleveland Clinic Quarterly_. **41** (3): 109â€“17\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3949/ccjm.41.3.109](https://doi.org/10.3949%2Fccjm.41.3.109) (inactive 12 July 2025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [4416806](https://pubmed.ncbi.nlm.nih.gov/4416806). [Archived](https://web.archive.org/web/20200320210418/https://www.ccjm.org/content/41/3/109.short) from the original on 20 March 2020. Retrieved 1 November 2013.`{{cite journal}}`: CS1 maint: DOI inactive as of July 2025 (link)\",\"description\":\"28. **^** Farmer RG, Mir-Madjlessi SH, Kiser WS (1974). [\\\"Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease\\\"](http://www.ccjm.org/content/41/3/109.short). _Cleveland Clinic Quarterly_. **41** (3): 109â€“17\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3949/ccjm.41.3.109](https://doi.org/10.3949%2Fccjm.41.3.109) (inactive 12 July 2025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [4416806](https://pubmed.ncbi.nlm.nih.gov/4416806). [Archived](https://web.archive.org/web/20200320210418/https://www.ccjm.org/content/41/3/109.short) from the original on 20 March 2020. Retrieved 1 November 2013.`{{cite journal}}`: CS1 maint: DOI inactive as of July 2025 (link)\",\"url\":\"http://www.ccjm.org/content/41/3/109.short\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"_**a**_ _**b**_ _**c**_ \\\"Tolerable upper intake levels: Calcium and vitamin D\\\". In Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2011, pp. 403â€“56.\",\"description\":\"29. ^ _**a**_ _**b**_ _**c**_ \\\"Tolerable upper intake levels: Calcium and vitamin D\\\". In Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2011, pp. 403â€“56.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ Johri N, Cooper B, Robertson W, et al. (2010). [\\\"An update and practical guide to renal stone management\\\"](https://www.karger.com/Article/PDF/000317196). _Nephron Clinical Practice_. **116** (3): c159-71. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000317196](https://doi.org/10.1159%2F000317196). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20606476](https://pubmed.ncbi.nlm.nih.gov/20606476). [Archived](https://web.archive.org/web/20210131093917/https://www.karger.com/Article/PDF/000317196) from the original on 31 January 2021. Retrieved 18 May 2019.\",\"description\":\"30. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ Johri N, Cooper B, Robertson W, et al. (2010). [\\\"An update and practical guide to renal stone management\\\"](https://www.karger.com/Article/PDF/000317196). _Nephron Clinical Practice_. **116** (3): c159-71. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000317196](https://doi.org/10.1159%2F000317196). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20606476](https://pubmed.ncbi.nlm.nih.gov/20606476). [Archived](https://web.archive.org/web/20210131093917/https://www.karger.com/Article/PDF/000317196) from the original on 31 January 2021. Retrieved 18 May 2019.\",\"url\":\"https://www.karger.com/Article/PDF/000317196\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** \\\"Summary\\\". In Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2011, pp. 1â€“14.\",\"description\":\"31. **^** \\\"Summary\\\". In Committee to Review Dietary Reference Intakes for Vitamin D and Calcium 2011, pp. 1â€“14.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"_**a**_ _**b**_ _**c**_ Parmar MS (June 2004). [\\\"Kidney stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421787). _BMJ_. **328** (7453): 1420â€“4\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.328.7453.1420](https://doi.org/10.1136%2Fbmj.328.7453.1420). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [421787](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421787). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15191979](https://pubmed.ncbi.nlm.nih.gov/15191979).\",\"description\":\"32. ^ _**a**_ _**b**_ _**c**_ Parmar MS (June 2004). [\\\"Kidney stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421787). _BMJ_. **328** (7453): 1420â€“4\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.328.7453.1420](https://doi.org/10.1136%2Fbmj.328.7453.1420). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [421787](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421787). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15191979](https://pubmed.ncbi.nlm.nih.gov/15191979).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC421787\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"** Liebman M, Al-Wahsh IA (May 2011). [\\\"Probiotics and other key determinants of dietary oxalate absorption\\\"](http://advances.nutrition.org/content/2/3/254.full.pdf) (PDF). _Advances in Nutrition_. **2** (3): 254â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3945/an.111.000414](https://doi.org/10.3945%2Fan.111.000414). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3090165](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090165). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22332057](https://pubmed.ncbi.nlm.nih.gov/22332057). [Archived](https://web.archive.org/web/20160116135506/http://advances.nutrition.org/content/2/3/254.full.pdf) (PDF) from the original on 16 January 2016.\",\"description\":\"33. **^** Liebman M, Al-Wahsh IA (May 2011). [\\\"Probiotics and other key determinants of dietary oxalate absorption\\\"](http://advances.nutrition.org/content/2/3/254.full.pdf) (PDF). _Advances in Nutrition_. **2** (3): 254â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3945/an.111.000414](https://doi.org/10.3945%2Fan.111.000414). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3090165](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090165). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22332057](https://pubmed.ncbi.nlm.nih.gov/22332057). [Archived](https://web.archive.org/web/20160116135506/http://advances.nutrition.org/content/2/3/254.full.pdf) (PDF) from the original on 16 January 2016.\",\"url\":\"http://advances.nutrition.org/content/2/3/254.full.pdf\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"** Committee on Fluoride in Drinking Water of the National Academy of Sciences (2006). [\\\"Chapter 9: Effects on the Renal System\\\"](http://www.nap.edu/openbook.php?record_id=11571\u0026page=268). _Fluoride in Drinking Water: A Scientific Review of EPA's Standards_. Washington, DC: The National Academies Press. pp. 236â€“48\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-309-65799-0. [Archived](https://web.archive.org/web/20110730220401/http://www.nap.edu/openbook.php?record_id=11571\u0026page=268) from the original on 30 July 2011.\",\"description\":\"34. **^** Committee on Fluoride in Drinking Water of the National Academy of Sciences (2006). [\\\"Chapter 9: Effects on the Renal System\\\"](http://www.nap.edu/openbook.php?record_id=11571\u0026page=268). _Fluoride in Drinking Water: A Scientific Review of EPA's Standards_. Washington, DC: The National Academies Press. pp. 236â€“48\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-309-65799-0. [Archived](https://web.archive.org/web/20110730220401/http://www.nap.edu/openbook.php?record_id=11571\u0026page=268) from the original on 30 July 2011.\",\"url\":\"http://www.nap.edu/openbook.php?record_id=11571\u0026page=268\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"** Ferraro PM, Mandel EI, Curhan GC, et al. (October 2016). [\\\"Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053786). _Clinical Journal of the American Society of Nephrology_. **11** (10): 1834â€“1844\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/CJN.01520216](https://doi.org/10.2215%2FCJN.01520216). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5053786](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053786). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27445166](https://pubmed.ncbi.nlm.nih.gov/27445166).\",\"description\":\"35. **^** Ferraro PM, Mandel EI, Curhan GC, et al. (October 2016). [\\\"Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053786). _Clinical Journal of the American Society of Nephrology_. **11** (10): 1834â€“1844\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/CJN.01520216](https://doi.org/10.2215%2FCJN.01520216). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5053786](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053786). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27445166](https://pubmed.ncbi.nlm.nih.gov/27445166).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053786\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"_**a**_ _**b**_ Riley JM, Kim H, Averch TD, et al. (December 2013). [\\\"Effect of magnesium on calcium and oxalate ion binding\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883082). _Journal of Endourology_. **27** (12): 1487â€“92\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1089/end.2013.0173](https://doi.org/10.1089%2Fend.2013.0173). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3883082](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883082). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24127630](https://pubmed.ncbi.nlm.nih.gov/24127630).\",\"description\":\"36. ^ _**a**_ _**b**_ Riley JM, Kim H, Averch TD, et al. (December 2013). [\\\"Effect of magnesium on calcium and oxalate ion binding\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883082). _Journal of Endourology_. **27** (12): 1487â€“92\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1089/end.2013.0173](https://doi.org/10.1089%2Fend.2013.0173). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3883082](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883082). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24127630](https://pubmed.ncbi.nlm.nih.gov/24127630).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883082\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"_**a**_ _**b**_ Negri AL, Spivacow FR, Del Valle EE (2013). \\\"[Diet in the treatment of renal lithiasis. Pathophysiological basis]\\\". _Medicina_. **73** (3): 267â€“71\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23732207](https://pubmed.ncbi.nlm.nih.gov/23732207).\",\"description\":\"37. ^ _**a**_ _**b**_ Negri AL, Spivacow FR, Del Valle EE (2013). \\\"[Diet in the treatment of renal lithiasis. Pathophysiological basis]\\\". _Medicina_. **73** (3): 267â€“71\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23732207](https://pubmed.ncbi.nlm.nih.gov/23732207).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"** Goodwin JS, Tangum MR (November 1998). \\\"Battling quackery: attitudes about micronutrient supplements in American academic medicine\\\". _Archives of Internal Medicine_. **158** (20): 2187â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinte.158.20.2187](https://doi.org/10.1001%2Farchinte.158.20.2187). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9818798](https://pubmed.ncbi.nlm.nih.gov/9818798).\",\"description\":\"38. **^** Goodwin JS, Tangum MR (November 1998). \\\"Battling quackery: attitudes about micronutrient supplements in American academic medicine\\\". _Archives of Internal Medicine_. **158** (20): 2187â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archinte.158.20.2187](https://doi.org/10.1001%2Farchinte.158.20.2187). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9818798](https://pubmed.ncbi.nlm.nih.gov/9818798).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"** Traxer O, Pearle MS, Gattegno B, et al. (December 2003). \\\"[Vitamin C and stone risk. Review of the literature]\\\". _Progres en Urologie_. **13** (6): 1290â€“4\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15000301](https://pubmed.ncbi.nlm.nih.gov/15000301).\",\"description\":\"39. **^** Traxer O, Pearle MS, Gattegno B, et al. (December 2003). \\\"[Vitamin C and stone risk. Review of the literature]\\\". _Progres en Urologie_. **13** (6): 1290â€“4\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15000301](https://pubmed.ncbi.nlm.nih.gov/15000301).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"** Ferraro PM, Curhan GC, Gambaro G, et al. (March 2016). [\\\"Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769668). _American Journal of Kidney Diseases_. **67** (3): 400â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2015.09.005](https://doi.org/10.1053%2Fj.ajkd.2015.09.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4769668](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769668). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26463139](https://pubmed.ncbi.nlm.nih.gov/26463139).\",\"description\":\"40. **^** Ferraro PM, Curhan GC, Gambaro G, et al. (March 2016). [\\\"Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769668). _American Journal of Kidney Diseases_. **67** (3): 400â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1053/j.ajkd.2015.09.005](https://doi.org/10.1053%2Fj.ajkd.2015.09.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4769668](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769668). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26463139](https://pubmed.ncbi.nlm.nih.gov/26463139).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769668\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Phillips R, Hanchanale VS, Myatt A, et al. (October 2015). [\\\"Citrate salts for preventing and treating calcium containing kidney stones in adults\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669). _Cochrane Database Syst Rev_. **2015** (10): CD010057. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD010057.pub2](https://doi.org/10.1002%2F14651858.CD010057.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9578669](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26439475](https://pubmed.ncbi.nlm.nih.gov/26439475).\",\"description\":\"41. ^ _**a**_ _**b**_ _**c**_ _**d**_ Phillips R, Hanchanale VS, Myatt A, et al. (October 2015). [\\\"Citrate salts for preventing and treating calcium containing kidney stones in adults\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669). _Cochrane Database Syst Rev_. **2015** (10): CD010057. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD010057.pub2](https://doi.org/10.1002%2F14651858.CD010057.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [9578669](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26439475](https://pubmed.ncbi.nlm.nih.gov/26439475).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"** Perazella MA, __Ch. 14: \\\"Urinalysis\\\"__. In Reilly \u0026 Perazella 2005, pp. 209â€“26.\",\"description\":\"42. **^** Perazella MA, __Ch. 14: \\\"Urinalysis\\\"__. In Reilly \u0026 Perazella 2005, pp. 209â€“26.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ Knudsen BE, Beiko DT, Denstedt JD, __Ch. 16: \\\"Uric Acid Urolithiasis\\\"__. In Stoller \u0026 Meng 2007, pp. 299â€“308.\",\"description\":\"43. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ Knudsen BE, Beiko DT, Denstedt JD, __Ch. 16: \\\"Uric Acid Urolithiasis\\\"__. In Stoller \u0026 Meng 2007, pp. 299â€“308.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"** _[Nephrolithiasis~Overview](https://emedicine.medscape.com/article/437096-Overview)_ at [eMedicine](EMedicine \\\"EMedicine\\\") Â§ Pathophysiology.\",\"description\":\"44. **^** _[Nephrolithiasis~Overview](https://emedicine.medscape.com/article/437096-Overview)_ at [eMedicine](EMedicine \\\"EMedicine\\\") Â§ Pathophysiology.\",\"url\":\"https://emedicine.medscape.com/article/437096-Overview\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"** Robertson WG, Peacock M, Nordin BE (July 1969). \\\"Calcium crystalluria in recurrent renal-stone formers\\\". _Lancet_. **2** (7610): 21â€“24\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(69)92598-7](https://doi.org/10.1016%2FS0140-6736%2869%2992598-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [4182793](https://pubmed.ncbi.nlm.nih.gov/4182793).\",\"description\":\"45. **^** Robertson WG, Peacock M, Nordin BE (July 1969). \\\"Calcium crystalluria in recurrent renal-stone formers\\\". _Lancet_. **2** (7610): 21â€“24\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(69)92598-7](https://doi.org/10.1016%2FS0140-6736%2869%2992598-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [4182793](https://pubmed.ncbi.nlm.nih.gov/4182793).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"** Elliot JS, Rabinowitz IN (March 1980). \\\"Calcium oxalate crystalluria: crystal size in urine\\\". _The Journal of Urology_. **123** (3): 324â€“327\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(17)55918-2](https://doi.org/10.1016%2FS0022-5347%2817%2955918-2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7359628](https://pubmed.ncbi.nlm.nih.gov/7359628).\",\"description\":\"46. **^** Elliot JS, Rabinowitz IN (March 1980). \\\"Calcium oxalate crystalluria: crystal size in urine\\\". _The Journal of Urology_. **123** (3): 324â€“327\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(17)55918-2](https://doi.org/10.1016%2FS0022-5347%2817%2955918-2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7359628](https://pubmed.ncbi.nlm.nih.gov/7359628).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"** Randall A (June 1937). [\\\"The Origin and Growth of Renal Calculi\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1390483). _Annals of Surgery_. **105** (6): 1009â€“1027\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/00000658-193706000-00014](https://doi.org/10.1097%2F00000658-193706000-00014). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1390483](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1390483). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17856988](https://pubmed.ncbi.nlm.nih.gov/17856988).\",\"description\":\"47. **^** Randall A (June 1937). [\\\"The Origin and Growth of Renal Calculi\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1390483). _Annals of Surgery_. **105** (6): 1009â€“1027\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/00000658-193706000-00014](https://doi.org/10.1097%2F00000658-193706000-00014). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1390483](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1390483). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17856988](https://pubmed.ncbi.nlm.nih.gov/17856988).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1390483\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"** Ratkalkar VN, Kleinman JG (December 2011). [\\\"Mechanisms of Stone Formation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252394). _Clinical Reviews in Bone and Mineral Metabolism_. **9** (3â€“4): 187â€“197\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s12018-011-9104-8](https://doi.org/10.1007%2Fs12018-011-9104-8). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3252394](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252394). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22229020](https://pubmed.ncbi.nlm.nih.gov/22229020).\",\"description\":\"48. **^** Ratkalkar VN, Kleinman JG (December 2011). [\\\"Mechanisms of Stone Formation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252394). _Clinical Reviews in Bone and Mineral Metabolism_. **9** (3â€“4): 187â€“197\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s12018-011-9104-8](https://doi.org/10.1007%2Fs12018-011-9104-8). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3252394](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252394). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22229020](https://pubmed.ncbi.nlm.nih.gov/22229020).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252394\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"** Khan SR (September 2014). [\\\"Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220551). _Translational Andrology and Urology_. **3** (3): 256â€“276\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3978/j.issn.2223-4683.2014.06.04](https://doi.org/10.3978%2Fj.issn.2223-4683.2014.06.04). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4220551](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220551). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25383321](https://pubmed.ncbi.nlm.nih.gov/25383321).\",\"description\":\"49. **^** Khan SR (September 2014). [\\\"Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220551). _Translational Andrology and Urology_. **3** (3): 256â€“276\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3978/j.issn.2223-4683.2014.06.04](https://doi.org/10.3978%2Fj.issn.2223-4683.2014.06.04). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4220551](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220551). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25383321](https://pubmed.ncbi.nlm.nih.gov/25383321).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220551\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"** Jones BD, Mobley HL (August 1988). [\\\"Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC211300). _Journal of Bacteriology_. **170** (8): 3342â€“3349\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/jb.170.8.3342-3349.1988](https://doi.org/10.1128%2Fjb.170.8.3342-3349.1988). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [211300](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC211300). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2841283](https://pubmed.ncbi.nlm.nih.gov/2841283).\",\"description\":\"50. **^** Jones BD, Mobley HL (August 1988). [\\\"Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC211300). _Journal of Bacteriology_. **170** (8): 3342â€“3349\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/jb.170.8.3342-3349.1988](https://doi.org/10.1128%2Fjb.170.8.3342-3349.1988). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [211300](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC211300). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2841283](https://pubmed.ncbi.nlm.nih.gov/2841283).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC211300\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"** Chmiel JA, Stuivenberg GA, Alathel A, et al. (December 2021). \\\"High-Throughput in vitro Gel-Based Plate Assay to Screen for Calcium Oxalate Stone Inhibitors\\\". _Urologia Internationalis_. **106** (6): 616â€“622\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000519842](https://doi.org/10.1159%2F000519842). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [34883484](https://pubmed.ncbi.nlm.nih.gov/34883484). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [245012979](https://api.semanticscholar.org/CorpusID:245012979).\",\"description\":\"51. **^** Chmiel JA, Stuivenberg GA, Alathel A, et al. (December 2021). \\\"High-Throughput in vitro Gel-Based Plate Assay to Screen for Calcium Oxalate Stone Inhibitors\\\". _Urologia Internationalis_. **106** (6): 616â€“622\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1159/000519842](https://doi.org/10.1159%2F000519842). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [34883484](https://pubmed.ncbi.nlm.nih.gov/34883484). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [245012979](https://api.semanticscholar.org/CorpusID:245012979).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"** Kanlaya R, Naruepantawart O, Thongboonkerd V (5 November 2019). [\\\"Flagellum Is Responsible for Promoting Effects of Viable _Escherichia coli_ on Calcium Oxalate Crystallization, Crystal Growth, and Crystal Aggregation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848068). _Frontiers in Microbiology_. **10** : 2507. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3389/fmicb.2019.02507](https://doi.org/10.3389%2Ffmicb.2019.02507). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6848068](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848068). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31749785](https://pubmed.ncbi.nlm.nih.gov/31749785).\",\"description\":\"52. **^** Kanlaya R, Naruepantawart O, Thongboonkerd V (5 November 2019). [\\\"Flagellum Is Responsible for Promoting Effects of Viable _Escherichia coli_ on Calcium Oxalate Crystallization, Crystal Growth, and Crystal Aggregation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848068). _Frontiers in Microbiology_. **10** : 2507. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3389/fmicb.2019.02507](https://doi.org/10.3389%2Ffmicb.2019.02507). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6848068](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848068). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31749785](https://pubmed.ncbi.nlm.nih.gov/31749785).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848068\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"_**a**_ _**b**_ _**c**_ Coe FL, Evan A, Worcester E (October 2005). [\\\"Kidney stone disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236703). _The Journal of Clinical Investigation_. **115** (10): 2598â€“608\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1172/JCI26662](https://doi.org/10.1172%2FJCI26662). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1236703](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236703). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16200192](https://pubmed.ncbi.nlm.nih.gov/16200192).\",\"description\":\"53. ^ _**a**_ _**b**_ _**c**_ Coe FL, Evan A, Worcester E (October 2005). [\\\"Kidney stone disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236703). _The Journal of Clinical Investigation_. **115** (10): 2598â€“608\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1172/JCI26662](https://doi.org/10.1172%2FJCI26662). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1236703](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236703). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16200192](https://pubmed.ncbi.nlm.nih.gov/16200192).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236703\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"** del Valle EE, Spivacow FR, Negri AL (2013). \\\"[Citrate and renal stones]\\\". _Medicina_. **73** (4): 363â€“8\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23924538](https://pubmed.ncbi.nlm.nih.gov/23924538).\",\"description\":\"54. **^** del Valle EE, Spivacow FR, Negri AL (2013). \\\"[Citrate and renal stones]\\\". _Medicina_. **73** (4): 363â€“8\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23924538](https://pubmed.ncbi.nlm.nih.gov/23924538).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"** [\\\"Educate Your Patients about Kidney Stones\\\"](https://www.kidney.org/sites/default/files/moonstone-professional-education-teaching-card-final.pdf) (PDF). _kidney.org_. [Archived](https://web.archive.org/web/20201026133550/https://www.kidney.org/sites/default/files/moonstone-professional-education-teaching-card-final.pdf) (PDF) from the original on 26 October 2020.\",\"description\":\"55. **^** [\\\"Educate Your Patients about Kidney Stones\\\"](https://www.kidney.org/sites/default/files/moonstone-professional-education-teaching-card-final.pdf) (PDF). _kidney.org_. [Archived](https://web.archive.org/web/20201026133550/https://www.kidney.org/sites/default/files/moonstone-professional-education-teaching-card-final.pdf) (PDF) from the original on 26 October 2020.\",\"url\":\"https://www.kidney.org/sites/default/files/moonstone-professional-education-teaching-card-final.pdf\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"** Caudarella R, Vescini F (September 2009). [\\\"Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment\\\"](https://www.researchgate.net/publication/38087757). _Archivio Italiano di Urologia, Andrologia_. **81** (3): 182â€“7\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19911682](https://pubmed.ncbi.nlm.nih.gov/19911682).\",\"description\":\"56. **^** Caudarella R, Vescini F (September 2009). [\\\"Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment\\\"](https://www.researchgate.net/publication/38087757). _Archivio Italiano di Urologia, Andrologia_. **81** (3): 182â€“7\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19911682](https://pubmed.ncbi.nlm.nih.gov/19911682).\",\"url\":\"https://www.researchgate.net/publication/38087757\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Anoia EJ, Paik ML, Resnick MI (2009). [\\\"Ch. 7: Anatrophic Nephrolithomy\\\"](https://books.google.com/books?id=GahMzaKgMKAC\u0026q=nephrolithiasis+diagnosis+radiographic\u0026pg=PA45). In Graham SD, Keane TE (eds.). _Glenn's Urologic Surgery_ (7th ed.). Philadelphia: Lippincott Williams \u0026 Wilkins. pp. 45â€“50\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-9141-0. [Archived](https://web.archive.org/web/20210414030139/https://books.google.com/books?id=GahMzaKgMKAC\u0026q=nephrolithiasis+diagnosis+radiographic\u0026pg=PA45) from the original on 14 April 2021. Retrieved 6 November 2020.\",\"description\":\"57. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Anoia EJ, Paik ML, Resnick MI (2009). [\\\"Ch. 7: Anatrophic Nephrolithomy\\\"](https://books.google.com/books?id=GahMzaKgMKAC\u0026q=nephrolithiasis+diagnosis+radiographic\u0026pg=PA45). In Graham SD, Keane TE (eds.). _Glenn's Urologic Surgery_ (7th ed.). Philadelphia: Lippincott Williams \u0026 Wilkins. pp. 45â€“50\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-9141-0. [Archived](https://web.archive.org/web/20210414030139/https://books.google.com/books?id=GahMzaKgMKAC\u0026q=nephrolithiasis+diagnosis+radiographic\u0026pg=PA45) from the original on 14 April 2021. Retrieved 6 November 2020.\",\"url\":\"https://books.google.com/books?id=GahMzaKgMKAC\u0026q=nephrolithiasis+diagnosis+radiographic\u0026pg=PA45\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"** Weaver SH, Jenkins P (2002). [\\\"Ch. 14: Renal and Urological Care\\\"](https://archive.org/details/illustratedmanua0000unse). _Illustrated Manual of Nursing Practice_ (3rd ed.). Lippincott Williams \u0026 Wilkins. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-58255-082-4.\",\"description\":\"58. **^** Weaver SH, Jenkins P (2002). [\\\"Ch. 14: Renal and Urological Care\\\"](https://archive.org/details/illustratedmanua0000unse). _Illustrated Manual of Nursing Practice_ (3rd ed.). Lippincott Williams \u0026 Wilkins. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-58255-082-4.\",\"url\":\"https://archive.org/details/illustratedmanua0000unse\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ Pietrow PK, Karellas ME (July 2006). [\\\"Medical management of common urinary calculi\\\"](http://www.aafp.org/afp/2006/0701/p86.pdf) (PDF). _American Family Physician_. **74** (1): 86â€“94\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16848382](https://pubmed.ncbi.nlm.nih.gov/16848382). [Archived](https://web.archive.org/web/20111123060406/http://www.aafp.org/afp/2006/0701/p86.pdf) (PDF) from the original on 23 November 2011.\",\"description\":\"59. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ Pietrow PK, Karellas ME (July 2006). [\\\"Medical management of common urinary calculi\\\"](http://www.aafp.org/afp/2006/0701/p86.pdf) (PDF). _American Family Physician_. **74** (1): 86â€“94\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16848382](https://pubmed.ncbi.nlm.nih.gov/16848382). [Archived](https://web.archive.org/web/20111123060406/http://www.aafp.org/afp/2006/0701/p86.pdf) (PDF) from the original on 23 November 2011.\",\"url\":\"http://www.aafp.org/afp/2006/0701/p86.pdf\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"** Brisbane W, Bailey MR, Sorensen MD (November 2016). [\\\"An overview of kidney stone imaging techniques\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443345). _Nature Reviews. Urology_. **13** (11): 654â€“662\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nrurol.2016.154](https://doi.org/10.1038%2Fnrurol.2016.154). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1759-4812](https://search.worldcat.org/issn/1759-4812). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5443345](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443345). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27578040](https://pubmed.ncbi.nlm.nih.gov/27578040).\",\"description\":\"60. **^** Brisbane W, Bailey MR, Sorensen MD (November 2016). [\\\"An overview of kidney stone imaging techniques\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443345). _Nature Reviews. Urology_. **13** (11): 654â€“662\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nrurol.2016.154](https://doi.org/10.1038%2Fnrurol.2016.154). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1759-4812](https://search.worldcat.org/issn/1759-4812). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5443345](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443345). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27578040](https://pubmed.ncbi.nlm.nih.gov/27578040).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443345\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"_**a**_ _**b**_ _**c**_ Smith RC, Varanelli M (July 2000). \\\"Diagnosis and management of acute ureterolithiasis: CT is truth\\\". _AJR. American Journal of Roentgenology_. **175** (1): 3â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2214/ajr.175.1.1750003](https://doi.org/10.2214%2Fajr.175.1.1750003). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10882237](https://pubmed.ncbi.nlm.nih.gov/10882237). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [73387308](https://api.semanticscholar.org/CorpusID:73387308).\",\"description\":\"61. ^ _**a**_ _**b**_ _**c**_ Smith RC, Varanelli M (July 2000). \\\"Diagnosis and management of acute ureterolithiasis: CT is truth\\\". _AJR. American Journal of Roentgenology_. **175** (1): 3â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2214/ajr.175.1.1750003](https://doi.org/10.2214%2Fajr.175.1.1750003). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10882237](https://pubmed.ncbi.nlm.nih.gov/10882237). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [73387308](https://api.semanticscholar.org/CorpusID:73387308).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"** Bushinsky D, Coe FL, Moe OW (2007). [\\\"Ch. 37: Nephrolithiasis\\\"](https://web.archive.org/web/20111008090923/http://www.expertconsultbook.com/expertconsult/op/book.do?method=display\u0026type=bookPage\u0026decorator=none\u0026eid=4-u1.0-B978-1-4160-3105-5..50039-6\u0026isbn=978-1-4160-3105-5#lpState=open\u0026lpTab=contentsTab\u0026content=4-u1.0-B978-1-4160-3105-5..50039-6%3Bfrom%3Dtoc%3Btype%3DbookPage%3Bisbn%3D978-1-4160-3105-5\u0026search=none). In Brenner BM (ed.). _Brenner and Rector's The Kidney_. Vol. 1 (8th ed.). Philadelphia: WB Saunders. pp. 1299â€“349\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4160-3105-5. Archived from [the original](http://www.expertconsultbook.com/expertconsult/op/book.do?method=display\u0026type=bookPage\u0026decorator=none\u0026eid=4-u1.0-B978-1-4160-3105-5..50039-6\u0026isbn=978-1-4160-3105-5#lpState=open\u0026lpTab=contentsTab\u0026content=4-u1.0-B978-1-4160-3105-5..50039-6%3Bfrom%3Dtoc%3Btype%3DbookPage%3Bisbn%3D978-1-4160-3105-5\u0026search=none) on 8 October 2011.\",\"description\":\"62. **^** Bushinsky D, Coe FL, Moe OW (2007). [\\\"Ch. 37: Nephrolithiasis\\\"](https://web.archive.org/web/20111008090923/http://www.expertconsultbook.com/expertconsult/op/book.do?method=display\u0026type=bookPage\u0026decorator=none\u0026eid=4-u1.0-B978-1-4160-3105-5..50039-6\u0026isbn=978-1-4160-3105-5#lpState=open\u0026lpTab=contentsTab\u0026content=4-u1.0-B978-1-4160-3105-5..50039-6%3Bfrom%3Dtoc%3Btype%3DbookPage%3Bisbn%3D978-1-4160-3105-5\u0026search=none). In Brenner BM (ed.). _Brenner and Rector's The Kidney_. Vol. 1 (8th ed.). Philadelphia: WB Saunders. pp. 1299â€“349\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4160-3105-5. Archived from [the original](http://www.expertconsultbook.com/expertconsult/op/book.do?method=display\u0026type=bookPage\u0026decorator=none\u0026eid=4-u1.0-B978-1-4160-3105-5..50039-6\u0026isbn=978-1-4160-3105-5#lpState=open\u0026lpTab=contentsTab\u0026content=4-u1.0-B978-1-4160-3105-5..50039-6%3Bfrom%3Dtoc%3Btype%3DbookPage%3Bisbn%3D978-1-4160-3105-5\u0026search=none) on 8 October 2011.\",\"url\":\"https://web.archive.org/web/20111008090923/http://www.expertconsultbook.com/expertconsult/op/book.do?method=display\u0026type=bookPage\u0026decorator=none\u0026eid=4-u1.0-B978-1-4160-3105-5..50039-6\u0026isbn=978-1-4160-3105-5#lpState=open\u0026lpTab=contentsTab\u0026content=4-u1.0-B978-1-4160-3105-5..50039-6%3Bfrom%3Dtoc%3Btype%3DbookPage%3Bisbn%3D978-1-4160-3105-5\u0026search=none\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"** Smith RC, Levine J, Rosenfeld AT (September 1999). [\\\"Helical CT of urinary tract stones. Epidemiology, origin, pathophysiology, diagnosis, and management\\\"](https://doi.org/10.1016%2FS0033-8389%2805%2970138-X). _Radiologic Clinics of North America_. **37** (5): 911â€“52, v. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0033-8389(05)70138-X](https://doi.org/10.1016%2FS0033-8389%2805%2970138-X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10494278](https://pubmed.ncbi.nlm.nih.gov/10494278).\",\"description\":\"63. **^** Smith RC, Levine J, Rosenfeld AT (September 1999). [\\\"Helical CT of urinary tract stones. Epidemiology, origin, pathophysiology, diagnosis, and management\\\"](https://doi.org/10.1016%2FS0033-8389%2805%2970138-X). _Radiologic Clinics of North America_. **37** (5): 911â€“52, v. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0033-8389(05)70138-X](https://doi.org/10.1016%2FS0033-8389%2805%2970138-X). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10494278](https://pubmed.ncbi.nlm.nih.gov/10494278).\",\"url\":\"https://doi.org/10.1016%2FS0033-8389%2805%2970138-X\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"** American College of Emergency Physicians (27 October 2014). [\\\"Ten Things Physicians and Patients Should Question\\\"](http://www.choosingwisely.org/doctor-patient-lists/american-college-of-emergency-physicians/). _Choosing Wisely_. [Archived](https://web.archive.org/web/20140307012443/http://www.choosingwisely.org/doctor-patient-lists/american-college-of-emergency-physicians/) from the original on 7 March 2014. Retrieved 14 January 2015.\",\"description\":\"64. **^** American College of Emergency Physicians (27 October 2014). [\\\"Ten Things Physicians and Patients Should Question\\\"](http://www.choosingwisely.org/doctor-patient-lists/american-college-of-emergency-physicians/). _Choosing Wisely_. [Archived](https://web.archive.org/web/20140307012443/http://www.choosingwisely.org/doctor-patient-lists/american-college-of-emergency-physicians/) from the original on 7 March 2014. Retrieved 14 January 2015.\",\"url\":\"http://www.choosingwisely.org/doctor-patient-lists/american-college-of-emergency-physicians/\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"** [\\\"American Urological Association | Choosing Wisely\\\"](https://web.archive.org/web/20170223133729/http://www.choosingwisely.org/societies/american-urological-association/). _www.choosingwisely.org_. Archived from [the original](http://www.choosingwisely.org/societies/american-urological-association/) on 23 February 2017. Retrieved 28 May 2017.\",\"description\":\"65. **^** [\\\"American Urological Association | Choosing Wisely\\\"](https://web.archive.org/web/20170223133729/http://www.choosingwisely.org/societies/american-urological-association/). _www.choosingwisely.org_. Archived from [the original](http://www.choosingwisely.org/societies/american-urological-association/) on 23 February 2017. Retrieved 28 May 2017.\",\"url\":\"https://web.archive.org/web/20170223133729/http://www.choosingwisely.org/societies/american-urological-association/\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"_**a**_ _**b**_ _**c**_ Fang LS (2009). [\\\"Chapter 135: Approach to the Paient with Nephrolithiasis\\\"](https://books.google.com/books?id=bIZvJPcSEXMC\u0026q=nephrolithiasis+%22physical+examination%22\u0026pg=PA964). In Goroll AH, Mulley AG (eds.). _Primary care medicine: office evaluation and management of the adult patient_ (6th ed.). Philadelphia: Lippincott Williams \u0026 Wilkins. pp. 962â€“7\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-7513-7. [Archived](https://web.archive.org/web/20210321183305/https://books.google.com/books?id=bIZvJPcSEXMC\u0026q=nephrolithiasis+%22physical+examination%22\u0026pg=PA964) from the original on 21 March 2021. Retrieved 6 November 2020.\",\"description\":\"66. ^ _**a**_ _**b**_ _**c**_ Fang LS (2009). [\\\"Chapter 135: Approach to the Paient with Nephrolithiasis\\\"](https://books.google.com/books?id=bIZvJPcSEXMC\u0026q=nephrolithiasis+%22physical+examination%22\u0026pg=PA964). In Goroll AH, Mulley AG (eds.). _Primary care medicine: office evaluation and management of the adult patient_ (6th ed.). Philadelphia: Lippincott Williams \u0026 Wilkins. pp. 962â€“7\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-7513-7. [Archived](https://web.archive.org/web/20210321183305/https://books.google.com/books?id=bIZvJPcSEXMC\u0026q=nephrolithiasis+%22physical+examination%22\u0026pg=PA964) from the original on 21 March 2021. Retrieved 6 November 2020.\",\"url\":\"https://books.google.com/books?id=bIZvJPcSEXMC\u0026q=nephrolithiasis+%22physical+examination%22\u0026pg=PA964\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"_**a**_ _**b**_ Semins MJ, Matlaga BR (September 2013). [\\\"Management of urolithiasis in pregnancy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792830). _International Journal of Women's Health_. **5** : 599â€“604\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2147/ijwh.s51416](https://doi.org/10.2147%2Fijwh.s51416). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3792830](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792830). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24109196](https://pubmed.ncbi.nlm.nih.gov/24109196).\",\"description\":\"67. ^ _**a**_ _**b**_ Semins MJ, Matlaga BR (September 2013). [\\\"Management of urolithiasis in pregnancy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792830). _International Journal of Women's Health_. **5** : 599â€“604\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2147/ijwh.s51416](https://doi.org/10.2147%2Fijwh.s51416). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3792830](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792830). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24109196](https://pubmed.ncbi.nlm.nih.gov/24109196).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792830\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"** Smith-Bindman R, Aubin C, Bailitz J, et al. (September 2014). [\\\"Ultrasonography versus computed tomography for suspected nephrolithiasis\\\"](https://escholarship.org/content/qt1cm5f8cd/qt1cm5f8cd.pdf?t=nwl44w) (PDF). _The New England Journal of Medicine_. **371** (12): 1100â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1404446](https://doi.org/10.1056%2FNEJMoa1404446). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25229916](https://pubmed.ncbi.nlm.nih.gov/25229916). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4511678](https://api.semanticscholar.org/CorpusID:4511678). [Archived](https://web.archive.org/web/20200314051953/https://escholarship.org/content/qt1cm5f8cd/qt1cm5f8cd.pdf?t=nwl44w) (PDF) from the original on 14 March 2020. Retrieved 25 September 2019.\",\"description\":\"68. **^** Smith-Bindman R, Aubin C, Bailitz J, et al. (September 2014). [\\\"Ultrasonography versus computed tomography for suspected nephrolithiasis\\\"](https://escholarship.org/content/qt1cm5f8cd/qt1cm5f8cd.pdf?t=nwl44w) (PDF). _The New England Journal of Medicine_. **371** (12): 1100â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1404446](https://doi.org/10.1056%2FNEJMoa1404446). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25229916](https://pubmed.ncbi.nlm.nih.gov/25229916). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4511678](https://api.semanticscholar.org/CorpusID:4511678). [Archived](https://web.archive.org/web/20200314051953/https://escholarship.org/content/qt1cm5f8cd/qt1cm5f8cd.pdf?t=nwl44w) (PDF) from the original on 14 March 2020. Retrieved 25 September 2019.\",\"url\":\"https://escholarship.org/content/qt1cm5f8cd/qt1cm5f8cd.pdf?t=nwl44w\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"** National Kidney and Urologic Diseases Information Clearinghouse (2007). [\\\"Kidney Stones in Adults (NIH Publication No. 08â€“2495)\\\"](https://web.archive.org/web/20110726181803/http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/). _Kidney \u0026 Urologic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/) on 26 July 2011. Retrieved 27 July 2011.\",\"description\":\"69. **^** National Kidney and Urologic Diseases Information Clearinghouse (2007). [\\\"Kidney Stones in Adults (NIH Publication No. 08â€“2495)\\\"](https://web.archive.org/web/20110726181803/http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/). _Kidney \u0026 Urologic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/) on 26 July 2011. Retrieved 27 July 2011.\",\"url\":\"https://web.archive.org/web/20110726181803/http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"_**a**_ _**b**_ Frassetto L, Kohlstadt I (2011). \\\"Treatment and prevention of kidney stones: an update\\\". _Am Fam Physician_. **84** (11): 1234â€“42\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22150656](https://pubmed.ncbi.nlm.nih.gov/22150656).\",\"description\":\"70. ^ _**a**_ _**b**_ Frassetto L, Kohlstadt I (2011). \\\"Treatment and prevention of kidney stones: an update\\\". _Am Fam Physician_. **84** (11): 1234â€“42\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22150656](https://pubmed.ncbi.nlm.nih.gov/22150656).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"** Becker KL (2001). [_Principles and practice of endocrinology and metabolism_](https://books.google.com/books?id=FVfzRvaucq8C\u0026pg=PA684) (3 ed.). Philadelphia, Pa. [u.a.]: Lippincott, Williams \u0026 Wilkins. p. 684\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-1750-2. [Archived](https://web.archive.org/web/20170908221053/https://books.google.com/books?id=FVfzRvaucq8C\u0026pg=PA684) from the original on 8 September 2017.\",\"description\":\"71. **^** Becker KL (2001). [_Principles and practice of endocrinology and metabolism_](https://books.google.com/books?id=FVfzRvaucq8C\u0026pg=PA684) (3 ed.). Philadelphia, Pa. [u.a.]: Lippincott, Williams \u0026 Wilkins. p. 684\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-1750-2. [Archived](https://web.archive.org/web/20170908221053/https://books.google.com/books?id=FVfzRvaucq8C\u0026pg=PA684) from the original on 8 September 2017.\",\"url\":\"https://books.google.com/books?id=FVfzRvaucq8C\u0026pg=PA684\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"** [\\\"Cystine stones\\\"](http://www.uptodate.com/contents/cystine-stones). _[UpToDate](UpToDate \\\"UpToDate\\\")_. [Archived](https://web.archive.org/web/20140226110022/http://www.uptodate.com/contents/cystine-stones) from the original on 26 February 2014. Retrieved 20 February 2014.\",\"description\":\"72. **^** [\\\"Cystine stones\\\"](http://www.uptodate.com/contents/cystine-stones). _[UpToDate](UpToDate \\\"UpToDate\\\")_. [Archived](https://web.archive.org/web/20140226110022/http://www.uptodate.com/contents/cystine-stones) from the original on 26 February 2014. Retrieved 20 February 2014.\",\"url\":\"http://www.uptodate.com/contents/cystine-stones\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"** Bailey \u0026 Love's/25th/1296\",\"description\":\"73. **^** Bailey \u0026 Love's/25th/1296\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"** National Endocrine and Metabolic Diseases Information Service (2008). [\\\"Renal Tubular Acidosis (NIH Publication No. 09â€“4696)\\\"](https://web.archive.org/web/20110728025351/http://kidney.niddk.nih.gov/kudiseases/pubs/tubularacidosis/). _Kidney \u0026 Urologic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/tubularacidosis/) on 28 July 2011. Retrieved 27 July 2011.\",\"description\":\"74. **^** National Endocrine and Metabolic Diseases Information Service (2008). [\\\"Renal Tubular Acidosis (NIH Publication No. 09â€“4696)\\\"](https://web.archive.org/web/20110728025351/http://kidney.niddk.nih.gov/kudiseases/pubs/tubularacidosis/). _Kidney \u0026 Urologic Diseases: A-Z list of Topics and Titles_. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Archived from [the original](http://kidney.niddk.nih.gov/kudiseases/pubs/tubularacidosis/) on 28 July 2011. Retrieved 27 July 2011.\",\"url\":\"https://web.archive.org/web/20110728025351/http://kidney.niddk.nih.gov/kudiseases/pubs/tubularacidosis/\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ De Mais D (2009). _ASCP Quick Compendium of Clinical Pathology_ (2nd ed.). Chicago: ASCP Press.\",\"description\":\"75. ^ _**a**_ _**b**_ _**c**_ _**d**_ De Mais D (2009). _ASCP Quick Compendium of Clinical Pathology_ (2nd ed.). Chicago: ASCP Press.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Weiss M, Liapis H, Tomaszewski JE, et al. (2007). [\\\"Chapter 22: Pyelonephritis and Other Infections, Reflux Nephropathy, Hydronephrosis, and Nephrolithiasis\\\"](https://books.google.com/books?id=oWymx2hp1OoC\u0026q=%22AA+amyloidosis%22+pyelonephritis\u0026pg=PA886). In Jennette JC, Olson JL, Schwartz MM, Silva FG (eds.). _Heptinstall's Pathology of the Kidney_. Vol. 2 (6th ed.). Philadelphia: Lippincott Williams \u0026 Wilkins. pp. 991â€“1082\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-4750-9. [Archived](https://web.archive.org/web/20210320231125/https://books.google.com/books?id=oWymx2hp1OoC\u0026q=%22AA+amyloidosis%22+pyelonephritis\u0026pg=PA886) from the original on 20 March 2021. Retrieved 6 November 2020.\",\"description\":\"76. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Weiss M, Liapis H, Tomaszewski JE, et al. (2007). [\\\"Chapter 22: Pyelonephritis and Other Infections, Reflux Nephropathy, Hydronephrosis, and Nephrolithiasis\\\"](https://books.google.com/books?id=oWymx2hp1OoC\u0026q=%22AA+amyloidosis%22+pyelonephritis\u0026pg=PA886). In Jennette JC, Olson JL, Schwartz MM, Silva FG (eds.). _Heptinstall's Pathology of the Kidney_. Vol. 2 (6th ed.). Philadelphia: Lippincott Williams \u0026 Wilkins. pp. 991â€“1082\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-4750-9. [Archived](https://web.archive.org/web/20210320231125/https://books.google.com/books?id=oWymx2hp1OoC\u0026q=%22AA+amyloidosis%22+pyelonephritis\u0026pg=PA886) from the original on 20 March 2021. Retrieved 6 November 2020.\",\"url\":\"https://books.google.com/books?id=oWymx2hp1OoC\u0026q=%22AA+amyloidosis%22+pyelonephritis\u0026pg=PA886\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"** Halabe A, Sperling O (1994). \\\"Uric acid nephrolithiasis\\\". _Mineral and Electrolyte Metabolism_. **20** (6): 424â€“31\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7783706](https://pubmed.ncbi.nlm.nih.gov/7783706).\",\"description\":\"77. **^** Halabe A, Sperling O (1994). \\\"Uric acid nephrolithiasis\\\". _Mineral and Electrolyte Metabolism_. **20** (6): 424â€“31\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7783706](https://pubmed.ncbi.nlm.nih.gov/7783706).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"** Kamatani N (December 1996). \\\"[Adenine phosphoribosyltransferase(APRT) deficiency]\\\". _Nihon Rinsho. Japanese Journal of Clinical Medicine_ (in Japanese). **54** (12): 3321â€“7\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8976113](https://pubmed.ncbi.nlm.nih.gov/8976113).\",\"description\":\"78. **^** Kamatani N (December 1996). \\\"[Adenine phosphoribosyltransferase(APRT) deficiency]\\\". _Nihon Rinsho. Japanese Journal of Clinical Medicine_ (in Japanese). **54** (12): 3321â€“7\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8976113](https://pubmed.ncbi.nlm.nih.gov/8976113).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"** Rosenberg LE, Durant JL, Elsas LJ (June 1968). \\\"Familial iminoglycinuria. An inborn error of renal tubular transport\\\". _The New England Journal of Medicine_. **278** (26): 1407â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM196806272782601](https://doi.org/10.1056%2FNEJM196806272782601). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5652624](https://pubmed.ncbi.nlm.nih.gov/5652624).\",\"description\":\"79. **^** Rosenberg LE, Durant JL, Elsas LJ (June 1968). \\\"Familial iminoglycinuria. An inborn error of renal tubular transport\\\". _The New England Journal of Medicine_. **278** (26): 1407â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM196806272782601](https://doi.org/10.1056%2FNEJM196806272782601). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5652624](https://pubmed.ncbi.nlm.nih.gov/5652624).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"** CoÅŸkun T, Ozalp I, Tokatli A (1993). \\\"Iminoglycinuria: a benign type of inherited aminoaciduria\\\". _The Turkish Journal of Pediatrics_. **35** (2): 121â€“5\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7504361](https://pubmed.ncbi.nlm.nih.gov/7504361).\",\"description\":\"80. **^** CoÅŸkun T, Ozalp I, Tokatli A (1993). \\\"Iminoglycinuria: a benign type of inherited aminoaciduria\\\". _The Turkish Journal of Pediatrics_. **35** (2): 121â€“5\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7504361](https://pubmed.ncbi.nlm.nih.gov/7504361).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"** [\\\"Patient Information about Crixivan for HIV (Human Immunodeficiency Virus) Infection\\\"](http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_ppi.pdf) (PDF). _CrixivanÂ® (indinavir sulfate) Capsules_. Whitehouse Station, New Jersey: Merck Sharp \u0026 Dohme Corporation. 2010. [Archived](https://web.archive.org/web/20110815003924/http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_ppi.pdf) (PDF) from the original on 15 August 2011. Retrieved 27 July 2011.\",\"description\":\"81. **^** [\\\"Patient Information about Crixivan for HIV (Human Immunodeficiency Virus) Infection\\\"](http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_ppi.pdf) (PDF). _CrixivanÂ® (indinavir sulfate) Capsules_. Whitehouse Station, New Jersey: Merck Sharp \u0026 Dohme Corporation. 2010. [Archived](https://web.archive.org/web/20110815003924/http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_ppi.pdf) (PDF) from the original on 15 August 2011. Retrieved 27 July 2011.\",\"url\":\"http://www.merck.com/product/usa/pi_circulars/c/crixivan/crixivan_ppi.pdf\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"** Schlossberg D, Samuel R (2011). [\\\"Sulfadiazine\\\"](https://books.google.com/books?id=sCXn0xOVKNoC). _Antibiotic Manual: A Guide to Commonly Used Antimicrobials_ (1st ed.). Shelton, Connecticut: People's Medical Publishing House. pp. 411â€“12\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-60795-084-4. [Archived](https://web.archive.org/web/20210320092903/https://books.google.com/books?id=sCXn0xOVKNoC) from the original on 20 March 2021. Retrieved 25 August 2020.\",\"description\":\"82. **^** Schlossberg D, Samuel R (2011). [\\\"Sulfadiazine\\\"](https://books.google.com/books?id=sCXn0xOVKNoC). _Antibiotic Manual: A Guide to Commonly Used Antimicrobials_ (1st ed.). Shelton, Connecticut: People's Medical Publishing House. pp. 411â€“12\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-60795-084-4. [Archived](https://web.archive.org/web/20210320092903/https://books.google.com/books?id=sCXn0xOVKNoC) from the original on 20 March 2021. Retrieved 25 August 2020.\",\"url\":\"https://books.google.com/books?id=sCXn0xOVKNoC\",\"favicon\":\"\"},{\"id\":\"83\",\"title\":\"** Carr MC, Prien EL, Babayan RK (December 1990). \\\"Triamterene nephrolithiasis: renewed attention is warranted\\\". _The Journal of Urology_. **144** (6): 1339â€“40\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(17)39734-3](https://doi.org/10.1016%2FS0022-5347%2817%2939734-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2231920](https://pubmed.ncbi.nlm.nih.gov/2231920).\",\"description\":\"83. **^** Carr MC, Prien EL, Babayan RK (December 1990). \\\"Triamterene nephrolithiasis: renewed attention is warranted\\\". _The Journal of Urology_. **144** (6): 1339â€“40\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(17)39734-3](https://doi.org/10.1016%2FS0022-5347%2817%2939734-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2231920](https://pubmed.ncbi.nlm.nih.gov/2231920).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"84\",\"title\":\"** McNutt WF (1893). [\\\"Section IV: Diseases of the Bladder, Chapter VII: Vesical Calculi (Cysto-lithiasis)\\\"](https://books.google.com/books?id=RP0oAAAAYAAJ\u0026q=cystolithiasis+symptoms\u0026pg=PA185). _Diseases of the Kidneys and Bladder: A Text-Book for Students of Medicine_. Philadelphia: J.B. Lippincott Company. pp. 185â€“6\\\\. [Archived](https://web.archive.org/web/20210414030140/https://books.google.com/books?id=RP0oAAAAYAAJ\u0026q=cystolithiasis+symptoms\u0026pg=PA185) from the original on 14 April 2021. Retrieved 6 November 2020.\",\"description\":\"84. **^** McNutt WF (1893). [\\\"Section IV: Diseases of the Bladder, Chapter VII: Vesical Calculi (Cysto-lithiasis)\\\"](https://books.google.com/books?id=RP0oAAAAYAAJ\u0026q=cystolithiasis+symptoms\u0026pg=PA185). _Diseases of the Kidneys and Bladder: A Text-Book for Students of Medicine_. Philadelphia: J.B. Lippincott Company. pp. 185â€“6\\\\. [Archived](https://web.archive.org/web/20210414030140/https://books.google.com/books?id=RP0oAAAAYAAJ\u0026q=cystolithiasis+symptoms\u0026pg=PA185) from the original on 14 April 2021. Retrieved 6 November 2020.\",\"url\":\"https://books.google.com/books?id=RP0oAAAAYAAJ\u0026q=cystolithiasis+symptoms\u0026pg=PA185\",\"favicon\":\"\"},{\"id\":\"85\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Gettman MT, Segura JW (March 2005). \\\"Management of ureteric stones: issues and controversies\\\". _BJU International_. **95** (Suppl 2): 85â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1464-410X.2005.05206.x](https://doi.org/10.1111%2Fj.1464-410X.2005.05206.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15720341](https://pubmed.ncbi.nlm.nih.gov/15720341). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [36265416](https://api.semanticscholar.org/CorpusID:36265416).\",\"description\":\"85. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Gettman MT, Segura JW (March 2005). \\\"Management of ureteric stones: issues and controversies\\\". _BJU International_. **95** (Suppl 2): 85â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1464-410X.2005.05206.x](https://doi.org/10.1111%2Fj.1464-410X.2005.05206.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15720341](https://pubmed.ncbi.nlm.nih.gov/15720341). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [36265416](https://api.semanticscholar.org/CorpusID:36265416).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"86\",\"title\":\"** Segura JW (February 1997). \\\"Staghorn calculi\\\". _The Urologic Clinics of North America_. **24** (1): 71â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0094-0143(05)70355-4](https://doi.org/10.1016%2FS0094-0143%2805%2970355-4). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9048853](https://pubmed.ncbi.nlm.nih.gov/9048853).\",\"description\":\"86. **^** Segura JW (February 1997). \\\"Staghorn calculi\\\". _The Urologic Clinics of North America_. **24** (1): 71â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0094-0143(05)70355-4](https://doi.org/10.1016%2FS0094-0143%2805%2970355-4). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9048853](https://pubmed.ncbi.nlm.nih.gov/9048853).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"87\",\"title\":\"_**a**_ _**b**_ Fink HA, Wilt TJ, Eidman KE, et al. (April 2013). [\\\"Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline\\\"](https://doi.org/10.7326%2F0003-4819-158-7-201304020-00005). _Annals of Internal Medicine_. **158** (7): 535â€“43\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-158-7-201304020-00005](https://doi.org/10.7326%2F0003-4819-158-7-201304020-00005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23546565](https://pubmed.ncbi.nlm.nih.gov/23546565).\",\"description\":\"87. ^ _**a**_ _**b**_ Fink HA, Wilt TJ, Eidman KE, et al. (April 2013). [\\\"Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline\\\"](https://doi.org/10.7326%2F0003-4819-158-7-201304020-00005). _Annals of Internal Medicine_. **158** (7): 535â€“43\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/0003-4819-158-7-201304020-00005](https://doi.org/10.7326%2F0003-4819-158-7-201304020-00005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23546565](https://pubmed.ncbi.nlm.nih.gov/23546565).\",\"url\":\"https://doi.org/10.7326%2F0003-4819-158-7-201304020-00005\",\"favicon\":\"\"},{\"id\":\"88\",\"title\":\"_**a**_ _**b**_ Qaseem A, Dallas P, Forciea MA, et al. (November 2014). [\\\"Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians\\\"](https://doi.org/10.7326%2Fm13-2908). _Annals of Internal Medicine_. **161** (9): 659â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/m13-2908](https://doi.org/10.7326%2Fm13-2908). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25364887](https://pubmed.ncbi.nlm.nih.gov/25364887).\",\"description\":\"88. ^ _**a**_ _**b**_ Qaseem A, Dallas P, Forciea MA, et al. (November 2014). [\\\"Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians\\\"](https://doi.org/10.7326%2Fm13-2908). _Annals of Internal Medicine_. **161** (9): 659â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7326/m13-2908](https://doi.org/10.7326%2Fm13-2908). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25364887](https://pubmed.ncbi.nlm.nih.gov/25364887).\",\"url\":\"https://doi.org/10.7326%2Fm13-2908\",\"favicon\":\"\"},{\"id\":\"89\",\"title\":\"** Goldfarb DS, Coe FL (November 1999). [\\\"Prevention of recurrent nephrolithiasis\\\"](http://www.aafp.org/afp/991115ap/2269.html). _American Family Physician_. **60** (8): 2269â€“76\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10593318](https://pubmed.ncbi.nlm.nih.gov/10593318). [Archived](https://web.archive.org/web/20050822183805/http://www.aafp.org/afp/991115ap/2269.html) from the original on 22 August 2005.\",\"description\":\"89. **^** Goldfarb DS, Coe FL (November 1999). [\\\"Prevention of recurrent nephrolithiasis\\\"](http://www.aafp.org/afp/991115ap/2269.html). _American Family Physician_. **60** (8): 2269â€“76\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10593318](https://pubmed.ncbi.nlm.nih.gov/10593318). [Archived](https://web.archive.org/web/20050822183805/http://www.aafp.org/afp/991115ap/2269.html) from the original on 22 August 2005.\",\"url\":\"http://www.aafp.org/afp/991115ap/2269.html\",\"favicon\":\"\"},{\"id\":\"90\",\"title\":\"_**a**_ _**b**_ Finkielstein VA, Goldfarb DS (May 2006). [\\\"Strategies for preventing calcium oxalate stones\\\"](http://www.cmaj.ca/cgi/reprint/174/10/1407). _CMAJ_. **174** (10): 1407â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1503/cmaj.051517](https://doi.org/10.1503%2Fcmaj.051517). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1455427](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1455427). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16682705](https://pubmed.ncbi.nlm.nih.gov/16682705). [Archived](https://web.archive.org/web/20081015202450/http://www.cmaj.ca/cgi/reprint/174/10/1407) from the original on 15 October 2008.\",\"description\":\"90. ^ _**a**_ _**b**_ Finkielstein VA, Goldfarb DS (May 2006). [\\\"Strategies for preventing calcium oxalate stones\\\"](http://www.cmaj.ca/cgi/reprint/174/10/1407). _CMAJ_. **174** (10): 1407â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1503/cmaj.051517](https://doi.org/10.1503%2Fcmaj.051517). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1455427](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1455427). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16682705](https://pubmed.ncbi.nlm.nih.gov/16682705). [Archived](https://web.archive.org/web/20081015202450/http://www.cmaj.ca/cgi/reprint/174/10/1407) from the original on 15 October 2008.\",\"url\":\"http://www.cmaj.ca/cgi/reprint/174/10/1407\",\"favicon\":\"\"},{\"id\":\"91\",\"title\":\"_**a**_ _**b**_ Fink HA, Wilt TJ, Eidman KE, et al. (July 2012). \\\"Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies\\\". _Comparative Effectiveness Reviews_ (61). Rockvill, MD: Agency for Healthcare Research and Quality. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22896859](https://pubmed.ncbi.nlm.nih.gov/22896859).\",\"description\":\"91. ^ _**a**_ _**b**_ Fink HA, Wilt TJ, Eidman KE, et al. (July 2012). \\\"Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies\\\". _Comparative Effectiveness Reviews_ (61). Rockvill, MD: Agency for Healthcare Research and Quality. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22896859](https://pubmed.ncbi.nlm.nih.gov/22896859).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"92\",\"title\":\"** Ferraro PM, Taylor EN, Gambaro G, et al. (August 2013). [\\\"Soda and other beverages and the risk of kidney stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731916). _Clinical Journal of the American Society of Nephrology_. **8** (8): 1389â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/CJN.11661112](https://doi.org/10.2215%2FCJN.11661112). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3731916](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731916). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23676355](https://pubmed.ncbi.nlm.nih.gov/23676355).\",\"description\":\"92. **^** Ferraro PM, Taylor EN, Gambaro G, et al. (August 2013). [\\\"Soda and other beverages and the risk of kidney stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731916). _Clinical Journal of the American Society of Nephrology_. **8** (8): 1389â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/CJN.11661112](https://doi.org/10.2215%2FCJN.11661112). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3731916](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731916). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23676355](https://pubmed.ncbi.nlm.nih.gov/23676355).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731916\",\"favicon\":\"\"},{\"id\":\"93\",\"title\":\"** [\\\"What are kidney stones?\\\"](https://web.archive.org/web/20130514122900/http://kidney.org.au/ForPatients/Management/KidneyStones/tabid/838/Default.aspx). _kidney.org_. Archived from [the original](http://www.kidney.org.au/ForPatients/Management/KidneyStones/tabid/838/Default.aspx) on 14 May 2013. Retrieved 19 August 2013.\",\"description\":\"93. **^** [\\\"What are kidney stones?\\\"](https://web.archive.org/web/20130514122900/http://kidney.org.au/ForPatients/Management/KidneyStones/tabid/838/Default.aspx). _kidney.org_. Archived from [the original](http://www.kidney.org.au/ForPatients/Management/KidneyStones/tabid/838/Default.aspx) on 14 May 2013. Retrieved 19 August 2013.\",\"url\":\"https://web.archive.org/web/20130514122900/http://kidney.org.au/ForPatients/Management/KidneyStones/tabid/838/Default.aspx\",\"favicon\":\"\"},{\"id\":\"94\",\"title\":\"** Taylor EN, Curhan GC (September 2006). [\\\"Diet and fluid prescription in stone disease\\\"](https://doi.org/10.1038%2Fsj.ki.5001656). _Kidney International_. **70** (5): 835â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.ki.5001656](https://doi.org/10.1038%2Fsj.ki.5001656). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16837923](https://pubmed.ncbi.nlm.nih.gov/16837923).\",\"description\":\"94. **^** Taylor EN, Curhan GC (September 2006). [\\\"Diet and fluid prescription in stone disease\\\"](https://doi.org/10.1038%2Fsj.ki.5001656). _Kidney International_. **70** (5): 835â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.ki.5001656](https://doi.org/10.1038%2Fsj.ki.5001656). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16837923](https://pubmed.ncbi.nlm.nih.gov/16837923).\",\"url\":\"https://doi.org/10.1038%2Fsj.ki.5001656\",\"favicon\":\"\"},{\"id\":\"95\",\"title\":\"_**a**_ _**b**_ Gul Z, Monga M (December 2014). [\\\"Medical and dietary therapy for kidney stone prevention\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710). _Korean Journal of Urology_. **55** (12): 775â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4111/kju.2014.55.12.775](https://doi.org/10.4111%2Fkju.2014.55.12.775). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4265710](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25512810](https://pubmed.ncbi.nlm.nih.gov/25512810).\",\"description\":\"95. ^ _**a**_ _**b**_ Gul Z, Monga M (December 2014). [\\\"Medical and dietary therapy for kidney stone prevention\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710). _Korean Journal of Urology_. **55** (12): 775â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4111/kju.2014.55.12.775](https://doi.org/10.4111%2Fkju.2014.55.12.775). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4265710](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25512810](https://pubmed.ncbi.nlm.nih.gov/25512810).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265710\",\"favicon\":\"\"},{\"id\":\"96\",\"title\":\"** [\\\"Citric Acid and Kidney Stones\\\"](https://www.uwhealth.org/files/uwhealth/docs/pdf/kidney_citric_acid.pdf) (PDF). _uwhealth.org_. [Archived](https://web.archive.org/web/20100705033118/http://www.uwhealth.org/files/uwhealth/docs/pdf/kidney_citric_acid.pdf) (PDF) from the original on 5 July 2010.\",\"description\":\"96. **^** [\\\"Citric Acid and Kidney Stones\\\"](https://www.uwhealth.org/files/uwhealth/docs/pdf/kidney_citric_acid.pdf) (PDF). _uwhealth.org_. [Archived](https://web.archive.org/web/20100705033118/http://www.uwhealth.org/files/uwhealth/docs/pdf/kidney_citric_acid.pdf) (PDF) from the original on 5 July 2010.\",\"url\":\"https://www.uwhealth.org/files/uwhealth/docs/pdf/kidney_citric_acid.pdf\",\"favicon\":\"\"},{\"id\":\"97\",\"title\":\"** Balawender K, Åuszczki E, Mazur A, et al. (June 2024). [\\\"The Multidisciplinary Approach in the Management of Patients with Kidney Stone Disease-A State-of-the-Art Review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11206918). _Nutrients_. **16** (12): 1932. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/nu16121932](https://doi.org/10.3390%2Fnu16121932). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [11206918](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11206918). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [38931286](https://pubmed.ncbi.nlm.nih.gov/38931286).\",\"description\":\"97. **^** Balawender K, Åuszczki E, Mazur A, et al. (June 2024). [\\\"The Multidisciplinary Approach in the Management of Patients with Kidney Stone Disease-A State-of-the-Art Review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11206918). _Nutrients_. **16** (12): 1932. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/nu16121932](https://doi.org/10.3390%2Fnu16121932). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [11206918](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11206918). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [38931286](https://pubmed.ncbi.nlm.nih.gov/38931286).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11206918\",\"favicon\":\"\"},{\"id\":\"98\",\"title\":\"** Heaney RP (March 2006). [\\\"Nutrition and chronic disease\\\"](https://doi.org/10.4065%2F81.3.297). _Mayo Clinic Proceedings_. **81** (3): 297â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4065/81.3.297](https://doi.org/10.4065%2F81.3.297). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16529131](https://pubmed.ncbi.nlm.nih.gov/16529131).\",\"description\":\"98. **^** Heaney RP (March 2006). [\\\"Nutrition and chronic disease\\\"](https://doi.org/10.4065%2F81.3.297). _Mayo Clinic Proceedings_. **81** (3): 297â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4065/81.3.297](https://doi.org/10.4065%2F81.3.297). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16529131](https://pubmed.ncbi.nlm.nih.gov/16529131).\",\"url\":\"https://doi.org/10.4065%2F81.3.297\",\"favicon\":\"\"},{\"id\":\"99\",\"title\":\"_**a**_ _**b**_ Tiselius HG (May 2003). \\\"Epidemiology and medical management of stone disease\\\". _BJU International_. **91** (8): 758â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1464-410X.2003.04208.x](https://doi.org/10.1046%2Fj.1464-410X.2003.04208.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12709088](https://pubmed.ncbi.nlm.nih.gov/12709088). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28256459](https://api.semanticscholar.org/CorpusID:28256459).\",\"description\":\"99. ^ _**a**_ _**b**_ Tiselius HG (May 2003). \\\"Epidemiology and medical management of stone disease\\\". _BJU International_. **91** (8): 758â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1464-410X.2003.04208.x](https://doi.org/10.1046%2Fj.1464-410X.2003.04208.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12709088](https://pubmed.ncbi.nlm.nih.gov/12709088). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [28256459](https://api.semanticscholar.org/CorpusID:28256459).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"100\",\"title\":\"_**a**_ _**b**_ Taylor EN, Stampfer MJ, Curhan GC (December 2004). [\\\"Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up\\\"](http://jasn.asnjournals.org/content/15/12/3225.full.pdf) (PDF). _Journal of the American Society of Nephrology_. **15** (12): 3225â€“32\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/01.ASN.0000146012.44570.20](https://doi.org/10.1097%2F01.ASN.0000146012.44570.20). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15579526](https://pubmed.ncbi.nlm.nih.gov/15579526). [Archived](https://web.archive.org/web/20170921054542/http://jasn.asnjournals.org/content/15/12/3225.full.pdf) (PDF) from the original on 21 September 2017. Retrieved 3 June 2011.\",\"description\":\"100. ^ _**a**_ _**b**_ Taylor EN, Stampfer MJ, Curhan GC (December 2004). [\\\"Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up\\\"](http://jasn.asnjournals.org/content/15/12/3225.full.pdf) (PDF). _Journal of the American Society of Nephrology_. **15** (12): 3225â€“32\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/01.ASN.0000146012.44570.20](https://doi.org/10.1097%2F01.ASN.0000146012.44570.20). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15579526](https://pubmed.ncbi.nlm.nih.gov/15579526). [Archived](https://web.archive.org/web/20170921054542/http://jasn.asnjournals.org/content/15/12/3225.full.pdf) (PDF) from the original on 21 September 2017. Retrieved 3 June 2011.\",\"url\":\"http://jasn.asnjournals.org/content/15/12/3225.full.pdf\",\"favicon\":\"\"},{\"id\":\"101\",\"title\":\"** Cicerello E, Merlo F, Maccatrozzo L (September 2010). \\\"Urinary alkalization for the treatment of uric acid nephrolithiasis\\\". _Archivio Italiano di Urologia, Andrologia_. **82** (3): 145â€“8\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21121431](https://pubmed.ncbi.nlm.nih.gov/21121431).\",\"description\":\"101. **^** Cicerello E, Merlo F, Maccatrozzo L (September 2010). \\\"Urinary alkalization for the treatment of uric acid nephrolithiasis\\\". _Archivio Italiano di Urologia, Andrologia_. **82** (3): 145â€“8\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21121431](https://pubmed.ncbi.nlm.nih.gov/21121431).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"102\",\"title\":\"** [\\\"Effect of addition of calcium hydroxide to foods rich in oxalic acid on calcium and oxalic acid metabolism | Request PDF\\\"](https://www.researchgate.net/publication/287536542). [Archived](https://web.archive.org/web/20211107061411/https://www.researchgate.net/publication/287536542_Effect_of_addition_of_calcium_hydroxide_to_foods_rich_in_oxalic_acid_on_calcium_and_oxalic_acid_metabolism) from the original on 7 November 2021. Retrieved 6 March 2021.\",\"description\":\"102. **^** [\\\"Effect of addition of calcium hydroxide to foods rich in oxalic acid on calcium and oxalic acid metabolism | Request PDF\\\"](https://www.researchgate.net/publication/287536542). [Archived](https://web.archive.org/web/20211107061411/https://www.researchgate.net/publication/287536542_Effect_of_addition_of_calcium_hydroxide_to_foods_rich_in_oxalic_acid_on_calcium_and_oxalic_acid_metabolism) from the original on 7 November 2021. Retrieved 6 March 2021.\",\"url\":\"https://www.researchgate.net/publication/287536542\",\"favicon\":\"\"},{\"id\":\"103\",\"title\":\"** Cameron JS, Simmonds HA (June 1987). [\\\"Use and abuse of allopurinol\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246665). _British Medical Journal_. **294** (6586): 1504â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.294.6586.1504](https://doi.org/10.1136%2Fbmj.294.6586.1504). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1246665](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246665). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3607420](https://pubmed.ncbi.nlm.nih.gov/3607420).\",\"description\":\"103. **^** Cameron JS, Simmonds HA (June 1987). [\\\"Use and abuse of allopurinol\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246665). _British Medical Journal_. **294** (6586): 1504â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.294.6586.1504](https://doi.org/10.1136%2Fbmj.294.6586.1504). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1246665](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246665). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3607420](https://pubmed.ncbi.nlm.nih.gov/3607420).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1246665\",\"favicon\":\"\"},{\"id\":\"104\",\"title\":\"** Macaluso JN (November 1996). \\\"Management of stone disease--bearing the burden\\\". _The Journal of Urology_. **156** (5): 1579â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(01)65452-1](https://doi.org/10.1016%2FS0022-5347%2801%2965452-1). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8863542](https://pubmed.ncbi.nlm.nih.gov/8863542).\",\"description\":\"104. **^** Macaluso JN (November 1996). \\\"Management of stone disease--bearing the burden\\\". _The Journal of Urology_. **156** (5): 1579â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0022-5347(01)65452-1](https://doi.org/10.1016%2FS0022-5347%2801%2965452-1). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8863542](https://pubmed.ncbi.nlm.nih.gov/8863542).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"105\",\"title\":\"** Pathan SA, Mitra B, Cameron PA (April 2018). \\\"A Systematic Review and Meta-analysis Comparing the Efficacy of Nonsteroidal Anti-inflammatory Drugs, Opioids, and Paracetamol in the Treatment of Acute Renal Colic\\\". _European Urology_. **73** (4): 583â€“595\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.eururo.2017.11.001](https://doi.org/10.1016%2Fj.eururo.2017.11.001). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29174580](https://pubmed.ncbi.nlm.nih.gov/29174580).\",\"description\":\"105. **^** Pathan SA, Mitra B, Cameron PA (April 2018). \\\"A Systematic Review and Meta-analysis Comparing the Efficacy of Nonsteroidal Anti-inflammatory Drugs, Opioids, and Paracetamol in the Treatment of Acute Renal Colic\\\". _European Urology_. **73** (4): 583â€“595\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.eururo.2017.11.001](https://doi.org/10.1016%2Fj.eururo.2017.11.001). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29174580](https://pubmed.ncbi.nlm.nih.gov/29174580).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"106\",\"title\":\"_**a**_ _**b**_ _**c**_ Seitz C, Liatsikos E, Porpiglia F, et al. (September 2009). \\\"Medical therapy to facilitate the passage of stones: what is the evidence?\\\". _European Urology_. **56** (3): 455â€“71\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.eururo.2009.06.012](https://doi.org/10.1016%2Fj.eururo.2009.06.012). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19560860](https://pubmed.ncbi.nlm.nih.gov/19560860).\",\"description\":\"106. ^ _**a**_ _**b**_ _**c**_ Seitz C, Liatsikos E, Porpiglia F, et al. (September 2009). \\\"Medical therapy to facilitate the passage of stones: what is the evidence?\\\". _European Urology_. **56** (3): 455â€“71\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.eururo.2009.06.012](https://doi.org/10.1016%2Fj.eururo.2009.06.012). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19560860](https://pubmed.ncbi.nlm.nih.gov/19560860).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"107\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Campschroer T, Zhu X, Vernooij RW, et al. (April 2018). [\\\"Alpha-blockers as medical expulsive therapy for ureteral stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494465). _The Cochrane Database of Systematic Reviews_. **2018** (4): CD008509. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD008509.pub3](https://doi.org/10.1002%2F14651858.CD008509.pub3). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6494465](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494465). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29620795](https://pubmed.ncbi.nlm.nih.gov/29620795).\",\"description\":\"107. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Campschroer T, Zhu X, Vernooij RW, et al. (April 2018). [\\\"Alpha-blockers as medical expulsive therapy for ureteral stones\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494465). _The Cochrane Database of Systematic Reviews_. **2018** (4): CD008509. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD008509.pub3](https://doi.org/10.1002%2F14651858.CD008509.pub3). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6494465](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494465). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29620795](https://pubmed.ncbi.nlm.nih.gov/29620795).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494465\",\"favicon\":\"\"},{\"id\":\"108\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ Shock Wave Lithotripsy Task Force (2009). [\\\"Current Perspective on Adverse Effects in Shock Wave Lithotripsy\\\"](https://web.archive.org/web/20130718072759/http://www.auanet.org/common/pdf/education/clinical-guidance/Shock-Wave-Therapy-WP.pdf) (PDF). _Clinical Guidelines_. Linthicum, Maryland: [American Urological Association](American_Urological_Association \\\"American Urological Association\\\"). Archived from [the original](https://www.auanet.org/common/pdf/education/clinical-guidance/Shock-Wave-Therapy-WP.pdf) (PDF) on 18 July 2013. Retrieved 13 October 2015.\",\"description\":\"108. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ Shock Wave Lithotripsy Task Force (2009). [\\\"Current Perspective on Adverse Effects in Shock Wave Lithotripsy\\\"](https://web.archive.org/web/20130718072759/http://www.auanet.org/common/pdf/education/clinical-guidance/Shock-Wave-Therapy-WP.pdf) (PDF). _Clinical Guidelines_. Linthicum, Maryland: [American Urological Association](American_Urological_Association \\\"American Urological Association\\\"). Archived from [the original](https://www.auanet.org/common/pdf/education/clinical-guidance/Shock-Wave-Therapy-WP.pdf) (PDF) on 18 July 2013. Retrieved 13 October 2015.\",\"url\":\"https://web.archive.org/web/20130718072759/http://www.auanet.org/common/pdf/education/clinical-guidance/Shock-Wave-Therapy-WP.pdf\",\"favicon\":\"\"},{\"id\":\"109\",\"title\":\"** Lingeman JE, Matlaga BR, Evan AP (2007). \\\"Surgical Management of Urinary Lithiasis\\\". In Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds.). _Campbell-Walsh Urology_. Philadelphia: W. B. Saunders. pp. 1431â€“1507.\",\"description\":\"109. **^** Lingeman JE, Matlaga BR, Evan AP (2007). \\\"Surgical Management of Urinary Lithiasis\\\". In Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds.). _Campbell-Walsh Urology_. Philadelphia: W. B. Saunders. pp. 1431â€“1507.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"110\",\"title\":\"** Preminger GM, Tiselius HG, Assimos DG, et al. (December 2007). \\\"2007 guideline for the management of ureteral calculi\\\". _The Journal of Urology_. **178** (6): 2418â€“34\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.juro.2007.09.107](https://doi.org/10.1016%2Fj.juro.2007.09.107). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17993340](https://pubmed.ncbi.nlm.nih.gov/17993340).\",\"description\":\"110. **^** Preminger GM, Tiselius HG, Assimos DG, et al. (December 2007). \\\"2007 guideline for the management of ureteral calculi\\\". _The Journal of Urology_. **178** (6): 2418â€“34\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.juro.2007.09.107](https://doi.org/10.1016%2Fj.juro.2007.09.107). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17993340](https://pubmed.ncbi.nlm.nih.gov/17993340).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"111\",\"title\":\"_**a**_ _**b**_ Evan AP, McAteer JA (1996). \\\"Ch. 28: Q-effects of Shock Wave Lithotripsy\\\". In Coe FL, Favus MJ, Pak CY, Parks JH, Preminger GM (eds.). [_Kidney Stones: Medical and Surgical Management_](https://archive.org/details/kidneystonesmedi0000unse). Philadelphia: Lippincott-Raven. pp. [549](https://archive.org/details/kidneystonesmedi0000unse/page/549)â€“60. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-0263-8.\",\"description\":\"111. ^ _**a**_ _**b**_ Evan AP, McAteer JA (1996). \\\"Ch. 28: Q-effects of Shock Wave Lithotripsy\\\". In Coe FL, Favus MJ, Pak CY, Parks JH, Preminger GM (eds.). [_Kidney Stones: Medical and Surgical Management_](https://archive.org/details/kidneystonesmedi0000unse). Philadelphia: Lippincott-Raven. pp. [549](https://archive.org/details/kidneystonesmedi0000unse/page/549)â€“60. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-0263-8.\",\"url\":\"https://archive.org/details/kidneystonesmedi0000unse\",\"favicon\":\"\"},{\"id\":\"112\",\"title\":\"_**a**_ _**b**_ _**c**_ Evan AP, Willis LR (2007). \\\"Ch. 41: Extracorporeal Shock Wave Lithotripsy: Complications\\\". In Smith AD, Badlani GH, Bagley DH, Clayman RV, Docimo SG (eds.). _Smith's Textbook on Endourology_. Hamilton, Ontario, Canada: B C Decker, Inc. pp. 353â€“65.\",\"description\":\"112. ^ _**a**_ _**b**_ _**c**_ Evan AP, Willis LR (2007). \\\"Ch. 41: Extracorporeal Shock Wave Lithotripsy: Complications\\\". In Smith AD, Badlani GH, Bagley DH, Clayman RV, Docimo SG (eds.). _Smith's Textbook on Endourology_. Hamilton, Ontario, Canada: B C Decker, Inc. pp. 353â€“65.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"113\",\"title\":\"_**a**_ _**b**_ _**c**_ Oestreich MC, Vernooij RW, Sathianathen NJ, et al. (Cochrane Urology Group) (November 2020). [\\\"Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092672). _The Cochrane Database of Systematic Reviews_. **2020** (11): CD013393. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD013393.pub2](https://doi.org/10.1002%2F14651858.CD013393.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8092672](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092672). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [33179245](https://pubmed.ncbi.nlm.nih.gov/33179245).\",\"description\":\"113. ^ _**a**_ _**b**_ _**c**_ Oestreich MC, Vernooij RW, Sathianathen NJ, et al. (Cochrane Urology Group) (November 2020). [\\\"Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092672). _The Cochrane Database of Systematic Reviews_. **2020** (11): CD013393. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD013393.pub2](https://doi.org/10.1002%2F14651858.CD013393.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8092672](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092672). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [33179245](https://pubmed.ncbi.nlm.nih.gov/33179245).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092672\",\"favicon\":\"\"},{\"id\":\"114\",\"title\":\"** Young JG, Keeley FX, __Ch. 38: \\\"Indications for Surgical Removal, Including Asymptomatic Stones\\\"__inRao, Preminger \u0026 Kavanagh 2011, pp. 441â€“454.\",\"description\":\"114. **^** Young JG, Keeley FX, __Ch. 38: \\\"Indications for Surgical Removal, Including Asymptomatic Stones\\\"__inRao, Preminger \u0026 Kavanagh 2011, pp. 441â€“454.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"115\",\"title\":\"** Wynberg JB, Borin JF, Vicena JZ, et al. (October 2012). \\\"Flexible ureteroscopy-directed retrograde nephrostomy for percutaneous nephrolithotomy: description of a technique\\\". _Journal of Endourology_. **26** (10): 1268â€“74\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1089/end.2012.0160](https://doi.org/10.1089%2Fend.2012.0160). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22563900](https://pubmed.ncbi.nlm.nih.gov/22563900).\",\"description\":\"115. **^** Wynberg JB, Borin JF, Vicena JZ, et al. (October 2012). \\\"Flexible ureteroscopy-directed retrograde nephrostomy for percutaneous nephrolithotomy: description of a technique\\\". _Journal of Endourology_. **26** (10): 1268â€“74\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1089/end.2012.0160](https://doi.org/10.1089%2Fend.2012.0160). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22563900](https://pubmed.ncbi.nlm.nih.gov/22563900).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"116\",\"title\":\"** Lam JS, Gupta M, __Ch. 25: \\\"Ureteral Stents\\\"__. In Stoller \u0026 Meng 2007, pp. 465â€“83.\",\"description\":\"116. **^** Lam JS, Gupta M, __Ch. 25: \\\"Ureteral Stents\\\"__. In Stoller \u0026 Meng 2007, pp. 465â€“83.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"117\",\"title\":\"** Ordonez M, Hwang EC, Borofsky M, et al. (Cochrane Urology Group) (February 2019). [\\\"Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365118). _The Cochrane Database of Systematic Reviews_. **2019** (2): CD012703. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD012703.pub2](https://doi.org/10.1002%2F14651858.CD012703.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6365118](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365118). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30726554](https://pubmed.ncbi.nlm.nih.gov/30726554).\",\"description\":\"117. **^** Ordonez M, Hwang EC, Borofsky M, et al. (Cochrane Urology Group) (February 2019). [\\\"Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365118). _The Cochrane Database of Systematic Reviews_. **2019** (2): CD012703. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD012703.pub2](https://doi.org/10.1002%2F14651858.CD012703.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6365118](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365118). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30726554](https://pubmed.ncbi.nlm.nih.gov/30726554).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365118\",\"favicon\":\"\"},{\"id\":\"118\",\"title\":\"** Marks AJ, Qiu J, Milner TE, et al. (6 January 2011), [__Ch. 26: \\\"Laser Lithotripsy Physics\\\"__](https://books.google.com/books?id=LlJy5XJOkSkC\u0026pg=PA302), Springer,[ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-84800-362-0, [archived](https://web.archive.org/web/20210220110253/https://books.google.com/books?id=LlJy5XJOkSkC\u0026pg=PA302) from the original on 20 February 2021, retrieved 6 November 2020 in Rao, Preminger \u0026 Kavanagh 2011, pp. 301â€“310.\",\"description\":\"118. **^** Marks AJ, Qiu J, Milner TE, et al. (6 January 2011), [__Ch. 26: \\\"Laser Lithotripsy Physics\\\"__](https://books.google.com/books?id=LlJy5XJOkSkC\u0026pg=PA302), Springer,[ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-84800-362-0, [archived](https://web.archive.org/web/20210220110253/https://books.google.com/books?id=LlJy5XJOkSkC\u0026pg=PA302) from the original on 20 February 2021, retrieved 6 November 2020 in Rao, Preminger \u0026 Kavanagh 2011, pp. 301â€“310.\",\"url\":\"https://books.google.com/books?id=LlJy5XJOkSkC\u0026pg=PA302\",\"favicon\":\"\"},{\"id\":\"119\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Romero V, Akpinar H, Assimos DG (2010). [\\\"Kidney stones: a global picture of prevalence, incidence, and associated risk factors\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931286). _Reviews in Urology_. **12** (2â€“3): e86-96. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2931286](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931286). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20811557](https://pubmed.ncbi.nlm.nih.gov/20811557).\",\"description\":\"119. ^ _**a**_ _**b**_ _**c**_ _**d**_ Romero V, Akpinar H, Assimos DG (2010). [\\\"Kidney stones: a global picture of prevalence, incidence, and associated risk factors\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931286). _Reviews in Urology_. **12** (2â€“3): e86-96. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2931286](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931286). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20811557](https://pubmed.ncbi.nlm.nih.gov/20811557).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931286\",\"favicon\":\"\"},{\"id\":\"120\",\"title\":\"** Lieske JC, Segura JW (2004). \\\"Ch. 7: Evaluation and Medical Management of Kidney Stones\\\". In Potts JM (ed.). [_Essential Urology: A Guide to Clinical Practice_](https://archive.org/details/essentialurology0000unse) (1st ed.). Totowa, New Jersey: Humana Press. pp. [117](https://archive.org/details/essentialurology0000unse/page/117)â€“52. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-58829-109-7.\",\"description\":\"120. **^** Lieske JC, Segura JW (2004). \\\"Ch. 7: Evaluation and Medical Management of Kidney Stones\\\". In Potts JM (ed.). [_Essential Urology: A Guide to Clinical Practice_](https://archive.org/details/essentialurology0000unse) (1st ed.). Totowa, New Jersey: Humana Press. pp. [117](https://archive.org/details/essentialurology0000unse/page/117)â€“52. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-58829-109-7.\",\"url\":\"https://archive.org/details/essentialurology0000unse\",\"favicon\":\"\"},{\"id\":\"121\",\"title\":\"** Lozano R, Naghavi M, Foreman K, et al. (December 2012). [\\\"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010\\\"](https://web.archive.org/web/20200519152712/https://zenodo.org/record/2557786). _Lancet_. **380** (9859): 2095â€“128\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(12)61728-0](https://doi.org/10.1016%2FS0140-6736%2812%2961728-0). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[10536/DRO/DU:30050819](https://hdl.handle.net/10536%2FDRO%2FDU%3A30050819). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [10790329](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10790329). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23245604](https://pubmed.ncbi.nlm.nih.gov/23245604). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1541253](https://api.semanticscholar.org/CorpusID:1541253). Archived from [the original](https://zenodo.org/record/2557786) on 19 May 2020.\",\"description\":\"121. **^** Lozano R, Naghavi M, Foreman K, et al. (December 2012). [\\\"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010\\\"](https://web.archive.org/web/20200519152712/https://zenodo.org/record/2557786). _Lancet_. **380** (9859): 2095â€“128\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0140-6736(12)61728-0](https://doi.org/10.1016%2FS0140-6736%2812%2961728-0). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[10536/DRO/DU:30050819](https://hdl.handle.net/10536%2FDRO%2FDU%3A30050819). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [10790329](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10790329). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23245604](https://pubmed.ncbi.nlm.nih.gov/23245604). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1541253](https://api.semanticscholar.org/CorpusID:1541253). Archived from [the original](https://zenodo.org/record/2557786) on 19 May 2020.\",\"url\":\"https://web.archive.org/web/20200519152712/https://zenodo.org/record/2557786\",\"favicon\":\"\"},{\"id\":\"122\",\"title\":\"** Windus D (2008). [_The Washington manual nephrology subspecialty consult_](https://books.google.com/books?id=sPgGqotdzqAC\u0026pg=PA235) (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams \u0026 Wilkins Health. p. 235\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-9149-6. [Archived](https://web.archive.org/web/20160909114412/https://books.google.com/books?id=sPgGqotdzqAC\u0026pg=PA235) from the original on 9 September 2016.\",\"description\":\"122. **^** Windus D (2008). [_The Washington manual nephrology subspecialty consult_](https://books.google.com/books?id=sPgGqotdzqAC\u0026pg=PA235) (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams \u0026 Wilkins Health. p. 235\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-7817-9149-6. [Archived](https://web.archive.org/web/20160909114412/https://books.google.com/books?id=sPgGqotdzqAC\u0026pg=PA235) from the original on 9 September 2016.\",\"url\":\"https://books.google.com/books?id=sPgGqotdzqAC\u0026pg=PA235\",\"favicon\":\"\"},{\"id\":\"123\",\"title\":\"** Glanvill J (December 2010). _Saducismus triumphatus, or, Full and plain evidence concerning witches and apparitions  : in two parts, the first treating of their possibility, the second of their real existence_. BiblioBazaar. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-171-33286-2. [OCLC](OCLC_\\\\(identifier\\\\) \\\"OCLC \\\\(identifier\\\\)\\\") [943229347](https://search.worldcat.org/oclc/943229347).\",\"description\":\"123. **^** Glanvill J (December 2010). _Saducismus triumphatus, or, Full and plain evidence concerning witches and apparitions  : in two parts, the first treating of their possibility, the second of their real existence_. BiblioBazaar. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-171-33286-2. [OCLC](OCLC_\\\\(identifier\\\\) \\\"OCLC \\\\(identifier\\\\)\\\") [943229347](https://search.worldcat.org/oclc/943229347).\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"124\",\"title\":\"** [Celsus AC](Aulus_Cornelius_Celsus \\\"Aulus Cornelius Celsus\\\") (1831). [\\\"Book VII, Chapter XXVI: Of the operation necessary in a suppression of urine, and lithotomy\\\"](https://books.google.com/books?id=p2kFAAAAQAAJ\u0026pg=PA311). In Collier GF (ed.). _A translation of the eight books of Aul. Corn. Celsus on medicine_ (2nd ed.). London: Simpkin and Marshall. pp. 306â€“14\\\\. [Archived](https://web.archive.org/web/20140708104311/http://books.google.com/books?id=p2kFAAAAQAAJ\u0026pg=PA311) from the original on 8 July 2014.\",\"description\":\"124. **^** [Celsus AC](Aulus_Cornelius_Celsus \\\"Aulus Cornelius Celsus\\\") (1831). [\\\"Book VII, Chapter XXVI: Of the operation necessary in a suppression of urine, and lithotomy\\\"](https://books.google.com/books?id=p2kFAAAAQAAJ\u0026pg=PA311). In Collier GF (ed.). _A translation of the eight books of Aul. Corn. Celsus on medicine_ (2nd ed.). London: Simpkin and Marshall. pp. 306â€“14\\\\. [Archived](https://web.archive.org/web/20140708104311/http://books.google.com/books?id=p2kFAAAAQAAJ\u0026pg=PA311) from the original on 8 July 2014.\",\"url\":\"Aulus_Cornelius_Celsus \\\"Aulus Cornelius Celsus\\\"\",\"favicon\":\"\"},{\"id\":\"125\",\"title\":\"_**a**_ _**b**_ Shah J, Whitfield HN (May 2002). \\\"Urolithiasis through the ages\\\". _BJU International_. **89** (8): 801â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1464-410X.2002.02769.x](https://doi.org/10.1046%2Fj.1464-410X.2002.02769.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11972501](https://pubmed.ncbi.nlm.nih.gov/11972501). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [44311421](https://api.semanticscholar.org/CorpusID:44311421).\",\"description\":\"125. ^ _**a**_ _**b**_ Shah J, Whitfield HN (May 2002). \\\"Urolithiasis through the ages\\\". _BJU International_. **89** (8): 801â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1464-410X.2002.02769.x](https://doi.org/10.1046%2Fj.1464-410X.2002.02769.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11972501](https://pubmed.ncbi.nlm.nih.gov/11972501). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [44311421](https://api.semanticscholar.org/CorpusID:44311421).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"126\",\"title\":\"_**a**_ _**b**_ Ellis H (1969). _A History of Bladder Stone_. Oxford, England: Blackwell Scientific Publications. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-632-06140-2.\",\"description\":\"126. ^ _**a**_ _**b**_ Ellis H (1969). _A History of Bladder Stone_. Oxford, England: Blackwell Scientific Publications. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-632-06140-2.\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"127\",\"title\":\"** [Bigelow HJ](Henry_Jacob_Bigelow \\\"Henry Jacob Bigelow\\\") (1878). [_Litholapaxy or rapid lithotrity with evacuation_](https://books.google.com/books?id=UUkSAAAAYAAJ). Boston: A. Williams and Company. p. 29\\\\. [Archived](https://web.archive.org/web/20210414060039/https://books.google.com/books?id=UUkSAAAAYAAJ) from the original on 14 April 2021. Retrieved 25 August 2020.\",\"description\":\"127. **^** [Bigelow HJ](Henry_Jacob_Bigelow \\\"Henry Jacob Bigelow\\\") (1878). [_Litholapaxy or rapid lithotrity with evacuation_](https://books.google.com/books?id=UUkSAAAAYAAJ). Boston: A. Williams and Company. p. 29\\\\. [Archived](https://web.archive.org/web/20210414060039/https://books.google.com/books?id=UUkSAAAAYAAJ) from the original on 14 April 2021. Retrieved 25 August 2020.\",\"url\":\"Henry_Jacob_Bigelow \\\"Henry Jacob Bigelow\\\"\",\"favicon\":\"\"},{\"id\":\"128\",\"title\":\"** Dwyer ME, Krambeck AE, Bergstralh EJ, et al. (July 2012). [\\\"Temporal trends in incidence of kidney stones among children: a 25-year population based study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482509). _The Journal of Urology_. **188** (1): 247â€“52\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.juro.2012.03.021](https://doi.org/10.1016%2Fj.juro.2012.03.021). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3482509](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482509). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22595060](https://pubmed.ncbi.nlm.nih.gov/22595060).\",\"description\":\"128. **^** Dwyer ME, Krambeck AE, Bergstralh EJ, et al. (July 2012). [\\\"Temporal trends in incidence of kidney stones among children: a 25-year population based study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482509). _The Journal of Urology_. **188** (1): 247â€“52\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.juro.2012.03.021](https://doi.org/10.1016%2Fj.juro.2012.03.021). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3482509](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482509). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22595060](https://pubmed.ncbi.nlm.nih.gov/22595060).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482509\",\"favicon\":\"\"},{\"id\":\"129\",\"title\":\"** [\\\"Diet and Definition of Kidney Stones, Renal Calculi\\\"](https://web.archive.org/web/20071117030318/http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/Diet_diseases/diet_for_renal.asp). Archived from [the original](http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/Diet_diseases/diet_for_renal.asp) on 17 November 2007. Retrieved 11 October 2013.\",\"description\":\"129. **^** [\\\"Diet and Definition of Kidney Stones, Renal Calculi\\\"](https://web.archive.org/web/20071117030318/http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/Diet_diseases/diet_for_renal.asp). Archived from [the original](http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/Diet_diseases/diet_for_renal.asp) on 17 November 2007. Retrieved 11 October 2013.\",\"url\":\"https://web.archive.org/web/20071117030318/http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/Diet_diseases/diet_for_renal.asp\",\"favicon\":\"\"},{\"id\":\"130\",\"title\":\"** Kirejczyk JK, Porowski T, Filonowicz R, et al. (February 2014). [\\\"An association between kidney stone composition and urinary metabolic disturbances in children\\\"](https://doi.org/10.1016%2Fj.jpurol.2013.07.010). _Journal of Pediatric Urology_. **10** (1): 130â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jpurol.2013.07.010](https://doi.org/10.1016%2Fj.jpurol.2013.07.010). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23953243](https://pubmed.ncbi.nlm.nih.gov/23953243).\",\"description\":\"130. **^** Kirejczyk JK, Porowski T, Filonowicz R, et al. (February 2014). [\\\"An association between kidney stone composition and urinary metabolic disturbances in children\\\"](https://doi.org/10.1016%2Fj.jpurol.2013.07.010). _Journal of Pediatric Urology_. **10** (1): 130â€“5\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jpurol.2013.07.010](https://doi.org/10.1016%2Fj.jpurol.2013.07.010). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23953243](https://pubmed.ncbi.nlm.nih.gov/23953243).\",\"url\":\"https://doi.org/10.1016%2Fj.jpurol.2013.07.010\",\"favicon\":\"\"},{\"id\":\"131\",\"title\":\"_**a**_ _**b**_ _**c**_ Barreto L, Jung JH, Abdelrahim A, et al. (Cochrane Urology Group) (June 2018). [\\\"Medical and surgical interventions for the treatment of urinary stones in children\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513049). _The Cochrane Database of Systematic Reviews_. **6** (6): CD010784. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD010784.pub2](https://doi.org/10.1002%2F14651858.CD010784.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6513049](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513049). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29859007](https://pubmed.ncbi.nlm.nih.gov/29859007).\",\"description\":\"131. ^ _**a**_ _**b**_ _**c**_ Barreto L, Jung JH, Abdelrahim A, et al. (Cochrane Urology Group) (June 2018). [\\\"Medical and surgical interventions for the treatment of urinary stones in children\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513049). _The Cochrane Database of Systematic Reviews_. **6** (6): CD010784. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD010784.pub2](https://doi.org/10.1002%2F14651858.CD010784.pub2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6513049](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513049). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29859007](https://pubmed.ncbi.nlm.nih.gov/29859007).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513049\",\"favicon\":\"\"},{\"id\":\"132\",\"title\":\"** Aune D, Mahamat-Saleh Y, Norat T, et al. (November 2018). [\\\"Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208979). _European Journal of Epidemiology_. **33** (11): 1033â€“1047\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10654-018-0426-4](https://doi.org/10.1007%2Fs10654-018-0426-4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6208979](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208979). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30066054](https://pubmed.ncbi.nlm.nih.gov/30066054).\",\"description\":\"132. **^** Aune D, Mahamat-Saleh Y, Norat T, et al. (November 2018). [\\\"Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208979). _European Journal of Epidemiology_. **33** (11): 1033â€“1047\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10654-018-0426-4](https://doi.org/10.1007%2Fs10654-018-0426-4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6208979](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208979). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30066054](https://pubmed.ncbi.nlm.nih.gov/30066054).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208979\",\"favicon\":\"\"},{\"id\":\"133\",\"title\":\"** Trinchieri A, Croppi E, Montanari E (June 2017). \\\"Obesity and urolithiasis: evidence of regional influences\\\". _Urolithiasis_. **45** (3): 271â€“278\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00240-016-0908-3](https://doi.org/10.1007%2Fs00240-016-0908-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27488444](https://pubmed.ncbi.nlm.nih.gov/27488444). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4585476](https://api.semanticscholar.org/CorpusID:4585476).\",\"description\":\"133. **^** Trinchieri A, Croppi E, Montanari E (June 2017). \\\"Obesity and urolithiasis: evidence of regional influences\\\". _Urolithiasis_. **45** (3): 271â€“278\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00240-016-0908-3](https://doi.org/10.1007%2Fs00240-016-0908-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27488444](https://pubmed.ncbi.nlm.nih.gov/27488444). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4585476](https://api.semanticscholar.org/CorpusID:4585476).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"134\",\"title\":\"** Zisman AL (October 2017). [\\\"Effectiveness of Treatment Modalities on Kidney Stone Recurrence\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628726). _Clinical Journal of the American Society of Nephrology_. **12** (10): 1699â€“1708\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/cjn.11201016](https://doi.org/10.2215%2Fcjn.11201016). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5628726](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628726). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28830863](https://pubmed.ncbi.nlm.nih.gov/28830863).\",\"description\":\"134. **^** Zisman AL (October 2017). [\\\"Effectiveness of Treatment Modalities on Kidney Stone Recurrence\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628726). _Clinical Journal of the American Society of Nephrology_. **12** (10): 1699â€“1708\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2215/cjn.11201016](https://doi.org/10.2215%2Fcjn.11201016). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5628726](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628726). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28830863](https://pubmed.ncbi.nlm.nih.gov/28830863).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628726\",\"favicon\":\"\"},{\"id\":\"135\",\"title\":\"** Stanford J, Charlton K, Stefoska-Needham A, et al. (5 June 2020). [\\\"The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275316). _BMC Nephrology_. **21** (1): 215. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/s12882-020-01805-w](https://doi.org/10.1186%2Fs12882-020-01805-w). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1471-2369](https://search.worldcat.org/issn/1471-2369). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7275316](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275316). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32503496](https://pubmed.ncbi.nlm.nih.gov/32503496).\",\"description\":\"135. **^** Stanford J, Charlton K, Stefoska-Needham A, et al. (5 June 2020). [\\\"The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275316). _BMC Nephrology_. **21** (1): 215. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/s12882-020-01805-w](https://doi.org/10.1186%2Fs12882-020-01805-w). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1471-2369](https://search.worldcat.org/issn/1471-2369). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7275316](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275316). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32503496](https://pubmed.ncbi.nlm.nih.gov/32503496).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275316\",\"favicon\":\"\"},{\"id\":\"136\",\"title\":\"** Duncan SH, Richardson AJ, Kaul P, et al. (1 August 2002). [\\\"Oxalobacter formigenes and Its Potential Role in Human Health\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124017). _Applied and Environmental Microbiology_. **68** (8): 3841â€“3847\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2002ApEnM..68.3841D](https://ui.adsabs.harvard.edu/abs/2002ApEnM..68.3841D). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/AEM.68.8.3841-3847.2002](https://doi.org/10.1128%2FAEM.68.8.3841-3847.2002). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0099-2240](https://search.worldcat.org/issn/0099-2240). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [124017](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12147479](https://pubmed.ncbi.nlm.nih.gov/12147479).\",\"description\":\"136. **^** Duncan SH, Richardson AJ, Kaul P, et al. (1 August 2002). [\\\"Oxalobacter formigenes and Its Potential Role in Human Health\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124017). _Applied and Environmental Microbiology_. **68** (8): 3841â€“3847\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2002ApEnM..68.3841D](https://ui.adsabs.harvard.edu/abs/2002ApEnM..68.3841D). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/AEM.68.8.3841-3847.2002](https://doi.org/10.1128%2FAEM.68.8.3841-3847.2002). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0099-2240](https://search.worldcat.org/issn/0099-2240). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [124017](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12147479](https://pubmed.ncbi.nlm.nih.gov/12147479).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124017\",\"favicon\":\"\"},{\"id\":\"137\",\"title\":\"** Ticinesi A, Milani C, Guerra A, et al. (28 April 2018). [\\\"Understanding the gutâ€“kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers\\\"](https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2017-315734). _Gut_. **67** (12): 2097â€“2106\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gutjnl-2017-315734](https://doi.org/10.1136%2Fgutjnl-2017-315734). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0017-5749](https://search.worldcat.org/issn/0017-5749). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29705728](https://pubmed.ncbi.nlm.nih.gov/29705728). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [14055215](https://api.semanticscholar.org/CorpusID:14055215).\",\"description\":\"137. **^** Ticinesi A, Milani C, Guerra A, et al. (28 April 2018). [\\\"Understanding the gutâ€“kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers\\\"](https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2017-315734). _Gut_. **67** (12): 2097â€“2106\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gutjnl-2017-315734](https://doi.org/10.1136%2Fgutjnl-2017-315734). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0017-5749](https://search.worldcat.org/issn/0017-5749). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29705728](https://pubmed.ncbi.nlm.nih.gov/29705728). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [14055215](https://api.semanticscholar.org/CorpusID:14055215).\",\"url\":\"https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2017-315734\",\"favicon\":\"\"},{\"id\":\"138\",\"title\":\"** Ramirez J, Guarner F, Bustos Fernandez L, et al. (24 November 2020). [\\\"Antibiotics as Major Disruptors of Gut Microbiota\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732679). _Frontiers in Cellular and Infection Microbiology_. **10** : 572912. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3389/fcimb.2020.572912](https://doi.org/10.3389%2Ffcimb.2020.572912). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2235-2988](https://search.worldcat.org/issn/2235-2988). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7732679](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732679). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [33330122](https://pubmed.ncbi.nlm.nih.gov/33330122).\",\"description\":\"138. **^** Ramirez J, Guarner F, Bustos Fernandez L, et al. (24 November 2020). [\\\"Antibiotics as Major Disruptors of Gut Microbiota\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732679). _Frontiers in Cellular and Infection Microbiology_. **10** : 572912. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3389/fcimb.2020.572912](https://doi.org/10.3389%2Ffcimb.2020.572912). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2235-2988](https://search.worldcat.org/issn/2235-2988). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7732679](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732679). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [33330122](https://pubmed.ncbi.nlm.nih.gov/33330122).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732679\",\"favicon\":\"\"},{\"id\":\"139\",\"title\":\"** Tasian GE, Jemielita T, Goldfarb DS, et al. (1 June 2018). [\\\"Oral Antibiotic Exposure and Kidney Stone Disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054354). _Journal of the American Society of Nephrology_. **29** (6): 1731â€“1740\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2017111213](https://doi.org/10.1681%2FASN.2017111213). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1046-6673](https://search.worldcat.org/issn/1046-6673). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6054354](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054354). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29748329](https://pubmed.ncbi.nlm.nih.gov/29748329).\",\"description\":\"139. **^** Tasian GE, Jemielita T, Goldfarb DS, et al. (1 June 2018). [\\\"Oral Antibiotic Exposure and Kidney Stone Disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054354). _Journal of the American Society of Nephrology_. **29** (6): 1731â€“1740\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1681/ASN.2017111213](https://doi.org/10.1681%2FASN.2017111213). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1046-6673](https://search.worldcat.org/issn/1046-6673). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6054354](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054354). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29748329](https://pubmed.ncbi.nlm.nih.gov/29748329).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054354\",\"favicon\":\"\"},{\"id\":\"140\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Pugh DG, Baird N (27 May 2012). [_Sheep \u0026 Goat Medicine - E-Book_](https://books.google.com/books?id=s-Z311q6CIcC). Elsevier Health Sciences. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4377-2354-0. [Archived](https://web.archive.org/web/20210414055355/https://books.google.com/books?id=s-Z311q6CIcC) from the original on 14 April 2021. Retrieved 17 June 2018.\",\"description\":\"140. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Pugh DG, Baird N (27 May 2012). [_Sheep \u0026 Goat Medicine - E-Book_](https://books.google.com/books?id=s-Z311q6CIcC). Elsevier Health Sciences. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4377-2354-0. [Archived](https://web.archive.org/web/20210414055355/https://books.google.com/books?id=s-Z311q6CIcC) from the original on 14 April 2021. Retrieved 17 June 2018.\",\"url\":\"https://books.google.com/books?id=s-Z311q6CIcC\",\"favicon\":\"\"},{\"id\":\"141\",\"title\":\"** Bushman DH, Emerick RJ, Embry LB (December 1965). \\\"Experimentally induced ovine phosphatic urolithiasis: relationships involving dietary calcium, phosphorus and magnesium\\\". _The Journal of Nutrition_. **87** (4): 499â€“504\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/jn/87.4.499](https://doi.org/10.1093%2Fjn%2F87.4.499). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5841867](https://pubmed.ncbi.nlm.nih.gov/5841867).\",\"description\":\"141. **^** Bushman DH, Emerick RJ, Embry LB (December 1965). \\\"Experimentally induced ovine phosphatic urolithiasis: relationships involving dietary calcium, phosphorus and magnesium\\\". _The Journal of Nutrition_. **87** (4): 499â€“504\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/jn/87.4.499](https://doi.org/10.1093%2Fjn%2F87.4.499). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5841867](https://pubmed.ncbi.nlm.nih.gov/5841867).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"142\",\"title\":\"** Stewart SR, Emerick RJ, Pritchard RH (May 1991). [\\\"Effects of dietary ammonium chloride and variations in calcium to phosphorus ratio on silica urolithiasis in sheep\\\"](https://web.archive.org/web/20190302075532/http://pdfs.semanticscholar.org/b1f1/b2a896e57ed8350fe826cffcb23496d2be2c.pdf) (PDF). _Journal of Animal Science_. **69** (5): 2225â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2527/1991.6952225x](https://doi.org/10.2527%2F1991.6952225x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [1648554](https://pubmed.ncbi.nlm.nih.gov/1648554). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [10130833](https://api.semanticscholar.org/CorpusID:10130833). Archived from [the original](http://pdfs.semanticscholar.org/b1f1/b2a896e57ed8350fe826cffcb23496d2be2c.pdf) (PDF) on 2 March 2019.\",\"description\":\"142. **^** Stewart SR, Emerick RJ, Pritchard RH (May 1991). [\\\"Effects of dietary ammonium chloride and variations in calcium to phosphorus ratio on silica urolithiasis in sheep\\\"](https://web.archive.org/web/20190302075532/http://pdfs.semanticscholar.org/b1f1/b2a896e57ed8350fe826cffcb23496d2be2c.pdf) (PDF). _Journal of Animal Science_. **69** (5): 2225â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2527/1991.6952225x](https://doi.org/10.2527%2F1991.6952225x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [1648554](https://pubmed.ncbi.nlm.nih.gov/1648554). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [10130833](https://api.semanticscholar.org/CorpusID:10130833). Archived from [the original](http://pdfs.semanticscholar.org/b1f1/b2a896e57ed8350fe826cffcb23496d2be2c.pdf) (PDF) on 2 March 2019.\",\"url\":\"https://web.archive.org/web/20190302075532/http://pdfs.semanticscholar.org/b1f1/b2a896e57ed8350fe826cffcb23496d2be2c.pdf\",\"favicon\":\"\"},{\"id\":\"143\",\"title\":\"** Forman SA, Whiting F, Connell R (May 1959). [\\\"Silica Urolithiasis In Beef Cattle : 3. Chemical and Physical Composition of the Uroliths\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581990). _Canadian Journal of Comparative Medicine and Veterinary Science_. **23** (5): 157â€“62\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1581990](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581990). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17649146](https://pubmed.ncbi.nlm.nih.gov/17649146).\",\"description\":\"143. **^** Forman SA, Whiting F, Connell R (May 1959). [\\\"Silica Urolithiasis In Beef Cattle : 3. Chemical and Physical Composition of the Uroliths\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581990). _Canadian Journal of Comparative Medicine and Veterinary Science_. **23** (5): 157â€“62\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1581990](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581990). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17649146](https://pubmed.ncbi.nlm.nih.gov/17649146).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1581990\",\"favicon\":\"\"},{\"id\":\"144\",\"title\":\"** Scott D, Buchan W (May 1988). [\\\"The effects of feeding pelleted diets made from either coarsely or finely ground hay on phosphorus balance and on the partition of phosphorus excretion between urine and faeces in the sheep\\\"](https://doi.org/10.1113%2Fexpphysiol.1988.sp003148). _Quarterly Journal of Experimental Physiology_. **73** (3): 315â€“22\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1113/expphysiol.1988.sp003148](https://doi.org/10.1113%2Fexpphysiol.1988.sp003148). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3399614](https://pubmed.ncbi.nlm.nih.gov/3399614).\",\"description\":\"144. **^** Scott D, Buchan W (May 1988). [\\\"The effects of feeding pelleted diets made from either coarsely or finely ground hay on phosphorus balance and on the partition of phosphorus excretion between urine and faeces in the sheep\\\"](https://doi.org/10.1113%2Fexpphysiol.1988.sp003148). _Quarterly Journal of Experimental Physiology_. **73** (3): 315â€“22\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1113/expphysiol.1988.sp003148](https://doi.org/10.1113%2Fexpphysiol.1988.sp003148). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [3399614](https://pubmed.ncbi.nlm.nih.gov/3399614).\",\"url\":\"https://doi.org/10.1113%2Fexpphysiol.1988.sp003148\",\"favicon\":\"\"},{\"id\":\"145\",\"title\":\"** Bravo D, Sauvant D, Bogaert C, et al. (2003). [\\\"III. Quantitative aspects of phosphorus excretion in ruminants\\\"](https://hal.archives-ouvertes.fr/hal-00900449/file/hal-00900449.pdf) (PDF). _Reproduction, Nutrition, Development_. **43** (3): 285â€“300\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1051/rnd:2003021](https://doi.org/10.1051%2Frnd%3A2003021). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14620634](https://pubmed.ncbi.nlm.nih.gov/14620634). [Archived](https://web.archive.org/web/20210416000942/https://hal.archives-ouvertes.fr/hal-00900449/file/hal-00900449.pdf) (PDF) from the original on 16 April 2021. Retrieved 29 August 2019.\",\"description\":\"145. **^** Bravo D, Sauvant D, Bogaert C, et al. (2003). [\\\"III. Quantitative aspects of phosphorus excretion in ruminants\\\"](https://hal.archives-ouvertes.fr/hal-00900449/file/hal-00900449.pdf) (PDF). _Reproduction, Nutrition, Development_. **43** (3): 285â€“300\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1051/rnd:2003021](https://doi.org/10.1051%2Frnd%3A2003021). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [14620634](https://pubmed.ncbi.nlm.nih.gov/14620634). [Archived](https://web.archive.org/web/20210416000942/https://hal.archives-ouvertes.fr/hal-00900449/file/hal-00900449.pdf) (PDF) from the original on 16 April 2021. Retrieved 29 August 2019.\",\"url\":\"https://hal.archives-ouvertes.fr/hal-00900449/file/hal-00900449.pdf\",\"favicon\":\"\"},{\"id\":\"146\",\"title\":\"** Waltner-Toews, D. and D. H. Meadows. 1980. Case report: Urolithiasis in a herd of beef cattle associated with oxalate ingestion. Can. Vet. J. 21: 61-62\",\"description\":\"146. **^** Waltner-Toews, D. and D. H. Meadows. 1980. Case report: Urolithiasis in a herd of beef cattle associated with oxalate ingestion. Can. Vet. J. 21: 61-62\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"147\",\"title\":\"** James LF, Butcher JE (December 1972). \\\"Halogeton poisoning of sheep: effect of high level oxalate intake\\\". _Journal of Animal Science_. **35** (6): 1233â€“1238\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2527/jas1972.3561233x](https://doi.org/10.2527%2Fjas1972.3561233x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [4647453](https://pubmed.ncbi.nlm.nih.gov/4647453).\",\"description\":\"147. **^** James LF, Butcher JE (December 1972). \\\"Halogeton poisoning of sheep: effect of high level oxalate intake\\\". _Journal of Animal Science_. **35** (6): 1233â€“1238\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2527/jas1972.3561233x](https://doi.org/10.2527%2Fjas1972.3561233x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [4647453](https://pubmed.ncbi.nlm.nih.gov/4647453).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"148\",\"title\":\"_**a**_ _**b**_ Kahn CM, ed. (2005). _Merck veterinary manual_ (9th ed.). Whitehouse Station: Merck \u0026 Co., Inc.\",\"description\":\"148. ^ _**a**_ _**b**_ Kahn CM, ed. (2005). _Merck veterinary manual_ (9th ed.). Whitehouse Station: Merck \u0026 Co., Inc.\",\"url\":\"\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"In 2015, 22.1 million cases occurred,[5] resulting in about 16,100 deaths.[6]\",\"explanation\":\"These figures are from GBD 2015 and are outdated. More recent GBD 2019 data indicates approximately 115 million incident cases and 13,279 deaths globally, reflecting changes in methodology and actual burden. Using 2015 data misrepresents the current global burden as of 2025.\",\"fixedText\":\"Update to: \\\"In 2019, approximately 115 million incident cases occurred, resulting in about 13,300 deaths.\\\" Retain original citations if keeping historical context, but add new for 2019 data.\",\"evidenceSource\":\"[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Frequency| 22.1 million (2015)[5]\",\"explanation\":\"The cited figure from GBD 2015 represents incident cases, not overall frequency (which could imply prevalence). GBD 2019 provides updated incident cases of 115 million, better aligning with current estimates. Mismatch leads to underestimation of burden.\",\"fixedText\":\"Revise infobox to: Frequency| 115 million incident cases (2019). Clarify as incident cases to match GBD terminology.\",\"evidenceSource\":\"[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Deaths| 16,100 (2015)[6]\",\"explanation\":\"Outdated mortality figure from GBD 2015. GBD 2019 reports 13,279 deaths, providing a more accurate current estimate.\",\"fixedText\":\"Update infobox to: Deaths| 13,300 (2019)\",\"evidenceSource\":\"[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9391934/)\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific mention of type 2 diabetes as a risk factor.\",\"explanation\":\"Recent reviews (2024) identify type 2 diabetes as a potential risk factor for nephrolithiasis, likely due to insulin resistance affecting urinary citrate and pH. This gap leaves the section incomplete on metabolic risks, consistent with broader article coverage in intro (obesity, gout) but not explicitly here.\",\"fixedText\":\"Add: Type 2 diabetes is associated with increased risk due to altered urinary chemistry.\",\"evidenceSource\":\"[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11392093/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"Kidney stones are primarily composed of calcium salts, with the most common being calcium oxalate (70-80%), followed by calcium phosphate and uric acid.[41]\\\"\",\"explanation\":\"The citation [41] (Phillips 2015 Cochrane review) states that 60% to 80% of kidney stones are composed of calcium salts (oxalate, phosphate, or both), but does not specify that calcium oxalate alone accounts for 70-80%. This mismatches the exact claim made.\",\"fixedText\":\"Adjust the percentage to reflect the source (60-80% for calcium salts) or cite a source that supports the specific calcium oxalate percentage, such as NIDDK [2].\",\"evidenceSource\":\"[41] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578669/\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"\\\"Small crystals formed in the kidney. The most common crystals are made of calcium oxalate and they are generally 4â€“5 mm.\\\"\",\"explanation\":\"Individual crystals (nuclei) in urine are microscopic (much smaller than 1 mm), not 4-5 mm. The 4-5 mm size refers to small kidney stones formed by aggregation of crystals, not the crystals themselves. This misrepresents the pathophysiology of stone formation.\",\"fixedText\":\"Revise to: \\\"Small crystals... The most common type of small stones are made of calcium oxalate and they are generally 4â€“5 mm.\\\" Or clarify \\\"initial crystal aggregates\\\".\",\"evidenceSource\":\"Standard pathophysiology: Crystals nucleate at ~0.1-1 Î¼m; stones grow to mm sizes. See Coe 2005 [53].\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"\\\"[Struvite](Struvite \\\"Struvite\\\") | 03%  | infections in the kidney and when urine is alkaline (high pH)\\\" (in Composition table)\",\"explanation\":\"The relative incidence of struvite stones is listed as \\\"03%\\\" in the table, which appears to be a typographical or formatting error, but contradicts the subsection text stating 10â€“15% and established medical literature indicating approximately 10%. This quantitative discrepancy misrepresents prevalence, potentially affecting clinical understanding of infection-related stones.\",\"fixedText\":\"Correct the table entry for struvite relative incidence to \\\"10%\\\" to align with the subsection and reliable sources.\",\"evidenceSource\":\"[web:10] (PMC article: \\\"Stones composed of uric acid, struvite and cystine are also common and account for approximately 9%, 10% and 1% of stones, respectively\\\")\"},{\"criticality\":\"Critical\",\"issueType\":\"Internal Contradiction\",\"problematicText\":\"Table lists struvite at \\\"03%\\\", but subsection \\\"About 10â€“15% of urinary calculi are composed of [struvite]\\\"\",\"explanation\":\"The table and subsection provide conflicting prevalence figures for struvite stones (3% vs. 10â€“15%), creating inconsistency within the section that could confuse readers on the frequency of this stone type.\",\"fixedText\":\"Update table to \\\"10â€“15%\\\" for struvite to resolve contradiction, matching subsection.\",\"evidenceSource\":\"Existing ref [76] supports 10â€“15%; align table to this.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Calcium hydroxide decreases urinary calcium when combined with food rich in oxalic acid such as green leafy vegetables.[102]\",\"explanation\":\"The cited source (a 2004 study) likely addresses the effect on oxalic acid metabolism rather than decreasing urinary calcium. Calcium from sources like hydroxide binds oxalate in the gut to reduce oxalate absorption and urinary oxalate excretion, but it does not decrease urinary calcium excretion; dietary calcium intake typically maintains or slightly increases urinary calcium while providing net benefit for stone prevention by reducing oxalate availability.\",\"fixedText\":\"Revise to: \\\"Calcium hydroxide can bind oxalic acid in foods rich in oxalate, such as green leafy vegetables, potentially reducing urinary oxalate levels and stone risk.\\\" If the source does not clearly support this, remove the subsection as it is not a standard recommendation in major guidelines.\",\"evidenceSource\":\"National Kidney Foundation guidelines on calcium oxalate stones[](https://www.kidney.org/kidney-topics/calcium-kidney-stones)\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"limiting cola, including sugar-sweetened soft drinks;[87][91][92] to less than one liter per week.[93]\",\"explanation\":\"The specific quantitative limit of \\\"less than one liter per week\\\" is arbitrary and not supported by evidence-based guidelines or studies, which instead recommend moderation or limiting to one serving per day or less to reduce risk, as daily consumption increases stone risk by about 23%.\",\"fixedText\":\"Revise to: \\\"limiting consumption of cola and sugar-sweetened soft drinks,\\\" and cite an authoritative source such as the 2013 study.\",\"evidenceSource\":\"Ferraro PM et al. (2013) \\\"Soda and Other Beverages and the Risk of Kidney Stones\\\"[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3731916/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific mention of updated guidelines or recent evidence on protein intake limits.\",\"explanation\":\"The claim limits animal protein to \\\"no more than two meals daily,\\\" which is vague and not aligned with quantitative recommendations in current guidelines (e.g., 0.8-1 g/kg body weight per day or \u0026lt;80-100 g/day total protein). This gap could mislead on precise dietary advice for prevention.\",\"fixedText\":\"Add clarification: \\\"limiting animal protein intake to about 0.8-1 g per kg of body weight per day (e.g., no more than 50-70 g for most adults),\\\" citing NIDDK or similar.\",\"evidenceSource\":\"NIDDK Eating, Diet, \u0026amp; Nutrition for Kidney Stones[](https://www.niddk.nih.gov/health-information/urologic-diseases/kidney-stones/eating-diet-nutrition)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"The tables citing [119] (2010 review) with data up to 1994 for prevalence and 2005 for incidence.\",\"explanation\":\"Data is over 20-30 years old; recent studies (e.g., NHANES 2017-2020) show US prevalence at 9.9%, not 5.2%; global trends show absolute incidence increasing despite age-standardized rates decreasing.\",\"fixedText\":\"Update tables with recent data or remove if not essential; cite new sources.\",\"evidenceSource\":\"[](https://journals.lww.com/juop/fulltext/2024/11000/kidney_stone_prevalence_among_us_population_.3.aspx); [](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext)\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"The number of deaths due to kidney stones is estimated at 19,000 per year being fairly consistent between 1990 and 2010.[121]\",\"explanation\":\"GBD 2021 estimates 2,859 deaths in 2021; intro cites 16,100 in 2015 from older GBD; discrepancy due to updated methodology, but claim outdated and inconsistent.\",\"fixedText\":\"Update to recent GBD estimate of approximately 2,900 deaths in 2021, noting low mortality.\",\"evidenceSource\":\"[6]; [](https://mednexus.org/doi/10.1097/CM9.0000000000003622)\"},{\"criticality\":\"Critical\",\"issueType\":\"Internal Contradiction\",\"problematicText\":\"United States | 116 (2000) | decreasing\",\"explanation\":\"Table claims decreasing trend, but recent data shows stable or increasing prevalence (8.9% to 9.9% 2007-2020), especially in women; contradicts text on increasing frequency.\",\"fixedText\":\"Correct trend to stable/increasing; update incidence to recent ~180/100,000 annually.\",\"evidenceSource\":\"[21]; [](https://www.renalandurologynews.com/reports/kidney-stone-prevalence-increasing-among-women-in-united-states/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"The total cost for treating urolithiasis was US$2 billion in 2003.[59]\",\"explanation\":\"Outdated; recent estimates project over $2.1 billion by 2030, with Medicare alone \u003e$1 billion annually; inflation and increased cases make original figure inaccurate for current context.\",\"fixedText\":\"Update to recent estimate, e.g., exceeding $2 billion annually as of 2020s.\",\"evidenceSource\":\"[](https://onlinelibrary.wiley.com/doi/full/10.1002/uro2.94)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"A 2010 review concluded that rates of disease are increasing.[119]\",\"explanation\":\"Recent GBD 2021 shows age-standardized incidence decreased 17.5% 1990-2021, though absolute cases increased to 106 million in 2021 due to population growth; nuanced trend not captured.\",\"fixedText\":\"Update to reflect recent trends: absolute burden increasing, age-standardized rates stable or declining in some regions.\",\"evidenceSource\":\"[](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No recent global burden data.\",\"explanation\":\"Lacks updated statistics on global prevalence (lifetime risk 8-15% in developed countries), incidence (106 million new cases in 2021), and regional variations; essential for comprehensive epidemiology section.\",\"fixedText\":\"Add recent GBD data: 106 million incident cases in 2021, higher prevalence in men (twice women), increasing in women and low-SDI countries.\",\"evidenceSource\":\"[13]; [](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00503-0/fulltext)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Examples of people who had kidney stone disease include Napoleon I, Epicurus, Napoleon III, Peter the Great, Louis XIV, George IV, Oliver Cromwell, Lyndon B. Johnson, Benjamin Franklin, Michel de Montaigne, Francis Bacon, Isaac Newton, Samuel Pepys, William Harvey, Herman Boerhaave, Roger Moore, and Antonio Scarpa.[126]\",\"explanation\":\"The cited source [126] is \\\"A History of Bladder Stone\\\" by Harold Ellis (1969), which specifically discusses the history of bladder stones, not kidney stones. Many of the listed individuals are documented in historical accounts as having suffered from bladder stones or urinary tract issues that may not be specifically kidney stones, leading to a mismatch between the claim (kidney stone disease) and the source.\",\"fixedText\":\"Remove the inline list and its citation, as it duplicates the \\\"See also: List of kidney stone formers\\\" and relies on an inappropriate source. Retain the see also link for verified kidney stone cases.\",\"evidenceSource\":\"Web search confirming book focus on bladder stones; e.g., Ellis H. (1969) A History of Bladder Stone. Blackwell, Oxford.\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"In 1901, a stone discovered in the pelvis of an ancient Egyptian mummy was dated to 4,800 BC.\",\"explanation\":\"This refers to a bladder stone found in the pelvic region, not a kidney stone. The article focuses on kidney stone disease (nephrolithiasis), so presenting a bladder stone (part of broader urolithiasis) without distinction misstates the scope, potentially misleading readers on the history specific to kidney stones.\",\"fixedText\":\"Rephrase to specify it as a urinary (bladder) stone and add a citation to an authoritative source.\",\"evidenceSource\":\"Web search: e.g., \\\"The first known stones were discovered in Egyptian mummies. In 1901, the English Archeologist E. Smith found a bladder stone from a 4500-5000 year old mummy.\\\"\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"New techniques in lithotomy began to emerge starting in 1520, but the operation remained risky. After Henry Jacob Bigelow popularized the technique of litholapaxy in 1878,[127] the mortality rate dropped from about 24% to 2.4%. However, other treatment techniques continued to produce a high level of mortality, especially among inexperienced urologists.[125][126]\",\"explanation\":\"Lithotomy and litholapaxy historically refer primarily to procedures for bladder stones, not kidney stones. The mortality figures and techniques described are for bladder stone surgery, misapplying them to the history of kidney stone disease without clarification. Citation [126] again mismatches as it covers bladder stones.\",\"fixedText\":\"Remove or rephrase bladder-specific surgical history to focus on kidney stone treatments, retaining the ESWL part which is kidney-relevant. Remove mismatched citations.\",\"evidenceSource\":\"Web search confirming litholapaxy as a bladder stone crushing technique; book [126] is bladder-specific.\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"\",\"explanation\":\"The section lacks mention of early surgical descriptions for kidney stones, such as Sushruta's techniques in ancient India around 600 BC, which is noted in the article introduction but expands the historical context here.\",\"fixedText\":\"Add a sentence on ancient Indian surgical history for completeness, citing [1].\",\"evidenceSource\":\"[1] Schulsinger DA (2014). Kidney Stone Disease: Say NO to Stones! Springer. p. 27.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"These stones are in the kidney in two thirds of reported cases, and in the ureter in the remaining cases.[129]\",\"explanation\":\"The cited source [129] links to a now-defunct page (404 error), making it unverifiable and unreliable. Recent studies (e.g., 2025 Turkish study) show ~76% in renal pelvis/kidney, ~10% in ureter, not 2/3 and 1/3, indicating mismatch and potential inaccuracy in proportions.\",\"fixedText\":\"Remove citation [129]. Revise claim to reflect recent data: approximately 75-80% in the kidney/renal pelvis, 10-40% in the ureter depending on study, with variations.\",\"evidenceSource\":\"[web:6] Pediatric Urinary Stone Disease: A 10-Year Single-Center ... (2025)\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"These stones are in the kidney in two thirds of reported cases, and in the ureter in the remaining cases.[129]\",\"explanation\":\"The 2/3 (67%) kidney and remaining (33%) ureter overstates ureteral involvement. A 2025 study reports 75.8% renal pelvis, 10.1% ureter; a 2012 study ~46% kidney-only vs. 40% ureter-only (adjusted). This discrepancy alters understanding of typical presentation.\",\"fixedText\":\"Update to: Stones are most commonly located in the kidney (approximately 70-80% of cases), with 10-40% in the ureter, based on recent epidemiological data.\",\"evidenceSource\":\"[web:6]; [web:7] Temporal Trends in Incidence of Kidney Stones Among Children (2012)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; overall section lacks recent context on rising incidence causes.\",\"explanation\":\"Section notes increasing incidence but cites 2012 data [128]. Recent evidence (up to 2024) links rise to obesity, high-sodium diets, and low fluid intake in children, a key knowledge gap for completeness and relevance as of 2025.\",\"fixedText\":\"Add: The increase is attributed to factors such as rising childhood obesity, increased consumption of sugary beverages, and dietary changes, with annual increases of 4-10% reported in recent decades.[](https://consultqd.clevelandclinic.org/why-more-children-are-getting-kidney-stones-and-the-best-way-to-manage-them)\",\"evidenceSource\":\"[web:5] Individualized care for pediatric kidney stones - Mayo Clinic (2024); [web:8] Why More Children Are Getting Kidney Stones (2018, trend continuing)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Dietary, fluid intake, and lifestyle factors remain major topics for research on prevention of kidney stones, as of 2017.[134]\",\"explanation\":\"The specified date (2017) is outdated given the current date (October 2025); multiple studies from 2020-2025 continue to investigate these factors, including associations with biological aging, physical activity, and dietary patterns, potentially misleading on the ongoing nature of research.\",\"fixedText\":\"Remove \\\"as of 2017\\\" and update citation to a more recent source, or add recent references to reflect continued research up to 2025.\",\"evidenceSource\":\"[](/pmc/articles/PMC11975591/) [2025 study on healthy dietary patterns and kidney stones]; [](https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1612347/full) [2025 study on vigorous physical activity]\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[Entire first paragraph]\",\"explanation\":\"The paragraph discusses ongoing research on metabolic syndrome, obesity, and diabetes but lacks updates on recent findings (2020-2025) confirming genetic correlations, prevalence trends in obese populations, and roles of physical activity and cardiometabolic indices, which provide stronger evidence for these risk factors.\",\"fixedText\":\"Add summary of recent evidence: e.g., \\\"Recent studies (as of 2025) confirm positive genetic associations between kidney stones, obesity, type 2 diabetes, and hypertension, with higher prevalence in metabolically unhealthy obese individuals.\\\" Cite new sources.\",\"evidenceSource\":\"[](/pmc/articles/PMC12230011/) [2025 study on metabolic health, weight status, and kidney stone prevalence]; [](https://www.mayoclinicproceedings.org/article/S0025-6196%2825%2900243-5/abstract) [2025 genetic associations study]\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[Gut microbiota subsection]\",\"explanation\":\"The subsection covers gut microbiota and O. formigenes up to 2020 but omits key 2020-2025 developments, including probiotics for oxalate degradation, engineered bacteria for treatment, clinical trials on O. formigenes colonization (with mixed efficacy), and dysbiosis in urinary/gut microbiota linked to stone formation, representing significant knowledge gaps in current research.\",\"fixedText\":\"Expand subsection with: Recent research (2020-2025) explores probiotics and engineered bacteria (e.g., modified Phocaeicola) to degrade oxalate and prevent stones; clinical trials show O. formigenes colonization reduces urinary oxalate but has mixed results in primary hyperoxaluria. Cite new sources.\",\"evidenceSource\":\"[](/pmc/articles/PMC12528112/) [2025 review on probiotics including O. formigenes]; [](https://www.news-medical.net/news/20250718/Microbial-therapy-uses-modified-bacteria-to-target-oxalate-in-the-gut.aspx) [2025 on engineered gut bacteria]; [](https://clinicaltrials.gov/study/NCT06330246) [Ongoing 2024-2025 trial on O. formigenes]\"}],\"slug\":\"Kidney_stone_disease\",\"title\":\"Kidney stone disease\",\"content\":\"$21\",\"description\":\"Kidney stone disease\\n\\n| Attribute | Details |\\n|---------------|-------------|\\n| Other names | Urolithiasis, kidney stone, renal calculus, nephrolithiasis, kidney stone disease,[1] |\\n| Specialty |...\",\"metadata\":{\"categories\":[\"Kidney stones\",\"Nephrolithiasis\",\"Renal calculi\",\"Urolithiasis\"],\"lastModified\":\"1761553399\",\"contentLength\":\"73644\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"274652\",\"recentViews\":\"274652\",\"dailyAvgViews\":9155.06640625,\"qualityScore\":1,\"lastViewed\":\"1761886993\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761886994203,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Kidney_stone_disease\"],\"queryHash\":\"[\\\"page\\\",\\\"Kidney_stone_disease\\\"]\"}]},\"children\":\"$L22\"}]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Kidney stone disease\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Kidney stone disease (known as nephrolithiasis , renal calculus disease or urolithiasis) is a crystallopathy and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper urinary tract.[2] Because renal calculi typically form in the kidney, if small enough, they are able to leave the urinary tract via the urine stream.[2] A small calculus may pass...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"Kidney stones, Nephrolithiasis, Renal calculi, Urolithiasis\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Kidney_stone_disease\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Kidney stone disease\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Kidney stone disease (known as nephrolithiasis , renal calculus disease or urolithiasis) is a crystallopathy and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper urinary tract.[2] Because renal calculi typically form in the kidney, if small enough, they are able to leave the urinary tract via the urine stream.[2] A small calculus may pass...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Kidney_stone_disease\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Kidney stone disease\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.399Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Kidney stone disease\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Kidney stone disease (known as nephrolithiasis , renal calculus disease or urolithiasis) is a crystallopathy and occurs when there are too many minerals in the urine and not enough liquid or hydration. This imbalance causes tiny pieces of crystal to aggregate and form hard masses, or calculi (stones) in the upper urinary tract.[2] Because renal calculi typically form in the kidney, if small enough, they are able to leave the urinary tract via the urine stream.[2] A small calculus may pass...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L23\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"24:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"25:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MDQxNThhMjUtMzhmYS00YTMwLThkMjQtN2MyNzlhY2ZlMjAw">self.__next_f.push([1,"22:[\"$\",\"$L24\",null,{\"children\":[\"$\",\"$L25\",null,{\"slug\":\"Kidney_stone_disease\"}]}]\n"])</script></body></html>